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1 Deutsche  Zusammenfassung 
Die Ausbildung biologischer Membranen und die daraus resultierende Abgrenzung von spe-
ziellen Reaktionskompartimenten stellen einen entscheidenden Schritt in der Evolution des 
Lebens dar. Dabei sind Membranen allerdings keine unpassierbaren Mauern, sondern hochse-
lektiv permeable Diffusionsbarrieren. Dies wird durch das Vorhandensein von spezifischen 
molekularen Kanälen und Pumpen bewerkstelligt. Der Transport von Molekülen über Memb-
ranen stellt einen vektoriellen Prozess dar, der den Stoffaustausch und die Kommunikation 
der einzelnen Kompartimente untereinander sowie mit der Umgebung ermöglicht. 
Eine Gruppe von Membranpumpen stellt die Familie der „ATP binding cassette“ (ABC) 
Transporter dar, eine der größten Familien paraloger Proteine, die die aktive Beförderung 
unterschiedlichster Substanzen über biologische Membranen ausführt. Vertreter dieser Super-
familie finden sich in allen bekannten Organismen von Bakterien bis hin zu Säugern und 
nehmen an einer Vielzahl von zellulären Prozessen teil. Sie sind an der Nährstoffaufnahme, 
dem Lipidtransport, an der Ionen- und Osmolyt-Homöostase sowie an der Antigenprozessie-
rung beteiligt. Unter Verbrauch von ATP transportieren sie gegen einen Konzentrationsgra-
dienten eine Fülle von chemischen Stoffen, wie z. B. Kohlenhydrate, Peptide, Proteine, Ste-
roide, Antibiotika, Metallionen sowie ein breites Spektrum an hydrophoben Substanzen. Ne-
ben der Transportaktivität können diese Proteine eine Funktion als Ionenkanäle, Regulatoren 
von Kanälen oder Rezeptoren haben. 
Einige Vertreter weisen eine hohe klinische Relevanz auf. Beispielsweise ist die Mutation des 
ABC Transporters CFTR die molekulare Grundlage für die Entstehung der cystischen Fibro-
se. Andere Vertreter dieser Proteinfamilie sind an dem Phänomen der Resistenzentwicklung 
verschiedener Gewebe während chemotherapeutischer Behandlungen beteiligt. Ihre Überex-
pression stellt ein ernstzunehmendes Problem bei der Behandlung von Tumoren und AIDS 
dar. Demzufolge ist die Aufklärung der Struktur und Funktionsweise dieser Molekülklasse 
von zentraler Bedeutung. 
Die Architektur von ABC Transportern ist trotz der Diversität der zu transportierenden Sub-
strate sehr ähnlich. Typischerweise besteht ein ABC Transporter aus vier Domänen: zwei 
Transmembrandomänen (TMD) und zwei Nukleotidbindungsdomänen (NBD). Definiert wird 
die Proteinfamilie durch die Homologie innerhalb der NBDs, welche die konservierten Se-
quenzabschnitte Walker A und B sowie die für ABC Proteine spezifische C-Schleife beinhal-
ten. Die NBDs gelten als die Motordomänen von ABC Transportern, die ATP hydrolysieren 
und dadurch die für den Transport benötigte Energie zur Verfügung stellen. 
Die Anordnung der Domänen ist variabel. Bei Prokaryonten werden vornehmlich alle vier 
Domänen einzeln translatiert. Hier kommt häufig ein periplasmatisches Bindungsprotein mit 
hoher Substrataffinität vor, das mit dem jeweiligen Transporter assoziiert ist. Eukaryontische 
ABC Transporter existieren als „Volltransporter“ bestehend aus einer Polypeptidkette mit je Chapter 1  Deutsche Zusammenfassung 
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zwei TMDs und zwei NBDs oder auch als „Halbtransporter“ wie beispielsweise der ABC 
Transporter Mdl1p (multidrug resistance like protein 1) mit jeweils einer TMD und einer 
NBD pro Genprodukt. 
Der Transportmechanismus, die Energetisierung sowie das strukturelle Zusammenspiel der 
verschiedenen Domänen innerhalb dieser Membranproteinkomplexe sind bisher größten-
teils unverstanden. Auch die (physiologisch relevanten) Substrate vieler ABC Proteine sind 
zumeist nicht identifiziert. In dieser Arbeit wird der ABC Transportkomplex Mdl1p der inne-
ren Mitochondrienmembran von Saccharomyces cerevisiae als Modellsystem funktionell und 
strukturell charakterisiert. Dabei soll die Tatsache nicht unerwähnt bleiben, dass die Bäcker-
hefe aufgrund leichter genetischer Manipulierbarkeit und schneller Produktion von Biomasse 
einen idealen Modellorganismus darstellt. 
Mdl1p spielt eine wichtige Rolle bei der Mitochondrienbiogenese, da es für den Export von 
Degradationsprodukten, wie z.B. falsch assemblierter Untereinheiten der Atmungskette, 
verantwortlich ist. Die innere Mitochondrienmembran ist neben der inneren Chloroplasten-
membran die einzige zelluläre Membran, die nicht direkt mit dem Cytosol in Kontakt tritt und 
folglich nicht der Qualitätskontrolle durch das Ubiquitin/Proteasomsystem unterliegt. Daher 
verfügen Mitochondrien über eine autonome, ATP abhängige Qualitätskontrolle, die durch 
einen proteolytischen Multienzymkomplex vermittelt wird. Die AAA Proteasen (ATPase as-
sociated with a variety of cellular activities) sind für den Abbau von falsch gefalteten Protei-
nen der inneren Mitochondrienmembran verantwortlich. Mdl1p exportiert vermutlich die da-
bei entstandenen Peptide aus der Matrix in den Intermembranraum des Mitochondriums. 
Aufgrund seines modulartigen Aufbaus kann der ABC Transporter Mdl1p in seine N-
terminale TMD und C-terminale NBD unterteilt werden. Die lösliche NBD (Aminosäuren 
D423 bis R695) wurde in Escherichia coli überexprimiert und über eine Affinitätsschleife zur 
Homogenität gereinigt. Die Aktivität des Proteins bezüglich ATP Bindung und Hydrolyse 
bleibt dabei erhalten. 
Interessanterweise ist die ATP Hydrolyse nicht linear von der Proteinkonzentration abhängig 
wie bei Arbeiten in der Arbeitsgruppe gezeigt wurde. Diese Beobachtung lässt auf einen nicht 
monomeren Zwischenzustand im ATPase Zyklus schließen. Tatsächlich kann in dieser Arbeit 
mittels der ATPase Inhibitoren ortho-Vanadat (Vi) und Berylliumfluorid (BeFx) ein wild-typ-
NBD-Dimer in Gelfiltrationsläufen beobachtet werden. Das Gleichgewicht zwischen Mono-
mer und Dimer ist dabei strikt abhängig von der eingesetzten Inhibitorkonzentration. Ortho-
Vanadat und BeFx stellen Analoga des anorganischen Phosphates dar. Sie arretieren einen 
Enzymzustand während der ATP Hydrolyse, in dem das ADP Molekül in der Bindungstasche 
verbleibt, während das Phosphat bereits dissoziert ist. Eine Stöchiometriebestimmung mit 
radioaktiv markiertem ATP ergab, dass das Dimer mit zwei Nukleotiden beladen ist und beide 
hydrolysiert sind. Chapter 1  Deutsche Zusammenfassung 
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Die Mutation des Glutamats 599 (E599) stromabwärts des Walker B Motivs zu einem Gluta-
min (Q) führt zu einer NBD mit stark verringerter ATPase-Aktivität. Dieses Glutamat ist in-
nerhalb der Familie der ABC Transporter hoch konserviert und seine Funktion während des 
Hydrolyseprozesses wird in der Literatur kontrovers diskutiert. In allen beschriebenen Fällen 
gilt diese Mutante jedoch als hydrolyse- bzw. transportdefizient. Die Mdl1p-NBD-Mutante 
bildet in Gegenwart von ATP ein stabiles Dimer. Stöchiometrieuntersuchungen an dem 
E599Q-NBD-Dimer zeigen, dass zwei Nukleotide inkorporiert sind. Nach einer Inkubation 
unter „Nicht-Hydrolysebedingungen“ (4 °C, ohne Mg
2+) bleiben zwei ATP Moleküle im Di-
mer erhalten. Wird die NBD jedoch bei 30 °C in Gegenwart von Mg
2+ inkubiert, kann ein 
Dimer isoliert werden, in dem ein ATP und ein ADP detektierbar ist. Auch nach einer Inkuba-
tion über mehrere Stunden, kann kein Dimer mit zwei ADP Molekülen erhalten werden. 
Dieses Ergebnis zeigt, dass zumindest ein ATP-Molekül zur Erhaltung des Dimers erforder-
lich ist. Hydrolyse beider Nukleotide führt zur Dissoziation des Komplexes. Basierend auf 
diesen Ergebnissen kann ein Modell für die ATP Hydrolyse erstellt werden, in dem die Bin-
dung der Nukleotide an die monomeren Untereinheiten eine Assoziation der NBDs induziert. 
Zwei ATP-Moleküle werden sequentiell hydrolysiert, bevor das Dimer mit gebundenen ADP-
Molekülen dissoziert. 
Bei Arbeiten in der Arbeitsgruppe wird innerhalb eines systematischen Ansatzes die Überex-
pression von Mdl1p als Gesamtprotein etabliert. Dazu kommen als prokaryontische Expressi-
onssysteme das gram-negative Bakterium Escherichia coli und das gram-positive Bakterium 
Lactococcus lactis zum Einsatz. Weiterhin wird der homologe eukaryontische Expressions-
wirt Sacharomyces cerevisiae verwendet. 
Das MDL1-Gen konnte durch das Einführen einer neuen und die Nutzung einer vorhandenen 
Restriktionschnittstelle in drei Kassetten unterteilt werden, die eine weitere genetische Mani-
pulation und Klonierung deutlich vereinfachen. So werden Kassetten mit und ohne N-
terminaler mitochondrialer Leitsequenz und verschiedenen Affinitätsschleifen konstruiert. Zu 
Zwecken detaillierter Untersuchung des Gesamttransporters wurde die schon von der NBD 
bekannte Mutante E599Q als auch die bei anderen ABC Transportern als ATP-
hydrolyseinaktiv bekannte Mutation des konservierten Histidins (H631) der H-Schleife zu 
einem Alanin generiert (H631 Æ A). 
Ergebnis dieser Arbeiten war, dass in E. coli im besten Fall 0,005 % Mdl1p (bezogen auf die 
Gesamtmembranproteinmenge) erzielt wurde, was deutlich unter der erwarteten und für wei-
tere Experimente erforderlichen Expressionsausbeute lag. Dabei wurde das Protein in ver-
schiedene „high-“ und „low-copy“ Vektoren mit unterschiedlichen Promotoren wie z. B. T7 
(IPTG-induziert), ARA (Arabinose-induziert) oder TRC (IPTG-induziert) kloniert. Weiterhin 
wurde die Expression in verschiedenen E. coli-Stämmen bei verschiedenen Wachstumstempe-
raturen getestet. Auch die Konzentration der Induktoren wie IPTG oder Arabinose und der 
Zeitpunkt sowie die Dauer der Induktion wurden systematisch variiert. Schließlich wurde 
Mdl1p zusammen mit der “Membraninsertionsmaschinerie” SecY, SecE, SecG und YidC und Chapter 1  Deutsche Zusammenfassung 
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in Stämmen, die seltene tRNAs codieren, exprimiert. Um das Translationsprodukt mögli-
cherweise besser vor degenerativen Prozessen innerhalb der Zelle zu schützen, werden diese 
mit höheren Konzentrationen Ethanol oder Sorbitol im Medium kultiviert, mit dem Ziel, auf 
diese Weise Chaperone zu induzieren. Die Expression wurde jeweils durch quantitativen 
Westerntransfer mit anschließender Immundetektion unter der Verwendung der Mdl1p-NBD 
als Referenz evaluiert. Ähnlich niedrige Ausbeuten von 0,01 % Mdl1p werden in L. lactis 
erzielt, wobei analoge Variationen der Expressionsbedingungen, wie für E. coli beschrieben, 
durchgeführt wurden. 
In beiden Ansätzen stellen die erhaltenen Mengen keine Verbesserung der Ausbeute im Ver-
gleich zum homologen Expressionssystem dar. Wie im Rahmen der Arbeiten zur Überexpres-
sion von Mdl1p bestimmt wurde, wird Mdl1p in S. cerevisiae bis zu 0,01 % des totalen mito-
chondrialen Membranproteingehalts exprimiert. Um die Mdl1p-Menge zu erhöhen, wurden in 
der Arbeitsgruppe verschiedene Ansätze getestet, wie beispielsweise die plasmidgetriebene, 
starke und konstitutive Expression über einen GPD-Promotor (Glycerolphosphatdehydrogen-
ase). Interessanterweise wird in diesem Fall weniger Protein erhalten als bei einer wildtyp-
Expression. Dies legte die Vermutung nahe, dass hohe Mengen Mdl1p von der Zelle nicht 
toleriert werden können. Grosse Mengen Mdl1p wurden letztlich nur über einen GAL1-
Promotor (Galaktose induzierbar) auf einem 2µ-Plasmid erreicht. 
Über die His(8)-Schleife am C-Terminus des Proteins und der Verwendung der Metall-
Affinitätschromatographie gelang im Rahmen dieser Arbeit die Isolierung von Mdl1p bis zu 
einer Homogenität von 95 %. Dabei wurde ein breites Spektrum an nicht-, einfach- und zwit-
terionischen Detergenzien zur Solubilisierung verwendet. Hier zeigen sich zwei wichtige As-
pekte: Erstens solubilisieren unterschiedliche Detergenzien Mdl1p in sehr unterschiedlichem 
Ausmaß. Mit dem Detergenz Tetradecylphosphocholine (FC-14) kann beispielsweise bis zu 1 
mg Protein pro Liter Hefekultur präpariert werden. Bei den Detergenzien Dodecylmaltosid 
(DDM) und Digitonin sind die Ausbeuten reduziert und belaufen sich auf 0,2 bzw. 0,1 mg pro 
Liter Zellkultur. 
Zweitens wird auch die Hydrolyseaktivität des gereinigten Proteins stark durch das Detergenz 
beeinflusst. So zeigt Mdl1p seine höchste Geschwindigkeit in Digitonin während in DDM nur 
noch ein Drittel der Geschwindigkeit detektiert werden kann. In FC-14 ist keine Hydrolysetä-
tigkeit mehr vorhanden. Daher wurden alle Experimente mit Protein durchgeführt, das in An-
wesenheit von Digitonin gereinigt wurde. 
Das solubilisierte Protein bindet ATP wie durch 8-azido-[α-
32P]ATP-photocross-linking-
Experimente gezeigt wurde und besitzt eine Hydrolyseaktivität mit einem KM(ATP) von 
0,85 mM und einer Wechselzahl von 2,5 ATP pro Sekunde. Die beiden Mutanten (E599Q, 
H631A), die in gleicher Weise und Menge exprimiert und präpariert werden können wie das 
Wildtyp-Protein, sind zwar in der Lage ATP zu binden, nicht jedoch es zu hydrolysieren. Chapter 1  Deutsche Zusammenfassung 
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Im Rahmen dieser Arbeit wird weiterhin die Existenz einer N-terminalen Leitsequenz von 
Mdl1p ermittelt und näher charakterisiert. In der Literatur werden spezifische Signalsequen-
zen diskutiert, die eine eindeutige Adressierung und einen Transport von Proteinen an ihren 
Einsatzort in den verschiedenen Zellorganellen gewährleisten. Für mitochondriale Proteine 
werden sowohl N-terminale Leitsequenzen unterschiedlicher Länge (bis zu 105 Aminosäuren) 
als auch interne, in der Proteinfaltung verschlüsselte, Leitstrukturen beschrieben. Auch für 
Mdl1p werden mittels computerbasierter Methoden („in silico“) verschiedene Sequenzen vor-
hergesagt. Daher soll die Frage nach Art und Länge der Zielsequenz für Mdl1p experimentell 
beantworten werden. Dazu wird das Protein über die His(8)-Schleife aus Mitochondrien präpa-
riert und mittels N-terminalem Edman-Abbau analysiert. Da die ersten 7 Aminosäuren se-
quenziert werden, kann eine eindeutige Alignierung der erhaltenen Sequenz mit der Gesamt-
Mdl1p-Sequenz erreicht werden. An Hand dieser Daten kann erstmals für einen mito-
chondrialen ABC Transporter aus Hefe experimentell eine N-terminale Leitsequenz gezeigt 
werden, die im Fall von Mdl1p 59 Aminosäuren beträgt. 
Mdl1p kann in Liposomen rekonstituiert werden, was in Zusammenarbeit mit dem Max-
Planck-Institut für Biophysik in Frankfurt durch Gefrierbruch-Elektronenmikroskopie nach-
gewiesen werden konnte. Hierbei blieb die ATP Hydrolysefähigkeit von Mdl1p nahezu erhal-
ten, was den Einsatz von Proteoliposomen für Importstudien ermöglicht. Ein Peptidtransport 
mit radioaktiv markierten Peptidbibliotheken einer Länge von 8 bzw. 23 Aminosäuren (dabei 
enthalten die Peptide alle proteinogenen Aminosäuren in gleichem Verhältnis mit Ausnahme 
von Cystein) konnte mit diesem System allerdings nicht gezeigt werden. 
Gründe für diese Ergebnisse werden in dieser Arbeit ausführlich diskutiert, was zu einer Neu-
bewertung der Rolle von Mdl1p als Peptidetransporter führt. 
Das solubilisierte Protein wurde in einer Kooperation mit dem Max-Planck-Institut für Bio-
physik in Frankfurt mittels Einzelpartikel-Elektronenmikroskopie untersucht, was Einsichten 
in den oligomeren und strukturellen Aufbau des Proteins ermöglicht. Dabei werden die Ein-
zelpartikel zu einer dreidimensionalen Ansicht rekonstruiert und mit den Kristallstrukturen 
des ABC Transporters MsbA verglichen. Diese zeigen MsbA in zwei sehr unterschiedlichen 
Konformationen, eine offene und eine geschlossene Form. Die Dimensionen der Partikel von 
Mdl1p kommen hierbei der offenen Form non MsbA am nächsten. Dabei wird auch deutlich, 
dass Mdl1p in Detergenz sehr wahrscheinlich als Homodimer vorliegt. 
Die vorliegende Arbeit mit ihren in vitro Studien zeigt zum ersten Mal eine Art „Fingerab-
druck“ des mitochondrialen ABC Transporters Mdl1p aus S. cerevisiae und stellt damit eine 
Basis für detaillierte Untersuchungen dieses Proteins dar. 
 Chapter 2  Summary 
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2 Summary 
The multidrug resistance like protein 1 (Mdl1p) belongs to the class of ATP binding cassette 
(ABC) transporters which comprise a large family of membrane proteins utilising ATP hy-
drolysis to drive up-hill transport of a wide variety of solutes across membranes. 
Mdl1p is a mitochondrial ABC transporter involved in the export of protein fragments derived 
from the proteolysis of non-assembled inner membrane proteins out of the mitochondrial ma-
trix. Mdl1p forms a homodimeric complex consisting of two polytrophic transmembrane do-
mains (TMDs) and two nucleotide binding domains (NBDs). The transport function and 
structural organisation of Mdl1p have not been elucidated yet. 
To characterise the ATP hydrolysis cycle of Mdl1p, the His-tagged NBD (amino acids D423-
R695) was over-expressed in Escherichia coli and purified to homogeneity. The isolated 
NBD was active in ATP binding and hydrolysis. The ATPase activity was non-linear regard-
ing to the protein concentration, indicating that the functional state is a dimer. Dimeric cata-
lytic transition states could be trapped and three different intermediate states were isolated, 
containing two ATPs, one ATP and one ADP, or two ADPs, which are trapped by ortho-
vanadate or beryllium fluoride. These experiments showed that (i) ATP binding to the NBDs 
induces dimerisation, (ii) in all isolated dimeric states, two nucleotides are present, (iii) phos-
phate can dissociate from the dimer, (iv) both nucleotides are hydrolysed, and (v) hydrolysis 
occurs in a sequential mode. 
Studies in the workgroup systematically screened for over-expression of the full-length 
Mdl1p and expression conditions were optimised. These studies showed that highest expres-
sion was obtained in S. cerevisiae, where the protein was over-expressed 100-fold. In this 
work over-expressed His-tagged protein was purified via immobilised metal-ion affinity 
chromatography that was active in ATP binding and hydrolysis with a turn-over of 2.5 ATP 
per second. 
N-terminal amino acid sequencing of purified Mdl1p by Edman degradation confirmed ex-
perimentally a N-terminal targeting sequence of a mitochondrial ABC transporter of S. cere-
visiae for the first time. This sequence was determined to be 59 amino acids in length. 
Mdl1p was reconstituted into liposomes, which was confirmed by freeze fracture electron 
microscopy. The reconstituted protein showed ATP hydrolysis similar to the solubilised 
Mdl1p. However peptide translocation with radiolabelled X(8) or X(23) libraries as done for the 
transporter associated with antigen processing TAP could not be shown with this setup. 
Furthermore, structural insights of the mitochondrial transport complex and its oligomeric 
state were obtained via single particle electron microscopy. It was shown that Mdl1p forms a 
homodimer in detergent. 
These in vitro studies provide the basis for further detailed investigation of the mitochondrial 
ABC transporter Mdl1p. Chapter 3  Introduction 
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3 Introduction 
The border of a cell is formed by a biological membrane, which defines the “inside” and “out-
side” of a cell. This boundary prevents molecules generated inside from diffusing out and 
harmful molecules from invading the cell. In addition to an external cell membrane, eu-
karyotic cells also contain internal membranes, which form organelles such as the nucleus, the 
mitochondria, the chloroplasts, the endoplasmatic reticulum, the Golgi apparatus, the perox-
isomes, and the lysosomes. This enables a cell to separate biochemical processes into differ-
ent compartments with different internal conditions and furthermore opens an elegant way of 
regulation and the control of biochemical processes. Specific systems have evolved to target 
selected proteins into or through membranes. Biological membranes have additional impor-
tant functions crucial for life, such as energy storage and creation and information transduc-
tion, which are regulated by the proteins associated with them. 
Solutes and proteins, which function outside the cell or in different compartments, have to 
pass the membrane without compromising its barrier function. This permeability is achieved 
by transport systems that allow molecules to be transported into or out of the cell or the dif-
ferent compartments. Several systems have been developed which transport solutes across 
membranes. One family of these transport proteins is the family of ATP binding cassette 
(ABC) transporters. 
3.1  Function and organisation of ABC proteins 
In 1982 the gene of the histidine permease was sequenced, and this gene was shown to encode 
the first representative of the ABC transporter superfamily, one of the largest families of 
paralogous transmembrane proteins (Higgins et al., 1982). 
ABC transporters use the energy of the hydrolysis of ATP to drive the active transport of sub-
strates across membrane lipid bilayers. Members of the ABC transporter superfamily are 
found in prokaryotes, eukaryotes and archaea. They take part in many cellular processes, and 
transport a wide set of substrates, like sugars and amino acids, hydrophobic drugs and lipids 
and even large proteins. The dysfunction of ABC transporters has been reported to play an 
important role in various human pathologies such as multidrug resistance (MDR/ ABCB1; 
MRP1/ABCC1), cystic fibrosis (CFTR/ABCC7), hypercholestemia (ABC1/ABCA1), adreno-
leukodystrophy (ALDP/ABCD1) and Stargardt’s disease (hABCR/ABCA4). In many organ-
isms, an additional group of ABC proteins (non-transporters) are found which do not contain 
a transmembrane domain (TMD) and most likely perform functions related to maintenance 
and repair of DNA and DNA transcription. 
ABC transporters are composed of a conserved central structure with two TMDs and two nu-
cleotide-binding domains (NBDs). The TMDs form the translocation pore, whereas the NBDs 
are responsible for ATP hydrolysis to energise the transport event (Higgins, 1992). All ABC 
transporters in eukaryotes function as exporters, but in prokaryotes and archaea, also import Chapter 3  Introduction 
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systems are found which work in concert with a substrate binding protein (SBP). The amino 
acid sequences of the TMDs of ABC transporters are highly diverse, while the NBDs are 
much more conserved. This finding suggests that also in unrelated transporters the mechanism 
and function of the NBDs is similar whereas the diversity in the sequence of the TMDs ex-
plains the broad substrate diversity of ABC proteins. 
Figure 3.1: Organisation of ABC proteins (modified from (Schmitt and Tampé, 2000). An ABC transporter consists 
of two transmembrane domains (blue), two nucleotide binding domains (grey) and in case of prokaryotic import 
systems of an additional periplasmic substrate binding protein (yellow). The domains have been found to be ar-
ranged in different ways: I) as five separate polypeptides (histidine permease), II) with fused NBDs and discrete 
TMDs (RbsA), III) with separated NBDs and fused TMDs (FhuCB), IV) with the SBP anchored in the membrane 
(Opp), V) with the NBD fused to the TMD (Mdl1p), VI) a single polypeptide (MDR1), VII) with an intercalating R 
domain (red; only known for CFTR). Furthermore also non-transporters, VIII) with only two fused NBDs (Rad50) 
exist. 
The TMDs and the NBDs can be found in a homo- or heterodimeric composition. The do-
mains can be arranged in any combination e.g. as separate polypeptides like in the case of 
several bacterial transporters, or as a single polypeptide like in the majority of the eukaryotic 
ABC transporters or they are expressed as half size transporters where a TMD is fused to a 
NBD (Figure 3.1). Several different arrangements are also observed but they are less frequent. 
A canonical TMD of an ABC transporter features six transmembrane helices (TMHs), but 
also here exceptions can be found (Schmitt and Tampé, 2000). Chapter 3  Introduction 
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3.1.1  Structures of nucleotide binding domains 
The NBDs contain the highly conserved Walker A (G-X-X-G-X-G-K-S/T) and Walker B (Φ-
Φ-Φ-Φ-D, where Φ is a hydrophobic residue) (Walker et al., 1982) motif. Furthermore, the 
D-, H-, Q- and C-loops can be found in the NBDs (Schmitt and Tampé, 2002). The latter one 
is the hallmark of ABC proteins and called ABC signature motif (L-S-G-G-Q). 
Figure 3.2: Crystal structure of a dimeric NBD. The structure shows two HlyB(H662A)-NBD monomers (light tan 
and light yellow), with ATP (stick representation) and Mg
2+ (green spheres) clamped at the interface. Conserved 
motifs are coloured in red (Walker A motif), brown (Q-loop), blue (C-loop or ABC signature motif), magenta 
(Walker B), black (D-loop), and green (H-loop). 
Structures of several isolated NBDs e.g. E. coli HisP (Hung et al., 1998), Thermococcus litor-
alis and E. coli MalK (Chen et al., 2003a; Diederichs et al., 2000), Methanococcus jannaschii 
MJ1276 (Karpowich et al., 2001), M. jannaschii MJ0796 (Yuan et al., 2001), human TAP1 
(Gaudet and Wiley, 2001), Sulfolobus solfataricus GlcV ,(Verdon et al., 2003a) E. coli HlyB 
(Schmitt et al., 2003; Zaitseva et al., 2005a), human CFTR (Lewis et al., 2004) Pyrococcus 
furiosus Pfu-867808-001 (Liu et al., 2005) and Alicyclobacillus acidocaldarius CysA 
(Scheffel et al., 2005) crystallised in the absence or presence of different nucleotides have 
been published. Chapter 3  Introduction 
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The structures of the different NBDs are remarkably similar. The monomer forms an L-
shaped molecule with two arms. The highly conserved arm I includes the Walker A and B 
motifs as well as the H- and Q-loop, while arm II contains the C-loop (Figure 3.2). Arm II 
contains mainly α-helices and also comprises a structurally diverse region of about 30 resi-
dues, which is thought to interact with the TMDs to transmit signals between the “motor” and 
the “gate” during the transport process (Schmitt et al., 2003). 
The residues of the Walker A motif interact with the ATP/ADP-phosphates (Chen et al., 
2003a; Gaudet and Wiley, 2001; Hopfner et al., 2000; Hung et al., 1998; Karpowich et al., 
2001; Verdon et al., 2003a; Yuan et al., 2001) and the aspartate of the Walker B motif coordi-
nates the Mg
2+ ion in the nucleotide binding site (Karpowich et al., 2001; Verdon et al., 
2003a; Yuan et al., 2001). The γ-phosphate of the sandwiched ATPs is complexed by a con-
served histidine and glutamate. The latter is one amino acid downstream of the Walker B mo-
tif and coordinates additionally via the phosphate a water molecule that was proposed to at-
tack the γ-phosphate. Thus, this glutamate was suggested to be the catalytic base (Moody et 
al., 2002; Verdon et al., 2003a; Yuan et al., 2001). Based on biochemical experiments, recent 
data suggest that substrate assisted catalysis, rather than a general base function in ABC ATP-
ases (Zaitseva et al., 2005c). Comparing different NBD structures with different nucleotide 
content, it was shown that the largest conformational changes are seen upon ATP binding 
within the Q-loop. ATP binding results in a rigid body movement of arm I towards arm II, 
while only minor differences are seen between the ADP bound and nucleotide free state. Re-
markably, the dimeric structure shows a head-to-tail orientation of the two NBDs and the two 
ATPs are bound at the interface of the two monomers between the Walker A motif from one 
monomer (cis-site) and the C-loop of the other monomer (trans-site). The dimeric forms of 
NBD crystal structures in the ATP bound state are supported by biochemical experiments 
showing ATP induced dimerisation (Janas et al., 2003; Moody et al., 2002; Zaitseva et al., 
2005c). 
3.1.2  Structures of full-length ABC transporters 
So far, X-ray structures of two different full-length ABC transporters have been solved, which 
was a tremendous step towards understanding the mechanism of this class of proteins. 
The E. coli (Chang and Roth, 2001), Vibrio cholera (Chang, 2003) and Salmonella typhi-
murium (Reyes and Chang, 2005) MsbA proteins are homodimeric half size transporters 
which function as lipid flippases, and are close homolog’s of the human and Lactococcus lac-
tis multidrug transporters P-glycoprotein and LmrA (Reuter et al., 2003). In the first two 
structures MsbA was crystallised in the absence of nucleotides in an open (E. coli) and closed 
(V. colera) conformation. In the open conformation, the two TMDs interact at the extra cellu-
lar ends of the membrane spanning helices to form an inverted V-shaped molecule with NBDs 
distant from each other and a large internal chamber accessible from the cytoplasm is formed 
between the interacting TMDs. In the closed conformation, both the TMDs and the NBDs are Chapter 3  Introduction 
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closely packed. The two structures suggest a highly dynamic sampling of the conformational 
space by the protein in the absence of nucleotides. The third x-ray structure of MsbA shows a 
complex with magnesium, ADP, inorganic vanadate and a rough-chemotype lipopolysaccha-
ride which is a potential substrate (Figure 3.3, A). Based on this structure together with the 
first two structures a model involving a rigid body torque of the two transmembrane domains 
during ATP hydrolysis was proposed. This suggests a mechanism by which the nucleotide-
binding domain communicates with the transmembrane domain. 
 
Figure 3.3: (A) Structure of MsbA (Reyes and Chang, 2005) trapped with Mg⋅ADP⋅Vi. The homodimer (monomers 
in green and blue) is shown perpendicular to the membrane (M). The two NBDs form a dimeric structure located n 
the cytosol (C) and enclose an ADP molecule. Two Ra lipopolysaccharide (LPS) molecules are bound on the 
periplasmic side (P). (B) Structure of the vitamin B12-transporter (Locher et al., 2002). The transporter is com-
posed of two BtuC membrane spanning subunits (purple and red), and two BtuD NBDs (green and blue). The 
cyclotetravanadate molecules found in the ATP binding sites, are depicted in ball and stick. The membranes are 
indicated with straight lines. 
The BtuCD structure (Locher et al., 2002) contains two copies of the TMD (BtuC) and two 
copies of the NBD (BtuD). In the crystal, the NBDs contain a cyclotetravanadate, and are 
slightly apart from each other (Figure 3.3, B). They are in contact with a cytoplasmic loop 
located between TMH 6 and 7. This loop is suggested to be involved in interdomain commu-
nication between the TMDs. The loop interacts with the Q-loop in the NBD and is hereby 
linked to the γ-phosphate (Mourez et al., 1997). Apparently, this interface is responsible for a 
specific interaction between the NBD and the TMD. The interface “senses” the nucleotide 
bound state and communicates with the TMD of the transporter, which in turn signals the in-Chapter 3  Introduction 
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formation of substrate binding in the other direction to the NBD. However, it remains un-
known in which way the energy of ATP binding or hydrolysis is passed to the TMDs. 
3.1.3  Catalytic cycle and proposed transport mechanism 
Several models which suggest how a translocation event is powered and achieved by an ABC 
transporter are discussed presently like the “two cylinder engine” model (van Veen et al., 
2000) the “alternating site” model (Senior et al., 1995) or the “flippase” model (Higgins and 
Gottesman, 1992). The second model was proposed because of extensive investigations of 
MDR1 (P-glycoprotein) and considered to be a general model for the catalytic cycle of ABC 
transporters. MDR1 is a full-size ABC transporter with an N- and C-terminal NBD on one 
polypeptide chain. Both NBDs bind MgATP, Mg-8-azido-ATP, or Mg-TNPATP (Liu and 
Sharom, 1997) and the two sites show approximately the same apparent nucleotide binding 
affinity. Experiments with the ATPase inhibitor ortho-vanadate (Vi) demonstrated that intact 
MDR1 in mammalian cell membranes, both NBD1 and NBD2 have the capacity to hydrolyse 
MgATP, and that the two nucleotide sites interact very strongly (Urbatsch et al., 1995a; Ur-
batsch et al., 1995b). This was apparent from the fact that trapping of ADP was sufficient to 
prevent turn-over. Moreover, Vi-induced trapping of ADP occurred non-selectively in either 
NBD, suggesting that the two sites normally alternate in catalysis. The alternating site model 
starts with a ATP-free NBD and a NBD which has bound ATP. ATP binding to the free site 
promotes ATP hydrolysis at the other site and induces a conformational change in this site, 
which prohibits hydrolysis at the later on loaded site. In addition, ATP hydrolysis leads to a 
high chemical potential state with bound ADP⋅Pi and relaxation of this site couples drug 
movement from the inside-facing, higher-affinity to outside facing, lower-affinity orientation 
and phosphate-release. After dissociation of the substrate also ADP leaves the NBD. The 
molecule is ready for another cycle, except that the NBDs have reversed their position, and 
the next hydrolysis event will occur in the NBD which was loaded in the cycle before (Senior 
and Gadsby, 1997). 
In anticipation the following shema combines several results of this work with other structural 
and biochemical data (for review see (Higgins and Linton, 2004) and draws a picture about 
the putative events, which occur during a transport cycle (Figure 3.4). 
Step I.  Binding of the substrate to its high affinity site on the TMDs is pre-
dicted to lower the activation energy for ATP dependent dimerisation, 
thus initiating the dimerisation of the NBDs and preventing futile ATP 
hydrolysis cycles in the absence of substrate. 
Step II & Step III. ATP binding induces NBD dimer formation. Dimerisation results in re-
orientation of the high affinity-binding site to the low affinity substrate 
release position. 
Step IV.  One ATP is hydrolysed as part of the transport cycle. Alternatively, this 
can be the step for reorientation of the substrate binding site. Chapter 3  Introduction 
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Step V.  The second ATP is hydrolysed returning the transporter to its basal, 
open configuration by destabilising the NBD closed dimer. After ATP 
hydrolysis, the closed dimer is destabilised by electrostatic repulsion 
between ADP coordinated with the Walker A motif of one NBD and Pi 
coordinated to the signature motif of the other NBD. This leads to rigid 
body rotation of the subdomains of each NBD, Pi and ADP release, and 
restoration of the open dimer configuration. 
Step VI.  Pi and ADP are released, restoring the protein to its basal state - ready 
to initiate another transport cycle. 
Figure 3.4: Schema for a substrate translocation cycle by an ABC export system. TMDs drawn in blue, NBDs 
depicted in grey. In this case “transport” means reorientation of the TMDs to a certain degree. Dimerisation upon 
ATP binding is represented by overlapping NBDs (see text for details). 
3.2  Peptide and protein transport over membranes 
Peptide and protein transport across biological membranes is essential for all kind of cells. 
Different ways are accomplished to fulfil this task. One way of peptide/protein transport is the 
use of the proton motive force by secondary active systems like DtpT (Hagting et al., 1994) or 
the twin arginine protein translocase (Tat) (Santini et al., 1998). The proton gradient is built 
and maintained by protein complexes composing the so-called respiratory chain (NADH-Q 
oxidoreductase, Q-cytochrome c oxido-reductase, and cytochrome c oxidase). 
Alternatively, translocases use the energy of ATP hydrolysis to energise and coordinate the 
translocation process of their substrates. Here I would like to briefly introduce three promi-Chapter 3  Introduction 
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nent representatives namely the Sec system as well as the translocase of the inner mitochon-
drial membrane (TIM) and the translocase of the outer mitochondrial membrane (TOM). 
The Sec pathway is found in prokaryotes where it resides in the inner plasmamembrane as 
well as in eukaryotes where it is a key component in the endoplasmatic reticulum (ER). It is 
the main route of protein export in most bacteria. Here I will introduce only the prokaryotic 
components (for reviews see (Driessen et al., 2001). Two distinct routes can be discriminated. 
The signal recognition particle (SRP) mainly guides ribosome bound nascent proteins to the 
membrane, whereas SecB facilitates the targeting of periplasmic and outer membrane pro-
teins. These routes converge at the translocase, a protein-conducting pore in the membrane 
that consists of the SecYEG complex. Membrane and secretory protein translation starts with 
a free cytosolic ribosome. In the SRP mediated pathway, the SRP recognises the signal se-
quence coming from the ribosome. The ribosome nascent chain complex (RNC) bound to 
SRP is then guided to FtsY − a membrane bound receptor. Binding of GTP to FtsY and SRP 
leads to dissociation of SRP from the RNC and releases it to the pore forming SecYEG com-
plex. SRP is released from FtsY by GTP hydrolysis allowing it to be recycled into the cytosol. 
FtsY remains bound to the membrane. The polypeptide chain continues to elongate until 
translation is complete. 
The chaperone SecB does not interact with a signal sequence but recognises longer nascent 
chains. SecB stabilises the translated N-terminus in denatured conformations, which most 
likely contain native like secondary structure elements without specific tertiary interactions. 
The SecB bound preproteins are guided to SecA, which is already associated with the translo-
con SecYEG. Targeting to the translocase requires high affinity binding of SecB to the C-
terminus of SecYEG-bound SecA. The preprotein binds to SecA, which enhances the SecB-
SecA interaction. That induces release of the preprotein from SecB with the simultaneous 
transfer to SecA. The release of SecB from the membrane is coupled to the binding of ATP to 
SecA. 
Almost all mitochondrial proteins are synthesised by ribosomes in the cytosol and imported 
posttranslational. Cytosolic chaperons guide the precursor proteins to the TOM-complex 
forming a general import pore (GIP). Presequence carrying proteins such as matrix proteins 
are transported by the presequence dependent TIM23-complex in a membrane potential de-
pendent manner. The ATP driven presequence translocase associated motor (PAM) completes 
the translocation process into the matrix. Non-cleavable hydrophobic inner membrane pro-
teins, such as carrier proteins, are directed by complexes of small TIM proteins through the 
intermembrane space (IMS) and are introduced into the inner membrane by the proton motive 
force (PMF) driven TIM22-complex. The precursors of β-barrel proteins of the outer mem-
brane are transferred from the TOM complex to the sorting and assembly machinery (SAM 
complex), again with the help of small TIM proteins in the IMS (for reviews see (Pfanner et 
al., 2004). Chapter 3  Introduction 
  15
In addition to these systems, ABC transporters are also used in order to move pep-
tides/proteins over membranes. In prokaryotes, one example is the sufficient uptake of nutri-
ents from the environment by the peptide importer families Dpp and Opp. Also very large 
substrates can be transported by ABC transporters e.g. E. coli strains can protect themselves 
by secreting haemolysin A, a 107 kDa protein via haemolysin B and D, which then lyses the 
attacked cells. The yeast a-factor, which is a dodecapeptide, is transported by the ABC trans-
porter Ste6p and enables two haploid cells to fuse to become diploid and benefit from recom-
bination. Another example is the adaptive immune system where peptide presentation on the 
cell surface enables an organism to protect itself from harmful effects. A key component of 
this process is the ABC transport complex TAP. 
3.2.1  Peptide import in prokaryotes driven by ABC transporters 
In prokaryotes, at least two families of primary active peptide importers are well known. The 
ABC transporter Dpp facilitates the uptake of di- and tripeptides (Foucaud et al., 1995; Sanz 
et al., 2001) and a second ABC transporter family the Opp system, catalyses the uptake of 
oligopeptides containing 4 up to 35 amino acid residues (Hagting et al., 1994; Tynkkynen et 
al., 1993). Peptide transport in micro-organisms is important for nutrition of the cell and vari-
ous signalling processes including regulation of gene expression, sporulation, chemo taxis, 
competence and virulence development (Kunji et al., 1998). As a common feature for import-
ers the peptide binding proteins DppA and OppA are responsible for substrate delivery to 
their cognate membrane complexes and take part in substrate selection (Doeven et al., 2004). 
They are anchored to the membrane via lipid modification of the N-terminal cysteine residue. 
3.2.2  The haemolysin system 
The toxin HlyA belongs to a protection shield of the gram-negative bacterium E. coli. Once 
released into the medium it perforates membranes of surrounding competitors. It is trans-
ported by a type I secretion complex composed of the proteins HlyB, HlyD, and TolC 
(Holland et al., 2005). TolC is a porin like protein in the outer membrane whereas HlyD func-
tions as connector of the inner and outer membrane. The substrate is thereby transported in a 
single step process across two membranes without the release of HlyA into the periplasmic 
gap. HlyB exhibits all conserved sequence stretches known for ABC transporters and forms 
the pore in the inner membrane. HlyB with its NBD provides the energy for the process by 
ATP hydrolysis (Zaitseva et al., 2005b). The functional unit of HlyB is supposed to be a 
homodimer. HlyA with its molecular mass of 107 kDa is translocated in an unfolded manner 
and (re)folds after dissociation from the translocase in the outer environment. The process is 
initiated by a so far unknown interaction between the last 60 amino acids of HlyA, which 
adopt a helix-turn-helix motif, and certain areas of the HlyB-NBD (Jarchau et al., 1994; 
Kenny et al., 1994). Chapter 3  Introduction 
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3.2.3  The a-factor transporter Ste6p 
Mating in S. cerevisiae results from the fusion of two haploid cells of opposite mating type, a 
and α, to form a diploid. The mating pheromones, a-factor and α-factor, stimulate receptors 
on cells of the opposite mating type to initiate cell fusion (Kurjan, 1992). The ability of cells 
to participate in mating relies on their ability to produce and respond to mating pheromones. 
Screens for mutations conferring a-specific sterility identified the STE6-gene (Oshima and 
Takano, 1980; Wilson and Herskowitz, 1984; Wilson and Herskowitz, 1987). Ste6p, which 
belongs to the multidrug resistance (MDR/ABCB) subfamily, was the first known yeast ABC 
transporter and is one of the best characterised ones (Kuchler et al., 1989; McGrath and Var-
shavsky, 1989). Ste6p appears to be located in the Golgi apparatus and endosome like com-
partments, but functions at the plasma membrane where it mediates ATP dependent secretion 
of the yeast a-factor pheromone (Kuchler et al., 1993; Kuchler et al., 1989). 
3.2.4  The transporter associated with antigen processing like (TAPL) 
TAPL is a human ABC transporter highly expressed in testis and moderately expressed in 
brain, spinal cord, and thyroid (Zhang et al., 2000). Even though, the targeting of TAPL is 
under debate evidences point to a lysosomal localisation as shown for examples in double 
immunofluorescence staining using anti-TAPL antibody and a panel of organelle markers. 
Pull-down assays with different tagged TAPL showed the homodimerisation of TAPL and in 
addition the ATP-dependent peptide transport was demonstrated (Wolters et al., 2005). The 
transport activity of TAPL strictly requires ATP hydrolysis. In contrast to TAP, which is a 
high-affinity transporter, no peptide-binding activity was detected for TAPL by rapid filter 
assays, suggesting a low-affinity transporter. The recognition principle of TAPL and TAP is 
similar, since both transporters recognise peptides via their backbone, including the free N- 
and C-termini, and by side chain interactions. The peptide specificity of TAPL is very broad, 
ranging from hexa- to 59-mer peptides with a slight preference for 23-mers. 
TAPL seems to work as a vacuum cleaner transporting a large variety of peptides with low 
affinity but high efficiency. The physiological role of TAPL is currently under debate. A 
function as peptide transporter in cross-presentation of endogenous antigens in the MHC class 
II pathway is discussed (for reviews see (Zhao et al., 2006) 
3.2.5  The transporter associated with antigen processing (TAP) 
Most nucleated cells in vertebrates present a pool of different peptides on their surfaces via 
major histocompatibility complex (MHC) I molecules for recognition by T cells. The pre-
sented peptides are generated by proteasomal degradation of endogenous or viral proteins in 
the cytosol of a cell. The transporter associated with antigen processing (TAP) transports pep-
tides from the cytosol across the membrane of the endoplasmatic reticulum (ER) into the lu-
men of the ER. In the ER, these peptides are loaded on MHC I molecules − comprising a 
α−chain and β2-microglobulin − in the so called peptide loading complex which further con-Chapter 3  Introduction 
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sists of the chaperones tapasin, calnexin, calreticulin and ERp57. TAP is a heterodimeric half 
size ABC transporter composed of TAP1 (ABCB2) and TAP2 (ABCB3) and both are essen-
tial for antigen processing (Powis et al., 1991; Spies and DeMars, 1991). As predicted by hy-
drophobicity analysis and sequence alignments with other known ABC transporters TAP1 and 
TAP2 contain ten and nine TMHs, respectively. For TAP1 the predicted topology was con-
firmed by cysteine scanning mutagenesis recently (Schrodt et al., 2006). The domain ar-
rangement shows an N-terminal TMD and a C-terminal NBD. Deletion of the N-terminal four 
(TAP1) or three (TAP2) putative TMHs does not affect peptide transport (Koch et al., 2004; 
Koch et al., 2005). The N-terminal helices are involved in tapasin-recruitment. The last cyto-
solic loop and a 15-amino acid stretch located in the last TMH of TAP1 and TAP2 were 
shown to be involved in peptide binding and are therefore called the peptide-binding site 
(Nijenhuis and Hammerling, 1996). Both NBDs of TAP1 and TAP2 are not equivalent which 
is mainly reflected in sequence differences of the C-loops. The C-loop in TAP2 is degener-
ated to L-A-A-G-Q compared to the canonical signature motif L-S-G-G-Q. Many approaches 
(Bouabe and Knittler, 2003; Chen et al., 2004) were undertaken to discover crucial conse-
quences but the physiological role of these difference are still under debate (for reviews see 
(Abele and Tampé, 2004). 
3.3  Relevance of mitochondrial processes in cellular biology 
The primary function of mitochondria is to use the redox energy stored in molecules like 
NADH2 and FADH2 to convert ADP and Pi to ATP. Beside this function mitochondria play 
an important role in many important cellular and metabolic tasks, such as apoptosis, regula-
tion of the cellular redox state, heme- and Fe/S-cluster synthesis, steroid synthesis and heat 
production. Several severe diseases are linked to aberrant biogenesis of mitochondria or ab-
normal function of these organelles (Abou-Sleiman et al., 2006; Chabi et al., 2005). 
Mitochondria consist of two compartments, the intermembrane space and the matrix, which 
are separated from the cytoplasm by two membranes, the outer mitochondrial membrane 
(OMM) and the inner mitochondrial membrane (IMM). The outer mitochondrial membrane is 
permeable to most small molecules and ions because it contains many copies of mitochondrial 
porin, a 30–35 kDa pore forming protein. In contrast, the IMM is intrinsically impermeable to 
nearly all ions and polar molecules. The inner membrane has a large surface, since it is folded 
into a series of internal ridges called cristae, and has very high protein content. Additionally 
the IMM exclusively contains a special lipid called cardiolipin. Many different transporters 
shuttle metabolites such as ATP, pyruvate, and citrate across the IMM. The matrix also con-
tains the mitochondrial DNA. Although these organelles enclose their own DNA, most mito-
chondrial proteins are encoded by the nuclear DNA. In S. cerevisiae only eight proteins are 
encoded by the mitochondrial DNA: Var1, a mitochondrial ribosomal subunit, Cox I, II, III, 
three subunits of the cytochrome c-oxidase, cytochrome b and subunits 6, 8 and 9 of the F1FO-
ATP-synthase. In an approach to determine the proteome of S. cerevisiae mitochondria the Chapter 3  Introduction 
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proteins of highly pure mitochondria were separated by several independent methods and ana-
lysed by tandem mass spectrometry (MS) (Sickmann et al., 2003). In this approach, 750 dif-
ferent proteins were identified. All known components of the oxidative phosphorylation ma-
chinery, the tricarboxylic acid cycle, and the stable mitochondria encoded proteins were 
found. Based on the mitochondrial proteins described in the literature so far, it was calculated 
that the identified proteins represent ~ 90 % of all mitochondrial proteins. Remarkably, the 
function of ~ 25 % of the identified proteins are still unknown. 
3.3.1  The proteolytic system in the inner mitochondrial membrane 
Maintenance of cellular functions needs constant proteolysis to degrade short-lived proteins in 
a regulatory process e.g. factors triggering cell cycle or those part of control systems which 
ensure proper assembly of multi enzyme complexes and prevent their potentially harmful ac-
cumulation. Different mechanisms, including sequence specific recognition events and tag-
ging strategies have been developed by the cell to ensure that these proteolytic processes are 
highly specific. ATP dependent proteases that use energy derived from ATP hydrolysis for 
selective degradation of cellular proteins play a key role in these processes (Schmidt et al., 
1999; Wickner et al., 1999). 
Figure 3.5: Proteolytic system of the IMM (modified from Arnold & Langer, 2002). Unfolded or non-assembled 
proteins embedded in the inner mitochondrial membrane (IMM) are degraded by AAA proteases. One way of 
peptide export is the tear down of protein complexes via the m-AAA protease which has its active centre placed in 
the matrix. Afterwards peptides are transferred into the inner mitochondrial space (IMS) by Mdl1p. From there 
they can pass the outer mitochondrial membrane (OMM) e.g. via porines. Chapter 3  Introduction 
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The IMM is probably the membrane with the highest protein content. The biogenesis of the 
respiratory chain complexes and the ATP synthase is a complex process requiring the coordi-
nated function of various membrane bound proteins like protein translocases and assembly 
factors. Therefore, a distinct quality control system is present in the membrane that selectively 
removes non-assembled polypeptides (Figure 3.5). The key components are two AAA prote-
ases, membrane embedded ATP dependent proteolytic complexes, with their catalytic sites 
eposed at opposite membrane surfaces (for review see (Arnold and Langer, 2002). 
Eukaryotic AAA proteases seem to be localised exclusively in mitochondria and chloroplasts. 
Three orthologues of the E. coli AAA ATPase FtsH have been found in human and yeast mi-
tochondria, and at least nine homologous have been identified in the genome of Arabidopsis 
thaliana so far (Adam et al., 2001; Juhola et al., 2000; Ogura and Wilkinson, 2001). In yeast, 
the subunits form two AAA proteases in the inner membrane of mitochondria with a native 
molecular mass of roughly one MDa. The m-AAA (matrix-oriented ATPases associated with 
a variety of cellular activities) is a heterooligomeric complex composed of Yta10p (Afg3) and 
Yta12p (Rca1) and exposes its active side into the matrix, whereas the i-AAA (inter mem-
brane space oriented ATPases associated with a variety of cellular activities) protease, forms a 
homooligomer of Yme1p subunits and the active side focus to the intermembrane space. The 
i-AAA protease subunits have one transmembrane domain, whereas two membrane spanning 
segments are predicted for m-AAA protease subunits (Langer, 2000). The importance of 
AAA proteases can be deduced from complementation studies in yeast, which revealed a 
functional conservation between human, Neurospora crassa and yeast i-AAA proteases 
(Klanner et al., 2001; Shah et al., 2000). 
3.4  Mitochondrial ABC transporters in S. cerevisiae 
The DNA sequence of S. cerevisiae was the first eukaryotic genome which was solved com-
pletely and revealed the existence of 29 (Decottignies and Goffeau, 1997) to 30 (Taglicht and 
Michaelis, 1998) ABC protein genes. These ABC proteins perform different functions rang-
ing from multi drug resistance, pheromone secretion and stress response to cellular detoxifica-
tion. Based on phylogenetic analysis yeast ABC proteins are classified into six subfamilies: 
MDR, PDR; MRP/CFTR, ALDp, YEF3, and the RLI subfamily (Decottignies and Goffeau, 
1997). 
The MDR family comprises four proteins: Ste6p, Atm1p, Mdl1p and Mdl2p. Except for 
Ste6p, which functions in the plasmamembrane (see above) the other members of the MDR 
family are targeted to the inner mitochondrial membrane. 
Atm1p was identified in S. cerevisiae as the first mitochondrial ABC transporter using a PCR 
approach (Leighton and Schatz, 1995) and was coincidentally identified in a genetic screen 
designed to find new components of c-type cytochrome biogenesis (Kispal et al., 1997). The 
ATM1-gene encodes a half size transporter of 690 amino acids containing an N-terminal TMD 
with six putative TMHs and a C-terminal NBD. Atm1p homologous are found in lower and Chapter 3  Introduction 
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higher eukaryotes. The typical sequence identity between different members of the Atm1p 
family is between 40 % and 50 %, and includes the TMD a region where homology between 
non-related ABC transporters is usually low. Remarkably, in prokaryotes and archaea no 
close homologs of Atm1p could be found. 
Atm1p contains a mitochondrial targeting sequence and it was shown by immunofluorescence 
and immunostaining using a myc-epitope-tagged that Atm1p is located in the mitochondria. 
The membrane orientation of Atm1p was determined in protease accessibility experiments 
where Atm1p in mitoplasts (mitochondria lacking the outer membrane) is resistant to prote-
ases added from the outside, while the protein is degraded after detergent lysis of the organ-
elles (Leighton and Schatz, 1995). Therefore, the ABC domain faces the matrix and suggests 
that Atm1p functions as a mitochondrial exporter. 
The lack of functional Atm1p leads to drastically elevated levels of free iron (non-heme, non-
Fe/S clusters) inside the mitochondrial matrix. ATM1 knock out strains grow poorly on rich 
media containing glucose (Kispal et al., 1997; Leighton and Schatz, 1995) and do not grow on 
non-fermentable carbon sources such as glycerol. These strains furthermore show a deficiency 
in holocytochromes, in the degradation of protein bound heme and increased concentrations 
of glutathione which can be explained by increased oxidative stress in ΔATM1 cells (Kispal et 
al., 1997). A further characteristic of the ΔATM1 strain is the loss of mtDNA yielding ρ
0 cells 
(Leighton and Schatz, 1995; Senbongi et al., 1999). Evidence against heme as a potential sub-
strate of Atm1p was confirmed by demonstrating that over-expressed peroxisomal catalase 
Cta1p (a heme containing protein) displayed almost the same activity in ΔATM1 cells com-
pared to wild-type cells. A trace guiding to the role of Atm1p came from the observation of a 
leucine auxotrophy of ΔATM1 cells (Kispal et al., 1999). Measurements of activities of en-
zymes involved in leucine biosynthesis showed a quantitative deficiency of isopropyl malate 
isomerase (Leu1p) even though the Leu1p polypeptide chain was present at wild-type levels. 
Leu1p is a cytosolic Fe/S protein that closely resembles aconitase of the mitochondrial matrix 
(Kohlhaw, 1988). No reduced activities as compared to wild-type cells were found for the 
first and third step of leucine biosynthesis. This finding suggests that Atm1p may perform a 
function in the maturation of cytosolic Fe/S proteins. 
Little is known about Mdl2p so far except its localisation in the inner mitochondrial mem-
brane and the fact that it does not form a heterodimeric transport complex with Mdl1p (Young 
et al., 2001). 
3.4.1  Mdl1p and its physiological function 
The MDL1-gene (ORF YLR188W) was discovered in an approach to identify members of the 
ABC transporter family (Dean et al., 1994). The MDL1-gene encodes a 695 amino acids long 
membrane protein with a N-terminal TMD and a C-terminal NBD. Hydrophobicity and se-
quence homology analysis suggested that Mdl1 contains six transmembrane helices with the 
N- and C-termini inside the mitochondrial matrix (Figure 3.6). The minimal functional unit Chapter 3  Introduction 
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was suggested to be a homodimer residing in the inner mitochondrial membrane. In order to 
characterise the released products, high-resolution size exclusion chromatography analysis of 
these supernatants were performed. About 30 % of the released material resolved as a hetero-
geneous peptide mixture which could be divided into two areas with molecular masses of 200 
to 600 daltons and 600 to 2100 daltons (Young et al., 2001). Mitochondria isolated from 
ΔMDL1 strains, showed significant differences in comparison to wild-type mitochondria. The 
release of long peptides (600 to 2100 Da) was reduced by 40 % in ΔMDL1 mitochondria. 
Over-expression of Mdl1p in ΔMDL1 cells restored this transport defect. Point mutations in 
the Walker A and B motifs and the L-S-G-G-Q-loop of Mdl1p which abolish ATP hydrolysis 
showed similar patterns in size exclusion analysis as observed in ΔMDL1 mitochondria 
(Young et al., 2001). Remarkably, peptides derived from mitochondrial encoded respiratory 
chain subunits have been detected in complex with class I major histocompatibility molecules 
at the surface of mammalian cells (Fischer Lindahl et al., 1991), suggesting that the Mdl1p 
homologous in higher eukaryotes are involved in the export of peptides from the mitochon-
drial matrix to present them on the surface of the cell. 
Figure 3.6. Scheme of the homodimeric ABC transport complex Mdl1p. According to hydrophobicity analysis and 
homology comparison each Mdl1p monomer includes a N-terminal transmembrane domain (TMD) with six trans-
membrane helices (TMH; numbered from 1 - 6) and a C-terminal nucleotide binding domain (NBD) forming a half 
size transporter. The active transport complex is thought to be a homodimer with the TMDs forming the transloca-
tion pathway for the solutes through the inner mitochondrial membrane and the NBDs powering the whole proc-
ess via ATP hydrolysis. The mitochondrial targeting sequence is cleaved off after import into the IMM. Chapter 3  Introduction 
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Another possible role of Mdl1p was found in a screen for yeast genes capable of suppressing 
the abnormalities of cellular iron metabolism demonstrated by ΔATM1 cells. One of the iden-
tified genes was Mdl1p. Over-expression of Mdl1p in ΔATM1 cells results in a reduction of 
mitochondrial iron content decreased sensitivity to H2O2 and transition metal toxicity 
(Chloupková et al., 2003). Additionally, the study on the effect of over-expression and dele-
tion of Mdl1p, showed a novel role for Mdl1p in the regulation of cellular resistance to oxida-
tive stress. 
A close homolog of Mdl1p in mice was discovered by searching for GATA-1 activated tran-
scripts in G1E cells. The transcription factor GATA-1 is essential for normal erythropoiesis 
and GATA-1 binding sites are found in promoters or enhancers of genes expressed selectively 
in erythroid cells. By subtractive analysis, a new ATP binding cassette transporter was found 
that is strongly and rapidly induced by GATA-1 (Shirihai et al., 2000). This protein named 
ABC-me is localised in the inner mitochondrial membrane and expressed at high levels in 
erythroid tissues of embryos and adults. ABC-me is induced during erythroid maturation in 
cell lines and primary haematopoietic cells, and its over-expression enhances haemoglobin 
synthesis in erythroleikemia cells. It was therefore speculated that Mdl1p like ABC-me may 
mediate mitochondrial transport functions related to heme biosynthesis. Chapter 3  Introduction 
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3.5 Aims  and  Motivation 
Transport processes over membranes are essential for all cells. The membrane protects the 
cell from the potential destructive outside, and membrane transporters ensure the maintenance 
and communication of the cell. In addition, the abundance of proteins during a cell cycle has 
to be regulated tightly to ensure proper function of the cell even over borders from different 
organelles. Mdl1p is an ABC transporter in the inner mitochondrial membrane involved in 
peptide transport from the matrix into the cytosol and therefore it might play a role in quality 
control and communication. 
Little is known about the physiological role of mitochondrial ABC transporters. Transporters 
residing in the inner mitochondrial membrane are difficult to analyse due to the complex two 
membrane architecture of mitochondria, the high membrane protein content with proteins 
with high affinity to ATP and the content of many different other transport systems. 
Furthermore, since the availability of purified active protein is limited due to low yield and 
the stable reconstitution is difficult, obtaining basic biochemical data and structural informa-
tion is challenging. 
Therefore, this work sets out to address the following main research topics for the transport 
ATPase Mdl1p: (i) the ATP hydrolysis cycle of the motor domains of Mdl1p, (ii) expression 
and purification of high yields of Mdl1p in an active state, (iii) reconstitution of Mdl1p into 
lipid vesicles in order to examine its role in peptide transport “in vitro”, (iv) structural inves-
tigation of the organisation and arrangement of the transport complex and (v) the establish-
ment of a setup to study Mdl1p “in vivo”. Chapter 4  Material 
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4 Material 
4.1 Chemicals 
Name Company 
[
35S]-Methionine Hartmann  Analytic 
[α-
32P]Adenosine-5'-triphosphate  Hartmann Analytic 
[γ-
32P]Adenosine-5'-triphosphate  Hartmann Analytic 
1,4-Dithiothreitol (DTT)  Sigma-Aldrich 
5-Amino-2,3-dihydro-1,4-phthalazinedione-3-aminophthal-
hydrazide (Luminol) 
Sigma-Aldrich 
8-Azido-[α-
32P]adenosine-5'-triphosphate  MP Biomedicals 
Acetic acid 99 %  Riedel de Haen 
Acetonitrile (ACN)  Roth 
Acrylamide Roth 
Acrylamide 30 % (Rotiphorese gel 30)  Roth 
Adenine Sigma-Aldrich 
Adenosine 5′-(β,γ-imido)triphosphate (AMP-PNP)  Sigma-Aldrich 
Adenosine 5′-[γ-thio]triphosphate (ATPγS)  Sigma-Aldrich 
Adenosine-5'-diphosphate (ADP)  Fluka 
Adenosine-5'-monophosphate (AMP)  Fluka 
Adenosine-5'-triphosphate (ATP)  Fluka 
Agar GibcoBRL 
Agarose Sigma-Aldrich 
Ammonium chloride  Merck 
Ammonium peroxodisulphate (APS)  Roth 
Ascorbate Sigma-Aldrich 
Ascorbic acid  Roth 
Berrylium chloride  Sigma-Aldrich 
Biobeads SM-2  BioRad 
Bisacrylamide Roth 
Bis-Tris Roth 
β-Mercapthoethanol  Roth 
Bovine serum albumin (BSA)  Sigma-Aldrich 
Bradford reagent  Pierce 
Bromphenolblue Merck 
Calcium chloride  Merck 
Calmodulin sepharose beads  GE Healthcare 
Chloramine T  Riedel de Haen 
Complete protease inhibitor (EDTA free)  Roche 
Coomassie Blue G  Sigma-Aldrich 
Cytosine-5'-triphosphate (CTP)  Fluka 
Developer solutions A & B  AGFA 
Dimethylsulfoxide (DMSO)  Fluka 
di-Potassium hydrogen phosphate  Roth 
di-Sodium hydrogen phosphate  Roth 
Dowex 1 x 8 anion exchange  Sigma-Aldrich 
E. coli lipids (total extract)  Avanti Polar Lipids Chapter 4  Material 
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EDTA, Disodium salt  Roth 
EGTA Roth 
Ethanol, abs.  Riedel de Haen 
Formaldehyde, 37 % (v/v)  Roth 
Formic acid  Roth 
Glycerol Roth 
Glycerol 2-phosphate  Sigma-Aldrich 
Glycine Roth 
HEPES Sigma-Aldrich 
Hydrochloric acid, 37 %  Merck 
Hydrogen peroxide, 30 %  Merck 
IgG sepharose beads  GE Healthcare 
Imidazole Fluka 
Isopropanol Roth 
Isopropyl β-D-1-thiogalactopyranoside (IPTG)  PeqLab 
L-Alanine Sigma-Aldrich 
L-Arginine Sigma-Aldrich 
L-Asparagine Sigma-Aldrich 
L-Aspartate Sigma-Aldrich 
L-Cysteine Sigma-Aldrich 
L-Glutamate Sigma-Aldrich 
L-Glutamine Sigma-Aldrich 
L-Glycine Sigma-Aldrich 
L-Histidine Sigma-Aldrich 
L-Isoleucine Sigma-Aldrich 
Lithium acetate  Roth 
Lithium chloride  Roth 
L-Leucine Sigma-Aldrich 
L-Lysine Sigma-Aldrich 
L-Methionine Sigma-Aldrich 
L-Phenylalanine Sigma-Aldrich 
L-Prolin Sigma-Aldrich 
L-Serin Sigma-Aldrich 
L-Tryptophan Sigma-Aldrich 
L-Tyrosin Sigma-Aldrich 
L-Valine Sigma-Aldrich 
Magnesium acetate  Roth 
Magnesium chloride  Riedel de Haen 
Magnesium sulphate  Merck 
Manganese chloride  Sigma-Aldrich 
Methanol  Riedel de Haen 
Microsint scintillation liquid Packard  Biosciences 
MOPS Roth 
N,N,N‘,N‘-Tetramethylethylendiamin (TEMED)  Sigma-Aldrich 
N,N-Dimethylformamide (DMF)  Fluka Chemie 
Sodium [125]iodide  Hartmann Analytic 
Nickel sulphate  Fluka 
Perchloric acid  Roth 
Phenylmethane sulfonyl fluoride (PMSF)  Sigma-Aldrich Chapter 4  Material 
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Phosphate standard solution  Sigma Aldrich 
Polyethylenglycol (PEG) 4000  Sigma-Aldrich 
Polyethylenimine cellulose plates  Merck 
Ponceau Red S  Sigma-Aldrich 
Potassium chloride  Roth 
Potassium acetate  Roth 
Potassium dihydrogen phosphate  Roth 
Rapid Fixer Solution G354  AGFA 
Salmon testes DNA  Sigma-Aldrich 
Silver nitrate  Roth 
Skim milk powder  Roth 
Sodium acetate  Roth 
Sodium azide  Roth 
Sodium bisulfite  Sigma-Aldrich 
Sodium carbonate  Merck 
Sodium chloride  Fluka 
Sodium dihydrogen phosphate  Roth 
Sodium fluoride  Sigma-Aldrich 
Sodium metavanadate  Sigma-Aldrich 
Sodium thiosulphate  Roth 
Sodium hydroxide  Riedel de Haen 
trans-4-Hydroxycinnamic acid (p-Coumaric acid)  Sigma-Aldrich 
Trichloracetic acid (TCA)  Roth 
Tricine Roth 
Trifluoroacetic acid, 98 % (v/v) (TFA)  Fluka 
Tris Roth 
Uridine-5'-triphosphate (UTP)  Fluka 
α-D-(+)-Galactose  Roth 
α-D-(+)-Glucose  Roth 
ε-Amino-n-caproic acid  Roth 
4.2 Detergents 
Name Company 
Decanoyl-n-hydroxyethylenglucamide (HEGA-10)  Anatrace 
Digitonin Calbiochem 
tetradecylphosphocholine (FC-14)  SynphaBase 
n-Dodecyl-β-D-maltopyranoside (DDM)  Anatrace 
n-Tetradecyl-n,n-dimethylamine-n-oxide (TDAO)  Anatrace 
Octaethylene glycol monododecyl ether (C12E18) Anatrace 
Octyl-β-D-glucopyranoside (OG)  Anatrace 
Sodium cholate  Anatrace 
Sodium dodecyl sulphate (SDS)  Roth 
Triton X-100  Anatrace 
Tween-20 Roth Chapter 4  Material 
  27
4.3 Cells  and  Media 
Name Company 
BL21(DE3) (E. coli) Novagen 
BY4743 (S. cerevisiae)  (Brachmann et al., 1998) 
W303-1A (S. cerevisiae)  (Thomas and Rothstein, 1989) 
Y24137 (S. cerevisiae)  (Brachmann et al., 1998) 
YLR188W (S. cerevisiae)  Open Biosystems  
Kanamycin Sigma  Aldrich 
Lactate Roth 
Peptone/Tryptone from Casein  Roth 
Yeast extract  Roth 
Yeast Nitrogen Base (with (NH4)2SO4) Invitrogen 
4.4  Enzymes, Markers and Kits 
Name Company 
Apyrase Sigma-Aldrich 
Benzonase Merck 
Hexokinase Sigma-Aldrich 
Lyticase Sigma-Aldrich 
Prestained Protein Marker, Broad Range  New England Biolabs 
Prestained Protein Molecular Weight Marker  MBI Fermentas 
Protein Molecular Weight Marker  MBI Fermentas 
TEV protease  Sigma-Aldrich 
Water HPLC grade  Merck 
BCA-kit Pierce 
4.5 Vectors 
Vector Relevant  Characteristics  Reference 
pMDL1p-NBD  pET28b carrying Mdl1p-NBD (D423-
R695) 
(Janas et al., 2003) 
pMDL1p-NBD(E599Q)  pET28b carrying E599Q-mutant Mdl1p-
NBD 
(Janas et al., 2003) 
pYES2.1/V5-His-TOPO-
Mdl1pfl 
pYES2.1/VS-His-TOPO
® carrying full-
length Mdl1p 
(Hofacker et al., 2006) 
pYES2.1/V5-His-TOPO-
Mdl1pfl_EQ 
pYES2.1/VS-His-TOPO
® carrying full-
length Mdl1p E599Q 
(Hofacker et al., 2006) 
pYES2.1/V5-His-TOPO-
Mdl1pfl_HA 
pYES2.1/VS-His-TOPO
® carrying full-
length Mdl1p H631A 
(Hofacker et al., 2006) 
4.6 Antibodies 
Antibody Source  Type/Dilution Specificity  Company 
R7/10  Rabbit  Polyclonal/1 : 500  C-term. of Mdl1p 
(KGGVIDLDNSVAREV) 
Research Ge-
netic Inc, Hunts-
ville 
Anti-Rabbit-IgG  Goat  Polyclonal/1 : 50,000  IgG (H + L)  Dianova 
Peroxidase an-
tiperoxidase 
Rabbit  Polyclonal/1 : 200  Protein A  Sigma-Aldrich Chapter 4  Material 
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4.7 Peptides 
Name Sequence/Reference 
R9LQK NH2-RRYQKSTEL-COOH (9-mer) 
R9LQK*  NH2-RΦYQΨSTEL-COOH (9-mer) 
T10 f-MYQR-Bpa
*-LYST-COOH (9-mer) 
T11 f-MYQR-Bpa
*-LYSTNAK-COOH (12-mer) 
X(8)  8-mer peptide library/(Uebel et al., 1995) 
X(23)  23-mer peptide library/(Uebel et al., 1995) 
4.8 Equipment 
Apparatus Manufacturer/Company 
Abbé refractometer  Krüss Optronic 
Autoclave 5075 ELVC  Tuttnauer Systec 
Cary 50 Bio UV Vis spectrophotometer  Varian 
Developer CP 1000  AGFA 
Incubator Kelvitron  Heraeus 
Infors Unitron   Infors 
Ino Lab pH-meter  WTW 
Kern 770 microbalance  Kern 
Light microscope  Leitz 
Liposofast extruder  Avestin 
Liquid scintillation counter LS 6500  Beckman 
Lumi imager F1  Roche 
Magnetic stirrer  Ikamag 
Membrane vacuum pump  Kobe 
Mettler PM 460 balance  Mettler 
Microwave T.D.S.  Samsung 
Milli Q-Plus water system  Millipore 
Multipipette Eppendorf 
EM208S electron microscope  FEI company 
Phosphor-Imager 445Si  Molecular Dynamics 
Polarstar Galaxy (ELISA reader)  BMG 
Power supply Elite 300 plus  Polymehr systems 
SDS-PAGE- BN-gel-apparatus  Institute workshop/BioRad/Hoeffer 
Thermomixer Eppendorf 
Vortexer  Bender & Hobein 
TVIPS 1Kx1K slow-scan CCD camera  Tietz 
Freeze-fracture unit 400T  Balzers 
Ikatherm HCB  IKA 
Aekta Explorer  GE Healthcare 
HiTrap Chelating (1 mL and 5 mL)  GE Healthcare 
SMART Chromtography System  GE Healthcare 
Superdex 200 HiLoad 16/60  GE Healthcare 
Superdex 200 HiLoad 26/60  GE Healthcare 
Superdex 200 PC 3.2/30  GE Healthcare 
Superdex 75 PC 3.2/30  GE Healthcare 
Superdex Peptide PC 3.2/30  GE Healthcare Chapter 4  Material 
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4.9 Centrifuges  and  Rotors 
Centrifuge Rotor 
Eppendorf Centrifuge 5417R  F-45-30-11 
Heraeus Sepatech Megafuge 1.0 R  BS4402/A 
Sorvall RC 3C Plus  H6000A 
Sorvall RC 5B Plus  GSA, GS3, SS34 
Beckman L-50  Ti 45, Ti 60, Ti 80, SW 27, SW 28 
Beckman TLX 100  TLA-55, TLA-100, TLA-110, TLA-120.2 
4.10 Supplementary material 
Material Company 
Biomax MS film  Kodak 
Cryotubes Nunc 
Cuvettes, plastic  Fisher Scientific 
Cuvettes, quartz glass  Hellma 
Douncer Braun 
Eppendorf tubes  Greiner 
Filter paper  Whatman 
Gloves, latex  Terumo Teruglove 
Gloves, nitril  Servoprax 
Microliter syringes  Hamilton 
Multiwellplates Greiner 
Nitrocellulose membrane  Schleicher & Schüll 
Pasteur pipettes  Merck 
PCR cups  Sarstedt 
Pipette tips  Greiner 
Pipettes Abimed 
Polycarbonate membranes, P.D. 400 nm  Avestin 
Spin columns  BioRad 
Spin concentrators (Amicon)  Millipore 
Sterile filters  Millipore 
Syringes (plastic, div volumes)  Braun 
Test tubes, sterile, 15 and 50 mL  Greiner Chapter 4  Material 
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4.11 Media, Buffers and Solutions 
4.11.1  Cell culture media 
LB medium (E. coli)  TYM medium (E. coli)  YEPD medium (S. cerevisiae) 
10 g/L peptone/tryptone  20 g/L peptone/tryptone  5 g/L yeast extract 
5 g/L yeast extract  5 g/L yeast extract  10 g/L (w/v) pepton/ 
tryptone 
5 g/L NaCl  0.1 M NaCl  20 mg/mL adenine 
  10 mM MgSO4  2 % (w/v) glucose 
   
or culture plates 2 % (w/v) agar 
is supplemented 
  or culture plates 2 % (w/v) agar 
is supplemented 
   
YEPGal medium 
(S. cerevisiae) 
Lactat medium 
(S. cerevisiae) 
SC medium 
(S. cerevisiae) 
5 g/L yeast extract  3 g/L yeast extract  6,7 g/L yeast nitrogen base 
with (NH4)2SO4 
10 g/L (w/v) pepton/ 
tryptone 
0.5 g/L glucose  1 x amino acid mix* 
20 mg/mL adenine  1 g/L KH2PO4  
2 % (w/v) galactose  1 g/L NH4Cl  
  0.5 g/L CaCl2  
  0.5 g/L NaCl   
  0.6 g/L MgCl2  
  2 % (v/v) lactic acid   
  adjust pH 5,5 with KOH  for culture plates 2 % (w/v) 
agar is supplemented 
* amino acid mix (20 x): 224 mg/L adenine, 768 mg/L arginine, 768 mg/L histidine, 1152 mg/L isoleucine, 
1152 mg/L leucine, 768 mg/L methionine, 960 mg/L phenylalanine, 1152 mg/L threonine, 768 mg/L tryptophan, 
288 mg/L tyrosine, 1152 mg/L valine 
4.11.2 Solutions  for  E. coli transformation 
TFBI solution  TFBII solution 
30 mM potassium acetate  10 mM Na-MOPS, pH 7.0 
50 mM MnCl2  75 mM CaCl2 
0.1 M KCl  10 mM KCl 
10 mM CaCl2  15 % (w/v) glycerol 
15 % (w/v) glycerol   
4.11.3 Solutions  for  S. cerevisiae transformation 
LiAc-TE buffer  Transformation-mix 
10 mM Tris-HCl, pH 7.5  PEG 4000 (40 % w/v) in LiAc-TE buffer  350 µL
1 mM EDTA  carrier DNA  25 µL
100 mM LiAc  plasmid DNA (0.1-10 µg DNA)  3 µLChapter 4  Material 
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4.11.4  Solutions for SDS-PAGE 
Collecting gel 
buffer 
Separating gel 
buffer 
SDS-Sample buffer 
(5 x) 
Running buffer 
(10 x) 
0.5 M Tris-HCl, 
pH 6.8  
1.5 M Tris-HCl, 
pH 8.8 
150 mM Tris-HCl, 
pH 6.8, 
250 mM Tris-HCl, 
pH 8.3 
0.4 % (w/v) SDS  0.4 % (w/v) SDS  6 % (w/v) SDS  1.92 M glycine, 
    30 % (w/v) glycerol  1 % (w/v) SDS 
    0.3 % (w/v) bromphenol-
blue 
 
4.11.5  Solutions for Tricine-PAGE 
Acrylamide  Cathode buffer (10 x)  Gel buffer (3 x)  Anode buffer (10 x) 
48 % (w/v) acrylamide   1 M Tris  3 M Tris-HCl, 
pH 8.45 
2 M Tris-HCl, 
pH 8.9 
1.5 % (w/v) bisacryla-
mide 
1 M Tricine  0.3 % (w/v) SDS   
dissolve in dH2O  1 % (w/v) SDS     
filtered and stored at 
RT in the dark 
    
4.11.6  Solutions for Blue-native gel electrophoresis 
Gel buffer (3 x)  Anode buffer  Cathode buffer 
150 mM Bis-Tris, pH 7.0  50 mM Bis-Tris, pH 7.0  15 mM Bis-Tris pH, 7.0 
200 mM ε-amino n-caproic acid    50 mM Tricine 
    +/- Coomassie blue G 
   
Digitonin buffer  Loading dye (10 x)   
20 mM Tris-HCl, pH 7.4  100 mM Bis-Tris, pH 7.0   
50 mM NaCl  500 mM ε-amino n-caproic acid   
10 % (v/v) glycerol  5 % (w/v) Coomassie blue G   
1 mM EDTA    
1 mM PMSF    
1 % (w/v) digitonin    
4.11.7  Solutions for Coomassie staining 
Stain solution  Destain solution 
40 % (v/v) methanol  40 % (v/v) methanol 
10 % (v/v) acetic acid  10 % (v/v) acetic acid 
0.25 % (w/v) Coomassie blue G   Chapter 4  Material 
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4.11.8  Solutions for Silver staining 
Fixation solution  Thiosulphate 
buffer 
Silver nitrate solu-
tion 
Developing solu-
tion 
30 % (v/v) ethanol  100 mM sodium- 
acetate pH 6.0 
0.1 % (w/v) AgNO3  2.5 % (w/v) Na2CO3 
10 % (v/v) acetic acid  30 % (v/v) ethanol  0.025 % (v/v) form- 
aldehyde 
0.05 % (v/v) form- 
aldehyde 
  1 mg NaS2O3/mL 
prior usage 
  
4.11.9  Buffers for electroblotting and immunodetection 
Blotting buffer  Blocking buffer  Wash buffer  10x TBS 
25 mM Tris-HCl, 
pH 8.2 
1x TBS  1x TBS  200 mM Tris-HCl, 
pH 8.0 
20 % (v/v) metha-
nol 
5 % (w/v) skim milk 
powder 
0.2 % (v/v) Tween-20  1.5 M NaCl 
192 mM glycine  0.2 % (v/v) Tween-20     
  0.1 % (w/v) NaN3    
      
ECL solution 1  ECL solution 2 
100 mM Tris-HCl, pH 8.5  100 mM Tris-HCl, pH 8.5 
2.5 mM luminol sodium salt  0.02 % H2O2 
0.4 mM coumaric acid   
4.11.10  Buffers for mitochondria isolation 
DTT buffer  Lyticase buffer  Homogenisation buffer  SEM buffer 
100 mM Tris-SO4, 
pH 9.4 
20 mM KPi, pH 7.4  10 mM Tris-HCl, 
pH 7.4 
20 mM MOPS, 
pH 7.2 
10 mM DTT  1.2 M sorbitol  600 mM sorbitol  250 mM sucrose 
    1 mM EDTA  1 mM EDTA 
    0.2 % BSA   
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5 Methods 
5.1 Molecular  Biology 
5.1.1 Cell  culture 
For expression of the Mdl1p-NBD the E. coli strain BL21(DE3) was transformed with the 
plasmids pMDL1p-NBD or pMDL1p-NBD(E599Q). LB medium was supplemented with 
50 µg/mL kanamycin after sterilisation and a 50 mL culture was inoculated with the transfor-
mants from an agarose plate and grown overnight at 37 °C and vigorous agitation. One litre of 
culture was inoculated 50 : 1 (v/v) with the overnight culture. The expression culture was 
grown at 37 °C to the midlogarithmic phase (OD600 = 0.5) for induction of protein expression 
with 0.2 mM IPTG. After 3 hours at 30 °C, cells were harvested (4,000 x g; 15 min; 4 °C) and 
the cell pellet was washed with water and recentrifuged (4,000 x g; 5 min; 4 °C). The pellet 
was frozen in liquid nitrogen and stored at -80 °C. 
For expression of full-length Mdl1p in S. cerevisiae the strain BY4743 (chapter 4.3) was 
transformed with the plasmid pYES2.1/V5-His-TOPO-Mdl1pfl, pYES2.1/V5-His-TOPO-
Mdl1pfl_EQ or pYES2.1/V5-His-TOPO-Mdl1pfl_HA and grown overnight in SC minimal 
medium (Sherman, 1991) supplemented with an amino acid mix without uracil and with 2 % 
glucose. Cells were harvested and resuspended to an OD600 of 0.4 in SC minimal medium 
supplemented with an amino acid mix without uracil and with 2 % galactose. Growth was 
continued at 30 °C and cells were harvested after 8 to 12 hours by centrifugation (5,000 x g; 
12 min; 4 °C). 
In order to test the influence of culture media in respect of the efficiency of the in organello 
synthesis and peptide export from mitochondria cells were grown in YEPD, YEPGal or Lactat 
medium. In all cases, a 5 mL starter culture was grown for at least 24 hours at 30 °C and used 
for inoculation of a 50 mL preculture (1 : 10) which was grown overnight at 30 °C. The main 
culture was inoculated with the preculture 40 : 1 and grown until an OD600 between 1 and 2 
was reached. 
5.1.2 Competent  E. coli cells 
An overnight culture of E. coli DH5α cells was diluted 1 : 100 in 100 mL TYM-medium and 
grown at 37 °C to an OD600 of 0.6. The culture was cooled on ice and the cells were harvested 
(1,000 x g; 10 min; 4 °C). 
The cell pellet was carefully resuspended in 10 mL sterile, ice-cold 0.1 M CaCl2 and incu-
bated on ice for 1.5 hours. After centrifugation the pellet was washed in 50 mL ice-cold TFBI 
solution and harvested again. The resulting pellet was resuspended in 5 – 10 mL TFBII solu-
tion. Cell aliquots of 100 µL were snap-frozen in liquid nitrogen and stored at -80 °C. Chapter 5  Methods 
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5.1.3  Transformation of competent E. coli cells 
Competent E. coli cells were thawed strictly on ice. Plasmid DNA (10 ng to 1 µg) was mixed 
with 100 µL of competent cells and incubated on ice for 30 minutes. The suspension was 
transferred to 42 °C for 45 seconds (heat shock). The cells were regenerated in 1 mL LB-
medium for 1 hour at 37 °C with vigorous agitation. The cell suspension was centrifuged 
(1,000 x g; 1 min; 25 °C) and plated on pre-warmed LB-agar plates supplemented with kana-
mycin (50 µg/mL) and incubated overnight at 37 °C. 
5.1.4 Transformation  of  S. cerevisiae cells 
The following stock solutions were prepared: 10 x TE buffer (100 mM Tris-HCl, pH 7.5; 
10 mM EDTA), 10 x lithium acetate (1M LiAc) and 50 % (w/v) PEG 4000. All solutions 
were autoclaved before use. Cryostocks of the designated cells were cultured for at least 
24 hours at 30 °C in 5 mL of the appropriate medium. Cells were washed with water and 
LiAc-TE buffer and finally resuspended in 50 µL LiAc-TE buffer. The carrier DNA 
(10 mg/mL Salmon testis DNA dissolved in TE buffer overnight at 4 °C, aliquoted and stored 
at -20 °C) was denatured at 95 °C for 20 minutes and placed on ice immediately. The LiAc-
treated cell suspension was added to the transformation mix and incubated at 30 °C for an 
hour. Subsequently, cells were placed at 42 °C for 10 minutes to trigger a heat shock response 
of the cells. 
The cells were sedimented (1,000 x g, 1 min, 4 °C) and the supernatant was discarded. For 
regeneration the cells were incubated for 1 hour in complex medium without selection pres-
sure. After harvesting, the cells were resuspended in a maximum of 100 µL of water, plated 
onto selective medium plates and incubated at 30 °C for 2 - 3 days. An additional selection 
step was performed by plating five to seven colonies onto a fresh selection agar-plate and in-
cubated for one day at 30 °C. 
5.1.5  Cryostocks of yeast cells 
5 ml YEPD medium was inoculated with a preexisting cryostock or started from an agarose-
plate and grown for two days at 30 °C. Subsequently cells were adjusted to 20 % (v/v) glyc-
erol (sterile), aliquoted to 500 µL, frozen in liquid nitrogen and stored at -80 °C. Chapter 5  Methods 
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5.2 Biochemical  Methods 
5.2.1 Standard  SDS-PAGE 
Sodium dodecyl sulphate polyacrylamid gel electrophoresis (SDS-PAGE) is used to separate 
proteins according to their size. SDS treatment of the samples dissociates non-covalent pro-
tein complexes into single subunits. Reducing agents like DTT are necessary to break disul-
phide bonds. Hence the structure of the protein is destroyed and polypeptide chains are un-
wound to filaments. As proteins associate with anionic SDS, the intrinsic charge of the protein 
is overcome producing identical mass/charge ratios and uniform ellipsoidal forms. In the elec-
trical field, polyanions are separated according to their molecular mass by the meshes of the 
polyacrylamide gel. 
After assembling the gel block the ingredients are mixed in a ration shown in the table below. 
The polymerisation reaction is started with 10 % (w/v) ammonium peroxidsulphate (APS; 
radical initialiser) and TEMED (radical stabiliser). 
  5 %  10 %  15 % 
30 % acrylamid  7 mL  24 mL  29 mL 
collecting gel buffer  5 mL  -  - 
separating gel buffer  -  18 mL  18 mL 
dH2O  28 mL  30 mL  25 mL 
APS  320 µL  470 µL  470 µL 
TEMED  32 µL  40 µL  40 µL 
After pouring the separation gel a layer of isopropanol is applied onto the surface, to get a 
sharp clear boundary between the separation and collecting gel. After 10 minutes of polymeri-
sation, the isopropanol is removed and the collecting gel is poured in the same manner. One 
comb per gel for the sample application was inserted before polymerisation. Wetted minigels 
can be stored for up to two weeks at 4 °C without effects on the resolution. Before electropho-
resis the proteins were dissolved in 5 x sample buffer supplemented with 40 mM DTT prior to 
usage. The soluble Mdl1p-NBD was incubated for 5 minutes at 95 °C and full-length Mdl1p 
as well as membrane protein fractions were incubated for 15 minutes at room temperature. 
SDS electrophoresis was performed at 120 V in the collecting gel and for 45 - 60 minutes at 
200 V in the separation gel at room temperature in a vertical flat bed apparatus with a plate 
size of 120 mm x 80 mm and a gel thickness of 0.75 mm. For molecular mass calibration 5 – 
8 µL of protein standard (s. chapter 4.4) was used. 
5.2.2 Tricine  SDS-PAGE 
After the assembling of a mid-size gel (16 x 8 cm
2, e.g. from BioRad), the stacking, spacer 
and separation gel solution are prepared according to the table below except for APS and 
TEMED which are only added directly before usage. After the separation gel is poured, it is 
directly overlaid with ~ 2.5 cm of the spacer gel. To ensure that the separation gel polymer-
ises before the spacer gel a excess of APS and TEMED is added. The spacer gel is covered by Chapter 5  Methods 
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isopropanol during the polymerisation process. After termination of the polymerisation and 
the removal of the isopropanol, the stacking gel (~ 1.5 cm) is poured. The samples run over-
night at either 80 V or 18 mA as limiting parameters. 
  4 % stacking gel  10 % spacer gel  16.5 % separation gel 
acrylamide  2.5 mL  6 mL  10 mL 
3 x gel buffer  7.5 mL  10 mL  10 mL 
glycerol     4  mL 
dH2O  20 mL  14 mL  6 mL 
10 % (w/v) APS  250 µL  100 µL  150 µL 
TEMED  25 µL  10 µL  15 µL 
5.2.3 Blue  Native-PAGE 
A gradient maker with a pump is used to pour a 16.5 % to 6 % gradient gel and a Hoeffer gel 
system is employed. Gels are poured the day prior to use and stored at 4 °C. Before loading 
the gel, samples are centrifuged (20.400 x g; 15 min; 4 °C) and 5 µL loading dye is added to 
45 µL sample. Cathode buffer (with Coomassie blue G) is gently overlaid on top of the sam-
ples and electrophoresis is as follows: 
The run was performed at 100 V in the stacking gel and 500 V in the gradient gel (total elec-
trophoresis time about 5 hours). The gel temperature was kept at 4 °C using a cooling water 
pump and magnetic stirrer. The cathode buffer is replaced by fresh cathode buffer without dye 
after the running front with Coomassie blue G has made its way through the gel. The electro-
phoresis run is complete just prior to exit of the blue front from the gel into the anode buffer. 
After documentation the proteins are transferred from the gel to a nitrocellulose membrane (s. 
chapter 5.2.5). 
6 % running gel  16.5 % running gel  Stacking gel 
3 mL gel buffer (3 x)  3 mL gel buffer (3 x)  2.5 mL gel buffer (3 x) 
1.07 mL acrylamide  
(49.5 % T, 3 % C) 
3.05 mL acrylamide 
(49.5 % T, 3 % C) 
0.6 mL acrylamide 
(49.5 % T, 3 % C) 
  1.8 mL glycerol   
38 µL APS (10 % (w/v))  30 µL APS (10 % (w/v))  30 µL APS (10 % (w/v)) 
3.8 µL TEMED  3 µL TEMED  3 µL TEMED 
add dH20 to 9 mL  add dH20 to 9 mL  add dH20 to 7.5 mL 
5.2.4  Coomassie and silver staining 
After electrophoretic separation of proteins via SDS-PAGE, the bands were fixed with acetic 
acid and stained by incubating the gel for 15 minutes in a solution of Coomassie brilliant blue. 
Excessive dye was removed with a mixture of acetic acid and methanol until distinct protein 
bands were visible. 
Silver staining is up to 100-fold more sensitive than Coomassie staining and can detect less 
than 10 ng protein. After fixation of the protein bands with acetic acid, contaminations are 
reduced with Na2S2O3. Rinsing the gel with water removes excess of Na2S2O3 which would Chapter 5  Methods 
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otherwise react with the silver reagent to form black silver sulphide. In the next step, the pro-
tein (functional groups and peptide bonds) reduces silver ions to silver nuclei. Harsh reductive 
agents like formaldehyde initiate reduction of all silver ions in the gel, but the silver nuclei 
dominate in growth and stain the protein bands black. The reaction is terminated by shifting 
the pH with acetic acid. 
For silver staining, the gel is incubated for 15 minutes in 50 mL fixation solution. In the next 
step the gel is shaken for 15 minutes in 50 mL thiosulphate buffer. Afterwards the gel is 
rinsed with water (4 x 5 min). For staining it is incubated for 30 minutes in 50 mL silver ni-
trate solution. After rinsing the gel with water the developing solution (100 mL) is added 
stepwise (2 x 20 mL, 1 x 60 mL) to enhance the contrast. The development of the gel is 
stopped with 1 mL acetic acid. Prior to scanning the gel is incubated for 5 minutes in water. 
5.2.5 Transfer  of  proteins  to nitrocellulose membranes 
The transfer of proteins from a SDS gel to a nitrocellulose membrane with subsequent immu-
nodetection is termed “Western Blotting”. The principles were described by (Renart et al., 
1979; Towbin et al., 1979). After separation of proteins by SDS-PAGE, they are blotted onto 
a membrane via electrotransfer. During electroblotting (Tankblotting, Semidry-Blotting) the 
SDS is removed from the protein due to different migration behaviour. The protein adheres to 
the membrane through hydrophobic interactions. 
Finally, the immunodetection is carried out by adding the first antibody against the blotted 
protein (antigen) followed by an antibody coupled to a reporter system like HRP. The enzyme 
catalyses the oxidation of luminol and the emitted chemiluminescence is enhanced by cou-
maric acid. 
The principle setup of the apparatus is depicted in Figure 5.1. The gel is placed on a nitrocel-
lulose membrane with dimensions of 10 cm x 7 cm and sandwiched by Whatmann paper 
soaked in blotting buffer. The sandwich is transferred to a Semidry apparatus from Bio-RAD 
with the nitrocellulose membrane facing the anode. The transfer runs for 1 hour with a current 
of 1,43 mA/cm
2. 
Alternatively, the blotting buffer soaked sandwich is placed in a tank blot apparatus (Bio-Rad) 
in which the transfer of proteins takes place overnight at 18 V. To determine whether the pro-
teins were transferred to the same extend, the membrane was stained with Ponceau Red 
(0.1 % Ponceau Red S (w/v), 5 % (v/v) acetic acid) for 5 minutes, and washed with water un-
til defined bands become visible. 
For immunodetection the membrane was incubated with blocking buffer for at least 
30 minutes at room temperature or overnight at 4 °C. After blocking the membrane was incu-
bated at room temperature for at least 1 hour with the primary antibody against Mdl1p which 
was diluted 1 : 500 in TBS-T (1 x TBS supplemented with 2 % Tween-20) completed with 
2 % (w/v) skim milk powder. After three times washing with wash buffer for 5 minutes, the Chapter 5  Methods 
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membrane was incubated with horseradish peroxidase conjugated second antibodies in an 
appropriate dilution for an hour. 
 
Figure 5.1: View of a Trans-Blot SD cell. 1: lid; 2: cathode; 3, 6: filter paper; 4: gel; 5: membrane; 7: anode; 
8: power cables; 9: base. 
Subsequently, the membrane was washed again three times and incubated with 10 mL ECL 
solution 1 for 5 minutes followed by 10 mL ECL solution 2 for 30 seconds. The chemilumi-
nescent signal was detected by a LumiImager. Alternatively, the ECL-system from GE 
Healthcare was used and the light reaction was detected by a photographic film. 
5.2.6  Purification of the Mdl1p-NBD 
The cloning of the NBD was done by Dr. Eva Janas, Institute of Biochemistry Goethe-
University Frankfurt and is described in (Janas et al., 2003). Briefly, the NBD-fragment was 
amplified by PCR on genomic DNA of S. cerevisiae. The resulting PCR fragment was puri-
fied and cloned into the BamHI and HindIII sites of pET28b resulting in plasmid pMDL1p-
NBD (chapter 4.5). Expression was controlled by the vector derived T7 promoter. The recom-
binant plasmid includes the expression cassette with an N-terminal His(6)-tag, a thrombin 
cleavage site and a T7-tag encoded by the vector (Figure 5.2). 
Figure 5.2: Schematic representation of the Mdl1p-NBD expression cassette. The cassette includes the vector 
derived His(6)-tag (purple), a thrombin cleavage site (blue) and a T7-tag (yellow) on the N-terminus of the NBD 
(grey). 
A conserved glutamate (E599, GAA) located one amino acid downstream of the Walker B 
motif was changed to glutamine (Æ CAA) resulting in the plasmid pMDL1p-NBD(E599Q). Chapter 5  Methods 
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E. coli strain BL21(DE3) was transformed with the plasmids and grown in LB medium with 
50 µg/mL kanamycin at 30 °C. At an OD600 of 0.5 the cells were induced with 0.2 mM IPTG, 
and after 3 hours the cells were harvested by centrifugation. 
To purify the NBD with the His(6)-tag ‘immobilised metal-ion affinity chromatography’ 
(IMAC) was applied. This method is used to separate His-tagged biomolecules via complex 
formation from the rest of low affine or non-binders. The column material consists of agarose 
modified with iminodiacetate. After loading with Ni
2+, a complex is formed with molecules, 
e.g. proteins, bearing a five or more times histidine repeat. The binding specificity is en-
hanced in the presence of low concentrations of imidazole, which competes with histidines for 
metal binding sites. His-tagged proteins are eluted in the order of increasing complex stability 
with an imidazole gradient. 
All buffers for chromatographic purposes were sterile filtered and degassed before use. Cells 
were pelleted and resuspended in lysis buffer (10 mM Na2HPO4/NaH2PO4, pH 7.6, 150 mM 
NaCl, 5 mM KCl, 20 mM imidazole, 1 mM PMSF) containing 1 % lysozyme, and 5 - 10 U 
benzonase and disrupted by French press treatment at 1,000 p.s.i. After centrifugation 
(100,000 x g; 1 h; 4 °C) the supernatant was applied via an Äkta explorer on a 5 mL HiTrap 
Chelating HP Ni-IDA column loaded with a Nickel sulphate solution (100 mM) and preequi-
librated with running buffer (10 mM Na2HPO4/NaH2PO4, pH 7.6, 150 mM NaCl, 5 mM KCl, 
20 mM imidazole). The chromatographic process was monitored by recording protein absorp-
tion at 280, 260 and 216 nm. After washing the column with a step gradient of 80 mM and 
100 mM imidazole, the protein is eluted with elution buffer (10 mM Na2HPO4/NaH2PO4, 
pH 7.6, 150 mM NaCl, 5 mM KCl, 250 mM imidazole). 
Further purification of the protein was achieved by a size exclusion chromatography (SEC) 
step to separate the NBD from contaminating proteins and high molecular aggregates. Se-
lected fractions from the IMAC containing the NBD were combined, concentrated via Ami-
con Ultra centrifugal filter device (MWCO 10,000 Da) and applied to a superdex 200 16/60 
HiLoad size exclusion chromatography column preequlibrated in size exclusion buffer 
(20 mM Tris-HCl, pH 8; 100 mM NaCl). 
The size exclusion chromatography separates molecules according to their molecular mass 
due to different permeation of analytes in a porous matrix. High molecular weight compounds 
are hindered from entering the matrix and elute in the void volume with the solvent. Low mo-
lecular weight substances move according to their size in the internal pore volume. Thus they 
are retained on the column and eluted within a characteristic elution volume. 
For column calibration a solution containing 0.5 % (w/v) each of aldolase (158 kDa), catalase 
(232 kDa) and thyroglobulin (669 kDa) in phosphate buffer were analysed after filtration. For 
each standard substance the logarithm of its molecular mass was plotted against the elution 
volume. Chapter 5  Methods 
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The NBD eluted with an apparent molecular weight of 33 kDa corresponding to the size of 
the monomer. Peak fractions of monomeric NBD were combined and concentrated up to 
10 mg/mL in an Amicon Ultra centrifugal filter device (MWCO 10,000 Da) and stored in the 
presence or absence of 5 mM ATP at 4 °C. The addition of ATP was figured out to have a 
positive effect on the stability of the NBD since almost no precipitation after several days of 
storage was observable. Wild-type and mutant proteins were purified to greater than 99 % 
homogeneity as assessed by Coomassie stained protein on SDS-PAGE and MALDI-TOF. 
5.2.7 Dimerisation  Assay 
For several mutants of ABC transporter NBDs e.g. MJ0796(E171Q), MJ1267(E179Q) 
(Moody et al., 2002) or GlcV(E166Q) (Verdon et al., 2003b) it was reported that a specific 
dimerisation occurs upon addition of ATP. This effect was used to examine the oligomeric 
state of the Mdl1p-NBD in more detail. 
Before use, ortho-vanadate stock solution adjusted to pH 8.0 was boiled for five minutes to 
break polymeric species. Before use, beryllium fluoride solution was prepared by mixing 
BeCl2 and NaF in a ratio of 1 : 100 (mol/mol). For non-radioactive assays, purified wild-type 
NBD (30 µM) was incubated with different concentrations of beryllium fluoride (BeFx) or 
ortho-vanadate in the presence or absence of nucleotides and nucleotide analogues for five 
minutes at 30 °C in binding buffer. The mutant NBD (E599Q, 30 µM) was incubated for 5 
minutes in the absence of Mg
2+ and on ice (non-hydrolysing conditions) or in the presence of 
5 mM Mg
2+ and at 30 °C (hydrolysing conditions) with different concentrations of nucleo-
tides and nucleotide analogues. The samples were applied to a Superdex 75 PC 3.2 size exclu-
sion chromatography column at a flow rate of 50 µL per minute at 4 °C in 20 mM, Tris pH 
8.0, 150 mM NaCl, and 5 mM MgCl2 as indicated. 
5.2.8  Determination of the Nucleotide Stoichiometry 
In this method, ATP is hydrolysed and the resulting ADP is captured in situ, via interaction 
with beryllium-fluoride or ortho-vanadate, that mimic different stages in hydrolysis, the pre 
hydrolysis state (BeFx) and the transition state (VO4) (Fisher et al., 1995; Smith and Rayment, 
1996). 
Radioactive trapping experiments were performed in the same buffer as non-radioactive trap-
ping experiments and separated by size exclusion chromatography. Fractions were analysed 
by β-counting, thin layer chromatography and for protein concentration by the BCA assay. 
Over the range of protein concentrations used, the absorption at 280 nm measured with the 
UV detector of the SMART system was linearly related to the protein concentration deter-
mined by the BCA assay. In particular, wild-type NBD (250 µM) was incubated with 500 µM 
MgATP supplemented with 0.1 µM of either [α-
32P]ATP or [γ-
32P]ATP (4,500 Ci/mmol) in 
the presence of BeFx (500 µM) for 5 minutes at 30 °C. The E599Q mutant (250 µM) was in-
cubated for 5 minutes in the absence of Mg
2+ and on ice. To follow one to two turn-overs of Chapter 5  Methods 
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the E599Q mutant, 250 µM NBD were incubated for prolonged time periods (0 – 500 min) at 
30 °C with limiting concentration of MgATP (250 – 500 µM) and tracer amounts of radioac-
tive ATP. To test whether ADP is incorporated in the dimer at a high ADP concentration, the 
E599Q mutant was incubated with 500 µM ADP and 0.1 µM [α-
32P]ADP in the presence of 
various concentration of unlabeled ATP (0, 5, 50, 100 and 500 µM) for 10 minutes at 30 °C. 
Alternatively, incorporation of ADP under limiting concentrations of MgATP was tested by 
incubation of the E599Q mutant (250 µM) with MgATP (250 – 500 µM) supplemented with 
tracer amounts of [α-
32P]ADP at 30 °C for 400 minutes. The [α-
32P]ADP was formed by in-
cubation of [α-
32P]ATP with hexokinase according to the manufacturers instructions and 
separated from hexokinase by Centricon 10 centrifugation. Full conversion to [α-
32P]ADP 
was confirmed by thin layer chromatography. 
In a similar approach, the nucleotide content in full-length Mdl1p was assayed. H631A-
mutant Mdl1p (50 µg/mL) was incubated with 4.82 mM ATP supplemented with 0.062 µM 
[γ-
32P]ATP for 5 minutes at 4 °C. The sample was applied to a Superdex 200 size exclusion 
chromatography column and fractions were analysed in respect of their nucleotide by β-
counting and protein content using the Bradford assay. 
5.2.9  Thin layer chromatography (TLC) 
The nucleotide composition of the dimer was analysed by TLC according to (Scheffers et al., 
2000). Immediately after size exclusion chromatography the fraction containing the NBD-
dimer was incubated with 15 mM EDTA for 30 minutes and precipitated with trichloroacetic 
acid (10 % w/v) for 30 minutes at 4 °C. After centrifugation at 20,400 x g for 5 minutes, the 
sample was neutralised with 0.5 M KHCO3, pH 8.3 and applied onto polyethylenimine (PEI) 
cellulose plates in 2 M formate and 250 mM LiCl. [α-
32P]ATP and [γ-
32P]ATP treated with 
hexokinase were used as references. 
5.2.10 Nucleotide  binding  assays 
Nucleotide binding was measured by 8-azido-[α-
32P]ATP photocross-linking experiments as 
described in (Wolters et al., 2005). Purified Mdl1p (0.5 µM) was incubated with increasing 
concentrations of 8-azido-[α-
32P]ATP for 5 minutes on ice and than irradiated with UV light 
for 5 minutes. For concentrations of 10 µM and above, 8-azido-[α-
32P]ATP was supple-
mented 1:5 (mol/mol) with non-radioactive 8-azido-ATP. Subsequently, samples were ana-
lysed by SDS-PAGE (10 %). Gels were dried and exposed to a Kodak SO230 phosphor 
screen. Photocross-linked protein was quantified by phosphor-imaging. The intensities (I) 
were plotted against the 8-azido-ATP concentration and fitted with a 1:1 Langmuir binding 
isotherm. To determine the half maximal inhibitory concentration (IC50) for ATP, equation 
5.1 was used (where bg displays background intensity). Chapter 5  Methods 
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Applying the Cheng-Prusoff equation (Cheng and Prusoff, 1973), the dissociation constant KD 
for ATP was derived from the IC50 value for ATP and the KD value for 8-azido-ATP as shown 
in equation 5.2. 
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5.2.11  Isolation of yeast mitochondria 
The mitochondria were isolated according to (Meisinger et al., 2000). Cells were harvested by 
centrifugation (5,800 x g; 12 min; RT), washed once with distilled water, resuspended with 
2 mL/g of wet weight cells in DTT buffer and incubated for 20 minutes at 30 °C under gentle 
shaking. The preincubation with DDT facilitates the break of disulphide bonds preparing the 
subsequent digestion of the cell wall by lyticase. After centrifugation (1,600 x g; 8 min; RT) 
the cell pellet was washed once with 1.2 M sorbitol in order to remove DTT traces. The cell 
pellet is resuspended in lyticase buffer at 7 mL/g wet weight cells. 4 mg lyticase per g wet 
weight of cells were added and the suspension was incubated at 30 °C with gentle shaking for 
45 minutes. Conversion of spheroplasts was checked measuring the OD600 of a 1 : 100 dilu-
tion (in dH2O) which decreases over time. Spheroplasts were harvested by centrifugation 
(1,600 x g; 8 min; 4°C) and washed very carefully in lyticase buffer without lyticase. After-
wards the speroplasts were resuspended in 7 mL/g wet weight of cells in homogenisation 
buffer and lysed by homogenisation with a tight fitting douncer (15 strokes) at 4 °C. The ho-
mogenate was centrifuged (700 x g; 10 min; 4 °C) to remove non-lysed speroplasts and cell 
debris. An additional clearing step is made (1,250 x g; 8 min; 4 °C) and the mitochondria 
were harvested with a high speed centrifugation step (11,250 x g; 15 min; 4 °C). The pellet 
was carefully washed with 5 mL SEM buffer and centrifuged (11,250 x g; 15 min; 4 °C) 
again. The crude mitochondria pellet was resuspend in SEM buffer to a final protein concen-
tration of 10 mg/mL, aliquoted, shock frozen with liquid nitrogen and stored at -80°C. 
The protocol described above provides a crude mitochondria preparation that contains signifi-
cant amounts of non-mitochondrial proteins, especially derived from the endoplasmatic re-
ticulum. Many applications, however, require a clear separation of mitochondria from micro-
somes. Therefore, a purification protocol using a sucrose density gradient was applied. The 
crude mitochondria fraction was loaded onto a three step sucrose gradient (1.5 mL 60 %, 
4 mL 32 %, 1.5 mL 23 %, 1.5 mL 15 % sucrose in 20 mM HEPES, pH 7.2). After centrifuga-
tion (76,000 x g, 3 h, 4 °C) in a SW 28 swinging-out rotor the purified mitochondria were 
recovered from the 60 %/32 % interface. Chapter 5  Methods 
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5.2.12 Tandem  Affinity  Purification 
The tandem affinity purification (TAP) tag consists of a calmodulin binding peptide, a TEV 
cleavage site and two IgG binding domains of Staphylococcus aureus protein A (Figure 5.3). 
 
Bild 5.3: Schematic representation of Mdl1p with a C-terminal TAP tag. Overview of the TAP purification strategy: 
After solubilisation the TAP tagged protein binds to IgG-sepharose beads via its protein A portion and is specifi-
cally eluted by TEV cleavage. The second purification step uses the high affinity of a calmodulin binding peptide 
to calmodulin sepharose beads. After the binding step and stringent washing the protein is eluted by addition of 
EGTA. 
S. cerevisiae strain YLR188W where Mdl1p is fused to a C-terminal TAP-tag was grown in 
YEPD medium to an OD600 of 1.5 and mitochondria were prepared. For tandem affinity puri-
fication of Mdl1p a modified protocol according to (Rigaut et al., 1999) was used. 750 µg 
mitochondria were pelleted (20,400 x g; 5 min; 4 °C) and resuspended in solubilisation buffer 
(20 mM Tris-HCl, pH 8; 150 mM NaCl; 20 % glycerol (w/v)) supplemented with 1.6 % (v/w) 
Triton X-100 and complete protease inhibitor and solubilised for 30 minutes on ice. Soluble 
and insoluble fractions were separated (190,000 x g; 20 min; 4 °C) and the supernatant was 
diluted 1 : 2 with solubilisation buffer in order to lower the Triton X-100 concentration. 50 µL 
of IgG-beads were washed 3 x with solubilisation buffer and the diluted sample was added to 
allow binding for 2 hours at 4 °C under gentle rotation. Beads were sedimented by gravity and Chapter 5  Methods 
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washed 3 x with 175 µL solubilisation buffer supplemented with 0.2 % (v/v) Triton X-100, 
1mM DTT and 0.5 mM EDTA. Protein was eluted by TEV cleavage. 
Therefore, the beads with bound protein were incubated with 20 units TEV protease for 1 to 4 
hours. Afterwards the supernatant was separated from the beads and used for electrophoretic 
analysis and immunodetection. 
In an alternative approach the supernatant was adjusted to 10 mM β-mercaptoethanol, 1 mM 
Mg-acetate, 1 mM imidazole and 2 mM CaCl2 after ultracentrifugation and added to 50 µL 
prewashed calmodulin beads. Binding was performed for 1 hours at 4°C. Beads were sedi-
mented by gravity and washed 3 x with buffer C. Protein was eluted 3 x with 50 µL of buffer 
E (10 mM β-mercaptoethanol; 10 mM Tris-HCl, pH 8.0; 150 mM NaCl; 1 mM Mg-acetate; 
1 mM imidazole; 2 mM EGTA; 0.2 % Triton X-100). 
5.2.13  In organello translation 
The translation of mitochondrial encoded proteins was modified according to a protocol from 
(McKee et al., 1984) with isolated mitochondria. 100 µL of 1.5 x translation buffer (0.9 M 
sorbitol; 22.5 mM KPi buffer pH 7.2; 30 mM Tris-HCl, pH 7.4; 225 mM KCl; 19 mM 
MgSO4; 6 mM ATP; 0.75 mM GTP; 2 mM NADH; 7.5 mM α-ketoglutarate; 7.5 mM phos-
phoenolpyruvate; 150 µM of all amino acids except methionine; 4.5 mg/mL BSA (fatty acid 
free)) was mixed with 33 µL H2O and 2 µL pyruvatkinase (2 mg/mL) and 10 µL mitochon-
drial suspension (10 µg/µL). The whole mix was incubated for 3 minutes at 30 °C. Subse-
quently 5 µL [
35S]-methionine was added and the mixture was incubated for an additional 20 
minutes. The chase was stopped upon addition of 38 µL 0,2 M unlabeled methionine. The 
sample was centrifuged for 5 minutes at 9,000 x g (4 °C) and the pellet was washed two times 
with 500 µL SHKCL buffer (50 mM HEPES-KOH, pH 7.4; 0.6 M sorbitol; 80 mM KCl) plus 
5 mM methionine. 
5.2.14 Monitoring  peptide  export from mitochondria 
The assay was basically performed as described by (Augustin et al., 2005). Purified mito-
chondria were resuspended in translation buffer (0.6 M sorbitol; 15 mM KPi buffer pH 7,2; 
20 mM Tris-HCl, pH 7.4; 150 mM KCl; 12.5 mM MgSO4; 4 mM ATP; 0.5 mM GTP; 1.25 
mM NADH; 5 mM α-ketoglutarate; 5 mM phosphoenolpyruvate; 100 µM of all amino acids 
except methionine; 3 mg/mL BSA (fatty acid free). After two additional washing steps using 
1 mL of SHKCl buffer, mitochondria were incubated in translation buffer lacking pyruvate 
kinase at a concentration of 10 mg/mL for 30 minutes at 37 °C to allow proteolysis to occur. 
Samples were separated into supernatant and pellet fractions by centrifugation (16,100 x g; 4 
min; 4 °C). Mitochondrial supernatants (50 µL) were subjected to size exclusion chromatog-
raphy at 12 °C using a Superdex peptide column (PC 3.2/30) (equilibrated in 40 % (v/v) ace-
tonitrile, 0.1 % (v/v) trifluoracetic acid). Chapter 5  Methods 
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5.2.15 Detergent  screening 
To test the solubilisation efficiencies of different detergents, mitochondria (5 mg/mL) were 
solubilised for 30 minutes in buffer S (50 mM Tris-HCl, pH 8.0; 150 mM NaCl; 15 % (v/v) 
glycerol; 2 mM imidazole) with DDM, FC-14 and digitonin in concentrations defined by a 
ρ-value of 15 and 50 respectively (eq. 5.3; where [lipid] is 0.1 times the protein concentration 
and the average molecular weight of a lipid was taken as 875 Da). 
 
[lipid]
CMC   -   ] [detergent
   = ρ   (eq. 5.3)
Fractions were separated by centrifugation (100,000 x g, 4 °C, 30 min) and soluble/insoluble 
Mdl1p was compared by Western blotting using an anti-Mdl1p antibody. 
5.2.16  Purification of full-length Mdl1p 
Cloning of the full-length MDL1 expression vectors pYES2.1/V5-His-TOPO-Mdl1fl, 
pYES2.1/V5-His-TOPO-Mdl1fl_EQ and pYES2.1/V5-His-TOPO-Mdl1fl_HA was done by 
S. Gompf, C. Presenti and C. van der Does, Institute of Biochemistry, University Frankfurt 
and described in (Hofacker et al., 2006). By introducing several new restriction sites, the 
MDL1-gene was systematically divided into three cassettes, thus facilitating later exchange 
between different constructs. MDL1 cassettes were amplified by PCR on genomic DNA of S. 
cerevisiae. Cassette I includes the N-terminus of Mdl1p until a silent ClaI site introduced be-
tween amino acid A220 and S221. Cassette II includes the middle domain of Mdl1p from the 
introduced ClaI site, to an intrinsic and unique BamHI site comprising amino acids S221 to 
D423. Cassette III includes the C-terminal NBD from amino acid P424 to V695. 
To generate the yeast over-expression vector, the MDL1-gene was amplified by PCR and 
cloned into pYES2.1/V5-His-TOPO via the TOPO TA Expression cloning kit. This resulted 
in a construct expressing Mdl1p with a C-terminal Gly(4)-spacer, a factor Xa cleavage site and 
a His(8)-tag via the galactose inducible promoter of pYES2.1 (Figure 5.4). 
 
Figure 5.4. Schematic representation of the Mdl1p full-length expression cassette. The cassette includes a newly 
introduced Kozak sequence, the mitochondrial targeting sequence (yellow), the transmembrane domain (blue) 
which is split up into two parts, the nucleotide binding domain (grey), a glycine spacer (orange) and a factor Xa-
cleavage site (green). The His(8)-tag (purple) lies on the 3´-end of the construct. 
Mitochondria (5 mg/mL) were solubilised in buffer S supplemented with 1 % (w/v) - corre-
sponding to a ρ-value of 15 - digitonin and complete protease inhibitor cocktail (EDTA free) 
for 30 minutes at 4 °C under gentle shaking. Soluble and insoluble fractions were separated 
by  centrifugation (100,000 x g, 4 °C, 30 min) and the supernatant was applied to a HiTrap 
chelating IDA-column loaded with Ni
2+ and equilibrated with IMAC buffer (50 mM Tris-Chapter 5  Methods 
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HCl, pH 8.0; 150 mM NaCl; 15 % (v/v) glycerol; 2 mM imidazol; 0.1 % digitonin). The col-
umn was washed with 60 and 120 mM imidazole and finally Mdl1p was eluted in IMAC 
buffer containing 200 mM imidazole. The identity of the purified protein was confirmed by 
western blotting and MALDI-TOF peptide mass fingerprint (PMF) analysis of the trypsin 
digested protein using Mascot (database NCBInr 20040521) as reference. 
For N-terminal aminoacid sequencing (Edman degradation) the protein was subjected to a 
10 % SDS-PAGE and subsequently transferred to a PVDF membrane. The membrane was 
Coomassie stained, welded in an autoclave bag and submitted for external sequencing (Bio-
technology Laboratory University of British Columbia, Canada) 
5.2.17  ATP hydrolysis assays 
The ATPase activity of the full-length Mdl1p was determined essentially as described in 
(Gorbulev et al., 2001). 25 µL of ATP buffer A (50 mM Tris-HCl, pH 8; 150 mM NaCl; 
10 mM DTT; 20 mM MgCl2) with varying concentrations of ATP supplemented with [γ-
32P]ATP (4 µCi) and 0.02 % (w/v) FC-14, 0.02 % (w/v) DDM or 0.1 % (w/v) digitonin was 
mixed with 25 µL of detergent solubilised protein and incubated for 10 minutes at 30 °C. The 
reaction was stopped by addition of 1 mL of reagent A (2.5 M H2SO4, 1 % (w/v) ammonium 
molybdate, 15 µL of 20 mM H3PO4). 2 mL of reagent B (isobutanol, cyclohexane, acetone 
and reagent A in a ratio of 5:5:1:0.1) were added and the sample was vortexed vigorously for 
30 seconds. After phase separation, 1 mL of the organic phase was mixed with scintillation 
fluid and the release of inorganic phosphate was determined by β-counting. Maximal velocity 
of the reaction vmax and the Michaelis constant KM were derived by fitting the data to the 
Michaelis-Menten equation (eq. 5.4; where [S] reflects the substrate concentration): 
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To see whether ATP hydrolysis shows a cooperative behaviour in respect of the ATP concen-
tration the Hill coefficient was determined using equation 5.5. 
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A similar protocol, using 25 µL of 0.4 mg/mL proteoliposomes was used to determine the 
ATPase activity of reconstituted Mdl1p. 
5.2.18 Reconstitution  of  Mdl1p 
E. coli lipids were suspended in buffer R (50 mM Tris-HCl, pH 7; 25 mM KCl) at a concen-
tration of 4 mg/mL. The lipid suspension was extruded 11 times through a 400 nm polycar-
bonate filter. The liposome suspension was then titrated to a final DDM concentration of 
4.2 mM and mixed in a lipid to protein ratio of 200 : 1 (mol/mol) with detergent solubilised Chapter 5  Methods 
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Mdl1p. Polystyrene beads (Bio-beads SM-2) were washed three times with methanol, five 
times with buffer R and incubated in a suspension of E. coli lipids. After incubation for 
30 minutes at room temperature, polystyrene beads were added to a final concentration of 
80 mg/mL, and the mixture was incubated overnight at 4 °C. Fresh Bio-beads (80 mg/mL) 
were added and an additional incubation was performed for 60 minutes at 4 °C. After removal 
of Bio-beads, proteoliposomes were pelleted by centrifugation (190,000 x g, 1 h, 4 °C), resus-
pended in buffer R, applied to a sucrose step gradient (10, 20, and 30 % (w/v)); centrifuged 
(100,000 x g; 18 h; 4 °C) and different fractions were collected. The sucrose concentration of 
each fraction was determined by an Abbé refractometer while the protein concentrations were 
determined by quantitative immunodetection using solubilised Mdl1p as reference. 
5.2.19 Phospholipid  concentration determination 
The lipid concentration was determined essentially as described (Chen et al., 1956). Samples 
of 10-100 µL were mixed with an equal volume of 70 % (v/v) perchloric acid and after drying 
the samples for 2 hours at 200 °C, 700 µL reagent C (2.5 % (w/v) ammonium molybdate, 
12.5 % perchloric acid) and 700 µL 3 % (w/v) ascorbic acid was added. Finally, the samples 
were incubated for 5 minutes at 100 °C and absorbance at 820 nm was measured and com-
pared to a phosphate standard. 
5.2.20 Freeze-fracture  electron  microscopy of reconstituted Mdl1p 
Freeze-fracture electron microscopy of reconstituted Mdl1p was done in collaboration with 
Dr. Winfried Haase in the department of Prof. Dr. Werner Kühlbrandt from the Max-Planck-
Institute of Biophysics Frankfurt. A drop from a suspension of reconstituted membrane vesi-
cles was placed between two small copper blades and rapidly frozen in ethane cooled to -
180 
oC. Samples were fractured in a freeze-fracture unit 400T and shadowed with plati-
num/carbon at an angle of 45
o. Replicas reinforced by pure carbon shadowing at an angle of 
90° were cleaned from organic material in chromo-sulphuric acid and analyzed by electron 
microscopy in an EM208S electron microscope. Images were taken with a TVIPS 1Kx1K 
slow-scan CCD camera. 
5.2.21 Peptide  photocross-linking and detection 
To elucidate the role of Mdl1p in peptide transport peptide cross-linking experiments were 
performed. As control samples microsomes prepared from Sf9 insect cells containing the TAP 
peptide transporter were used (kindly provided by Dr. Min Chen). 
An approach according to (Uebel et al., 1997) was chosen and the following peptides were 
selected: R9* (NH2-RΦYQΨSTEL-COOH, Figure 5.5) with the cross-linker function 
trifluoromethyl-diazirinophenylalanine on position 2 and the peptide T10 (f-MYQR-Bpa-
LYST-COOH) with the cross-linker 4-benzoyl-L-phenylalanyl (Bpa) in position 5. Chapter 5  Methods 
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Figure 5.5: The photoactivateable peptide R9* which was used for cross-linking experiments to elucidate the role 
of Mdl1p in peptide transport (Uebel et al., 1997). 
T10 was designed according to findings that formylated peptides were found in complex with 
class I major histocompatibility molecules at the surface of mammalian cells as so called mi-
nor antigens derived from mitochondrial encoded respiratory chain subunits e. g. subunit I of 
cytochrome c oxidase. The original sequence of Cox1p from S. cerevisiae (MVQRWLYS 
TNAK) was modified to meet the requirements of photocross-linking hence tryptophane in 
position 5 was exchanged for Bpa and valine in position 3 was interchanged with tyrosine in 
order to label the peptide with Na
125I. 
The photocross-linker peptides were labelled with Na
125I (see 5.2.22) and added to 12.5 µg 
microsomes to reach a final concentration of 4 µM. The same peptide concentration was used 
for experiments using mitochondria prepared from S. cerevesiae strains expressing either no 
Mdl1p or Mdl1p under different conditions. 75 µg mitochondria were solubilised in SEM 
buffer containing 0.8 % Triton X-100 for 10 minutes. Peptide binding was allowed for 
3 minutes in ice-cooled aluminium devices and UV irradiation was performed for 10 minutes 
at 350 nm with a UV lamp. In a second set cross-linker peptides were competed out by using 
a 100-fold excess of non-labelled R9 (without the cross-linker function) or T10. Samples were 
incubated with 1 x loading buffer for 10 minutes at 65 °C and subjected to a 10 % SDS-
PAGE. The gel was exposed to a Biomax x-ray film after drying and the autoradiography was 
developed after 48 hours using an automated film developer machine. 
5.2.22 Peptide  iodination 
Iodination of peptide libraries and peptide transport was performed essentially as described in 
(Chen et al., 2003b) and (Hunter and Greenwood, 1964). Chloramine T solution (1 mg/mL) 
and sodium bisulfite (0.17 mg/mL) were freshly prepared in PBS, pH 7.0. The reaction was 
routinely performed with 1.5 nmol peptide in a total volume of 50 µL and 1 µL (100 µCi) 
Na
125I. The reaction was started by addition of 10 µL chloramine T. After 5 minutes incuba-
tion at room temperature, the reaction was stopped by addition of 120 µL Na2S2O5 (sodium 
bisulphite). Free iodine was removed by anion exchange chromatography using Dowex 1 x 8 
material. Dowex (10 mg) was equilibrated in PBS, pH7.0 containing 0.2 % dialysed BSA and 
was washed two times with PBS buffer without BSA. The Dowex suspension (220 µL) was Chapter 5  Methods 
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added to the radiolabeled reaction mix, vortexed and incubated for 5 minutes at room tem-
perature. The suspension was applied to an empty spin column and centrifuged for 2 minutes 
at 20,400 x g. The eluat contained the radiolabelled peptide in a concentration of approxi-
mately 3.75 µM. 
5.2.23  Peptide transport Assay 
Proteoliposomes (0.5 µg of Mdl1p) were preincubated with 4.8 mM ATP and 10 mM MgCl2 
in 50 µL of transport buffer (50 mM Tris-HCl, pH 7; 25 mM KCl; 0.1 mM DTT) for 1 minute 
at 30 °C. The transport reaction was started by adding 
125I-labeled X(8) and X(23) peptide librar-
ies (Uebel et al., 1995) to a final concentration of 2 µM. The reaction was stopped after 
6 minutes at 30 °C by addition of 500 µL ice-cold transport buffer supplemented with 10 mM 
EDTA and stored on ice. After centrifugation, the pellets were washed once and radioactivity 
was quantified by γ-counting. To determine background levels of radioactivity samples were 
treated with apyrase (1 unit) instead of MgATP. 
5.2.24  Single Particle electron microscopy and image analysis 
After IMAC preparation purified Mdl1p was concentrated (Amicon Ultra-4, MWCO 
100,000 Da) to 1 mg/mL and subjected to a Superdex 200 PC 3.2 size exclusion chromatog-
raphy column equilibrated with SEC-buffer (50 mM Tris-HCl, pH 8; 150 mM NaCl; 0.1 % 
digitonin). Peak fractions corresponding to a molecular weight of about 440 kDa (based on 
the soluble marker proteins β-amylase (200 kDa), apoferritin (443 kDa) and thyroglobulin 
(669 kDa) in 20 mM HEPES pH 7, 100 mM NaCl, 10 % (v/v) glycerol) containing Mdl1p 
were pooled and analysed by negative staining in an electron microscope using 2 % uranyl 
acetate. 
Single Particle Electron Microscopy of Mdl1p was done in collaboration with Dr. Kirstin 
Model in the department of Prof. Dr. Werner Kühlbrandt from the Max-Planck-Institute of 
Biophysics Frankfurt. 
EM images were recorded on film under low-dose conditions in a CM120 electron micro-
scope. For three-dimensional reconstruction, tilt pairs were collected at 0° and 48° tilt and 
corresponding micrographs digitised on a Zeiss SCAI Scanner with 7 µm pixel size. Particle 
images were analysed using the SPIDER package (Frank et al., 1996). XMIPP software 
(Sorzano et al., 2004) was used for classification of untilted images based on the Kohonen 
neural network. The first maps were obtained from a total data set of 2 x 1404 projections by 
the random conical tilt method (Radermacher et al., 1987). The known pseudo two-fold sym-
metry of the complex was imposed. After refinement of all three Euler angles the final vol-
ume was computed. 
A low-pass filtered volume of a closed MsbA form was calculated from the pdb-file with Ac-
cession number 1PF4 and the atomic structures of the PDB files 1Z2R, 1JSQ and 1PF4 were 
overlayed using Chimera software (Pettersen et al., 2004). Chapter 6  Results 
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6 Results 
6.1  Characterisation of the nucleotide binding domain of Mdl1p 
Today’s picture of how ABC transporters translocate their substrates over a membrane in-
cludes the idea of a series of conformational changes in response to ATP binding and hy-
drolysis of the NBDs, and binding, reorientation and release of substrate at the TMDs. De-
spite extensive research to obtain structural information, only little is known about intermedi-
ate states during a transport process. This work addresses the question how ATP binding and 
hydrolysis might influence the translocation of substrates mediated by Mdl1p. It is proposed 
that this half-size transporter forms a homodimer in its minimal active form. Various aspects 
of the mechanism how the motor domains of ABC transporters cooperate can be learned from 
the isolated NBDs. Therefore, the Mdl1p-NBD was cloned, purified and investigated. Differ-
ent intermediate states of the NBD during an ATP binding and hydrolysis cycle are studied in 
detail. 
6.1.1  Purification of wild-type and E599Q mutant Mdl1p-NBDs 
Based on sequence alignments (Figure 6.1) in which Mdl1p was compared to other character-
ised ABC transporters (eukaryotic) or NBDs of ABC transporters (prokaryotic) the MDL1-
gene was cut behind an intrinsic and unique BamHI restriction site producing the C-terminal 
domain (amino acids D423 to R695) of Mdl1p. 
To gain insight into the ATP hydrolysis cycle, a mutant of Mdl1p-NBD was created based on 
mutations in different ABC transporters, which affected ATPase activity (Moody et al., 2002; 
Urbatsch et al., 2000b). The mutations in the NBDs of P-glycoprotein (E552Q; E1197Q) were 
reported to result in a highly impaired ATPase activity (Urbatsch et al., 2000b). A comparable 
mutation of the archaeal NBDs of MJ0796 and MJ1267 (E171Q/E179Q) induced an ATP-
dependent dimerisation of the NBDs (Moody et al., 2002). Hence, an equivalent mutation of 
the conserved glutamate (E599Q) of Mdl1p-NBD was introduced by site-directed mutagene-
sis. 
Both constructs were over-expressed in E. coli BL21(DE3) and purified by immobilised metal 
affinity chromatography (IMAC) followed by size exclusion chromatography. Both the wild-
type protein as well as the E599Q mutant was purified to homogeneity as shown by 
coomassie stained SDS-PAGE (Figure 6.2) and the identity of the protein band was confirmed 
by MALDI-TOF MS. About 50 mg purified protein at a concentration of 10 mg/mL was ob-
tained from one litre culture. Chapter 6  Results 
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Figure 6.1. CLUSTAL W (1.83) multiple sequence alignment of different ABC transporter NBDs. Conserved motifs 
are marked and coloured separately. ATP contact sites from the protein are labelled by red stars, interactions 
within the NBD monomer are marked with green stars and black stars indicate contacts in the dimer interface. Chapter 6  Results 
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Figure 6.2. Expression and purification of wild-type (WT) and mutant (E599Q) NBD of Mdl1p. Coomassie stained 
15 % SDS-PAGE containing crude extract of non-induced (-) and induced (+) cells, purified NBD after Ni
+-
chelating affinity purification (Ni) and gel filtration (GF). M indicates protein marker in kDa. 
The activity of the isolated wild-type NBD was analysed with respect of ATP and ADP bind-
ing using 8-azido-[α-
32P]ATP photolabeling experiments. Photolabeling with 8-azido-[α-
32P]ATP was specifically competed by excess of unlabeled nucleoside di/triphosphates (Janas 
et al., 2003). 
The IC50, roughly reflecting the KD(ATP) value, was determined to be 2 µM for MgATP and 
64 µM for MgADP. The absence of Mg
2+ dramatically reduced the affinity of nucleotides to 
the NBD. The affinity for MgCTP, MgGTP and MgUTP was roughly 30-fold lower com-
pared to MgATP (Janas et al., 2003). 
The isolated NBD was active in ATP hydrolysis with a KM(ATP) of 0.6 mM and showed no 
cooperativity with increasing ATP concentration (Hill coefficient of 1.0; (Janas et al., 2003). 
The ATPase activity was observed to be non-linearly dependent on the protein concentration. 
The specific ATPase activity increased over two orders of magnitude at higher protein con-
centrations. At concentrations above 250 µM the NBD precipitated. Based on a Vmax of 25 
ATP per NBD and minute, a K0.5(NBD) of 75 µM and a Hill coefficient of 1.7 were determined, 
suggesting that the active form of the enzyme is a dimer. Also at low (5 µM) and high 
(150 µM) NBD concentrations, the KM(ATP) was 0.6 mM and showed no cooperativity with 
increasing ATP concentration. The NBD had a maximal ATPase activity at a pH of 8 – 9, 
comparable to the pH of the mitochondrial matrix (Janas et al., 2003). Chapter 6  Results 
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6.1.2  The active form of the NBD is a dimer 
It is postulated that the interaction of both NBDs plays a central role in the catalytic cycle of 
ABC transporters (Nikaido, 2002). So far, size exclusion chromatography experiments with 
isolated NBDs (e.g. HisP and P-gp) did not demonstrate ATP-dependent dimerisation, inde-
pendent of the presence of nucleotides or non-hydrolysable analogues like AMP-PNP (Kerr, 
2002; Nikaido et al., 1997). The wild-type Mdl1p-NBD appeared as a monomer in size exclu-
sion chromatography studies independent of the presence of different nucleotides. 
To analyse intermediate states of the ATPase cycle, the NBD was trapped using ortho-
vanadate (Vi) or beryllium fluoride (BeFx). As shown by myosin x-ray structures the va-
nadate-inhibited complex resembles a post-hydrolysis state while the complex trapped by 
BeFx represents a pre-hydrolysis state (Fisher et al., 1995). After 5 minutes of pre-incubation 
of the NBD with BeFx in the presence of MgATP at 30 °C, a stable dimer corresponding to a 
molecular mass of 66 kDa was observed by size exclusion chromatography even in the ab-
sence of MgATP and BeFx in the mobile phase (Figure 6.3 A.). The formation of the dimer 
was dependent on the concentration of BeFx. At a concentration of 1 mM BeFx, almost 80 % 
of the protein was detected as a dimer. The same result was observed with ortho-vanadate 
(Figure 6.3 B). Importantly, neither pre-incubation of the NBD with MgADP or 
MgAMP-PNP in the presence of BeFx/Vi at 30 °C, nor incubation with MgATP and BeFx/Vi 
at 4 °C induced dimerisation of the NBDs. Omission of Mg
2+ from the reaction inhibited the 
formation of the dimer. This demonstrated that ATP hydrolysis is essential for the formation 
of the BeFx/Vi-stabilised dimer. 
Figure 6.3. Formation of the ATP-induced dimer. After pre-incubation of the wild-type NBD (30 µM) with increas-
ing concentrations of different ATP hydrolysis inhibitors for 5 minutes at 30 °C in the presence of MgATP (500 
µM), the formation of the dimer was monitored by size exclusion chromatography. Arrows indicate the void vol-
ume (Vo), and column calibration standards bovine serum albumin (66 kDa) and carbonic anhydrase (29 kDa). 
(A) Trapping with BeFx (0 mM, straight line; 0.25 mM, long dashes; 0.5 mM, intermediate dashes; and 1 mM, 
short dashes). (B) Trapping using ortho-vanadate (0 mM, straight line; 0.5 mM, long dashes; 2.5 mM, intermedi-
ate dashes; and 5 mM, short dashes). 
To test dimer stability fractions corresponding to the dimer were combined after size exclu-
sion chromatography and immediately re-injected to a subsequent size exclusion chromatog-
raphy run. It was observed that a peak at the position of the monomer appeared while the Chapter 6  Results 
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dimer peak almost disappeared, demonstrating that trapping of the dimer by BeFx is not irre-
versible (Janas et al., 2003). 
6.1.3 E599Q  mutant  NBDs 
The mutant NBD bound ATP to the same extent as the wild-type NBD as analysed by 8-
azido-ATP photolabeling experiments (Janas et al., 2003). No steady-state ATP hydrolysis 
was observed by measuring the release of Pi using the malachite green assay. To assay the 
ability of the mutant to form nucleotide-dependent dimers, the mutant NBD was incubated 
with MgATP on ice for 5 minutes. Size exclusion chromatography showed that MgATP in-
duced dimerisation in a concentration-dependent manner (Figure 6.4). The E599Q NBD 
dimer was stable during size exclusion chromatography even without nucleotides in the mo-
bile phase, indicating that the ATP-induced dimer only slowly dissociates. Importantly, ADP 
did not induce dimerisation, and the addition of ADP to the monomers impaired ATP-
dependent dimer formation. Furthermore, dimerisation was independent of the Mg
2+-
concentration (0 – 5 mM). MgAMP-PNP or MgATPγS could bind to the wild-type and mu-
tant NBD of Mdl1p to the same extent as MgATP, but did not induce dimerisation (Janas et 
al., 2003). Based on these results it was concluded that presence of ATP is required for the 
formation of both wild-type and mutant dimer. 
 
Figure 6.4. ATP dependent dimerisation of the E599Q mutant. After pre-incubation of the E599Q mutant (30 µM) 
with increasing concentrations of MgATP (0 µM, straight line; 20 µM; long dashes; 200 µM, intermediate dashes; 
and 500 µM short dashes) for 5 minutes on ice, the formation of the dimer was monitored by size exclusion chro-
matography. 
6.1.4  Nucleotide composition of the dimer 
In order to see changes of the nucleotide composition in the occluded state (the NBD dimer 
with two trapped nucleotides) the ATP hydrolysis cycle of the NBDs was followed. There-
fore, the wild-type NBD was incubated with tracer amounts of either [α-
32P]ATP or [γ-
32P]ATP under BeFx-trapping conditions and applied to the size exclusion chromatography 
column. Radioactive nucleotides exclusively coeluted with the dimer, whereas no nucleotides 
were observed in fractions corresponding to the monomer (Figure 6.5). The amount of [α-
32P]ATP bound per wild-type dimer was determined and a stoichiometry of two nucleotides Chapter 6  Results 
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per dimer was obtained (Figure 6.5 A, open circles). Incubation of the NBD with ATP/BeFx 
in the presence of [γ-
32P]ATP resulted in a dimer with almost no radioactive nucleotides in-
corporated (Figure 6.5 A, filled circles, Table 6.1). 
Table 6.1. Nucleotide composition of the dimer (average of 5 experiments). 
These results demonstrate that two ATP molecules are hydrolysed in the BeFx-trapped wild-
type dimer and the [γ-
32P]i is released from the complex. This was confirmed by TLC analysis 
(Figure 6.5 A). 
Figure 6.5. Nucleotide stoichiometry of trapped NBDs. (A) Wild-type NBD (250 µM) was trapped using MgATP 
(500 µM) and BeFx (500 µM) for 5 minutes at 30 °C in the presence of tracer amounts of either [α-
32P]MgATP ({) 
or [γ-
32P]- MgATP (•), and separated by size exclusion chromatography (left panel). The nucleotide concentration 
was determined by β-counting and the protein concentration (straight line) by the BCA assay and OD280. The 
middle panel shows a TLC of the nucleotides incorporated into the dimer. (B) E599Q mutant (250 µM) was 
trapped with ATP (500 µM) and tracer amounts of either [α-
32P]ATP ({) or [γ-
32P]ATP (•) in the absence of Mg
2+ 
for 5 minutes on ice, and separated by size exclusion chromatography (left panel). The nucleotide and protein 
concentration was determined as above. The middle panel shows a TLC of the nucleotides incorporated into the 
dimer. Schemes on the right depict the isolated states. *, the BeFx-trapped state. 
Nucleotide/dimer, 
(mol/mol) 
Wild-type 30 °C, 
BeFx-trapped 
E599Q 4 °C, 
no Mg
2+, ATP 
E599Q 30 °C, 
Mg
2+, limiting ATP 
[γ-
32P]ATP 0.01  ± 0.01  2.50 ± 0.18  1.16 ± 0.06 
[α-
32P]ATP 1.76  ± 0.06  2.27 ± 0.15  2.18 ± 0.14 
[α-
32P]ADP  - -  0.02 ± 0.0 Chapter 6  Results 
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Under the same conditions, incorporation of [α-
32P]ADP into the dimer was not observed, 
even in the presence of different concentrations of ATP (data not shown). In experiments with 
the E599Q mutant, performed at 4 °C and in the absence of Mg
2+, the nucleotides coeluted 
exclusively with the dimer as well. In this experiment, the amount of both [α-
32P]ATP and [γ-
32P]ATP bound per dimer was equal and a stoichiometry of two ATP molecules per dimer 
was obtained (Figure 6.5 B, Table 6.1). TLC analysis demonstrated that ATP and not ADP 
and Pi were incorporated into the dimer. As mentioned above, incubation with non-
hydrolysable ATP analogues did not trigger dimer formation. The data from both the BeFx-
trapped wild-type NBD and the E599Q mutant suggest that at least two different intermediate 
states can be isolated during the ATP hydrolysis cycle. Importantly, both states contain two 
nucleotides. In one state, the nucleotides are two ATPs as shown for the E599Q mutant while 
in the other state both nucleotides have been hydrolysed to ADP and Pi as demonstrated for 
the trapped wild-type NBD. This suggests that ATP binding on both NBDs induces formation 
of the dimer and after hydrolysis of both ATP molecules to ADP, the dimeric complex disso-
ciates and ADP is released. 
6.1.5  ATP hydrolysis cycle of Mdl1p-NBD 
An important remaining question is how the ATPs are hydrolysed during one cycle. Using 
radiolabelled ATP, it was determined that the E599Q mutant, at 30 °C and in the presence of 
Mg
2+ was still able to hydrolyse ATP with a turn-over rate of 0.5 ATP per hour (Janas et al., 
2003). Thus the ATPase activity of the E599Q mutant was 3,000-fold reduced compared to 
the ATPase activity of the wild-type NBD. The amount of released phosphate in the radioac-
tive ATPase assay increased linearly over several hours, indicating that the E599Q mutant can 
make multiple turn-overs. The strongly reduced turn-over rate was used as a tool to examine 
the hydrolysis cycle in more detail. When the dimer was incubated with limiting amounts of 
ATP at 30 °C in the presence of Mg
2+ in order to allow only one or two ATP hydrolysis turn-
overs, the size exclusion chromatography analysis of the E599Q mutant showed that, over 
time, the amount of dimeric NBD decreases and the amount of monomeric NBD increases 
(e.g. after 400 min, Figure 6.6 A and B, left panel). The nucleotide composition of the remain-
ing dimer was analysed, and found to contain one ATP and one ADP (Figure 6.6 A., Ta-
ble 6.1). TLC analysis of the dimer confirmed an intermediate state containing equal amounts 
of ATP and ADP (Figure 6.6 A, middle panel). The dimers isolated after prolonged incuba-
tion times at 30 °C (Figure 6.6 B, left panel) reached a stoichiometry of one ATP and one 
ADP (6.6 B., right panel), suggesting that this is a stable intermediate state, which can be de-
tected under limiting ATP conditions. 
To exclude that the ADP found in the dimer is derived from ADP rebinding from the solution, 
ADP incorporation was followed under exactly the same conditions using [α-
32P]ADP as a 
tracer. Under these conditions no incorporation of [α-
32P]ADP was detected (Table 6.1). This 
demonstrated that the dimer-bound ADP is derived from hydrolysis of the first ATP. The in-Chapter 6  Results 
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termediate state suggests that the ATP hydrolysis occurs by a sequential mechanism, and that 
in the E599Q mutant hydrolysis of the second ATP is slower than hydrolysis of the first. 
 
Figure 6.6: Nucleotide stoichiometry of trapped NBDs. (A) The E599Q mutant (250 µM) was pre-incubated with 
ATP (250 µM) and tracer amounts of [α−
32P]ATP or [γ−
32P]ATP at 30 °C for 400 minutes in presence of Mg
2+, and 
isolated by SEC. The nucleotide concentration was determined by β-counting and the protein concentration 
(straight line) by the BCA assay and OD280. The middle panel shows a TLC of the nucleotides incorporated into 
the dimer. The scheme on the right depicts the isolated state. (B) Dissociation of the E599Q mutant dimer over 
time (0 min, straight line; 100 min, long dashes; 200 min, intermediate-long dashes; 400 min, intermediate 
dashes; 500 min, short dashes) monitored by SEC after incubation under ATP-limiting conditions. The right panel 
shows the ATP/ADP composition of the isolated dimers. Chapter 6  Results 
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6.2  Characterisation of the full-length ABC transporter Mdl1p 
To study the function of Mdl1p, biochemical data and structural information are of key im-
portance. Therefore, the availability of purified and active protein and a stable reconstitution 
method is required. This part of the work set out to establish high-level over-expression and 
optimisation of the purification as well as the reconstitution of full-length Mdl1p. 
6.2.1 Identification  of  interaction partners of Mdl1p 
The yeast TAP-fusion library is comprised of 4,247 open reading frames tagged with a high-
affinity epitope and expressed from its natural chromosomal location (Ghaemmaghami et al., 
2003). This library contains a strain with a C-terminal TAP-tagged version of Mdl1p. 
Mitochondria prepared from this strain were used for a tandem affinity purification approach 
to test its capability to obtain highly purified protein and to analyse potential binding partners. 
Figure 6.7: Tandem affinity purification of Mdl1p. Immunodetection of Mdl1p after western transfer. Triton X-100 
solubilised mitochondria were used for tandem affinity purification of Mdl1p: supernatant after ultracentrifugation 
(S), pellet after ultracentrifugation (P), supernatant after binding to IgG-sepharose beads (unbound material; U), 
Mdl1p bound to IgG-beads (I1), TEV cleavage after 1, 2 or 4 hours (1 – 3), supernatant after TEV elution (E1), 
Mdl1p still bound to IgG-beads after TEV cleavage (I2), supernatant after binding to calmodulin sepharose beads 
(unbound material; U2), Mdl1p bound to calmodulin beads (C1), supernatant after EGTA elution from calmodulin 
beads (E2), Mdl1p still bound to calmodulin beads after EGTA elution (C2). 
Figure 6.7 shows different steps during a tandem affinity purification. TAP-Mdl1p is almost 
completely solubilised from mitochondrial membranes (S, P) and protein A was detectable 
using peroxidase antiperoxidase soluble complex (PAP) in the solubilisate (data not shown). 
Almost all solubilised TAP-tagged Mdl1p binds to calmodulin sepharose beads (U2, C1) and 
half of the bound material can be eluted from the beads with EGTA (E2, C2). Up to 50 % of 
Mdl1p binds to IgG sepharose beads (U, I1). However TEV elution of Mdl1p from IgG 
sepharose beads was never obtained (1, 2, 3) even after changing cleavage conditions e.g. 
temperature (4 °C, 30 °C, 37 °C), time (1, 2, 4 hours and overnight), amount of TEV (5, 10, 
20 U), or the kind of TEV-protease (TEV, rTEV). In addition, Mdl1p solubilised from mito-
chondria and directly used for TEV treatment was not cleaved since no shift was detectable 
on immuno blots. Unfortunately, Mdl1p could not be detected by either Coomassie or in sil-
ver staining of gels (data not shown) after TAP-purification. This is probably due to the low 
expression from the wild-type promoter. Therefore, no binding partners of Mdl1p were identi-
fied using this method. Chapter 6  Results 
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6.2.2 Solubilisation  and  purification of Mdl1p 
Mdl1p is normally expressed at low levels (Ghaemmaghami et al., 2003), and is almost not 
affected through different stimuli as shown in various array approaches. Quantitative im-
munoblotting using the purified Mdl1p-NBD as reference demonstrated that Mdl1p is ex-
pressed to approximately 0.01 % of total mitochondrial protein. Hence, over-expression was 
aspired using several approaches. To ease further cloning, the MDL1-gene was systematically 
divided in small cassettes, thus facilitating the exchange between different constructs, and 
cloned in the S. cerevisiae plasmid p426-GPD behind a strong constitutive GPD-promoter 
and into pYES3PA2AAC2 behind a glycerol promoter. Surprisingly, both attempts resulted in 
protein amounts even lower than the wild-type levels (S. Gompf, Instiute of Biochemistry, 
Goethe-University Frankfurt; personal communication and (Hofacker et al., 2006). 
Therefore, also expression of Mdl1p in E. coli was investigated. High and low copy number 
plasmids with different inducible promoters were tested under varying growth conditions and 
in various hosts. The expression levels were evaluated by quantitative western blotting and 
immunodetection. To improve the expression chaperones were induced by growth at 42 °C or 
in 1 M sorbitol, and coexpression with rare tRNAs or the SecY, SecE, SecG and YidC com-
ponents of the E. coli translocase was tested. The different expression conditions did however 
not strongly affect the level of Mdl1p expression (data not shown), and only low expression 
levels were obtained (C. Presenti, Institute of Biochemistry, Goethe-University Frankfurt; 
personal communication and (Hofacker et al., 2006). 
Since L. lactis has been suggested to be a good host for over-expression of mitochondrial pro-
teins (Kunji et al., 2003) Mdl1p was expressed in L. lactis. Expression of Mdl1p from a plas-
mid with a nisin inducible promoter led to an approximately two fold higher expression level 
(0.01 % of total membrane protein) compared to E. coli but the expression levels were still 
very low (C. Presenti, Institute of Biochemistry, Goethe-University Frankfurt; personal com-
munication and (Hofacker et al., 2006). 
Since only low levels of expression were obtained in both E. coli and L. lactis it was further 
tried to over-express Mdl1p in S. cerevisiae in an inducible manner. The MDL1-gene was 
cloned into pYES2.1 behind the inducible GAL1-promoter. Remarkably, over-expression of 
Mdl1p after induction was time-dependent with an optimum between 8 and 12 hours (S. 
Gompf, Institute for Biochemistry, Goethe-University Frankfurt; personal communication and 
(Hofacker et al., 2006). 
Mdl1p was over-expressed 100-fold, up to 1 % of total mitochondrial protein. The remarkable 
optimum in over-expression after induction (Simone), and the reduced levels of Mdl1p ex-
pression from a constitutive promoter suggest that high levels of the protein are disfavoured, 
and results in increased instability or degradation of the protein. The pathway via this degra-
dation occurs is currently unknown. However, using an inducible promoter, and a certain in-
duction time of 12 hours, high levels of Mdl1p suitable for purification were obtained. Chapter 6  Results 
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To optimise the Mdl1p solubilisation, several detergents were tested at two different ρ-values 
(Figure 6.8). 
Figure 6.8: Solubilisation of Mdl1p in different detergents. (A) Mitochondria (500 µg total protein) were resus-
pended in buffer S whereas digitonin was exchanged for detergents as indicated. Detergent concentrations were 
used to reach ρ-values of 15 or 50 respectively where ρ is given by: ρ = [detergent] x CMC/[lipid]. The lipid con-
centration was estimated using an average molecular mass of 875 Da and a lipid to protein ratio of 0.1. Soluble 
and insoluble fractions were separated by ultracentrifugation. Insoluble material (p) was applied together with the 
corresponding supernatant (s) to a 10% SDS-PAGE. Mdl1p was detected by chemiluminescence after western 
transfer. (B) The signals were quantified and a ratio of supernatant vs. supernatant plus pellet (total) was calcu-
lated. 
The subsequent order was obtained: tetradecylphosphocholine (FC-14) showed by far the 
highest solubilisation efficiency (> 70 % solubilised Mdl1p) followed by n-tetradecyl-n,n-
dimethylamine-n-oxide (TDAO, 66 %), sodium cholate (56 %), Triton X-100 (53 %) and fi-
nally dodecylmaltoside (DDM, 48 %), octaethylene glycol monododecyl ether (C12E8, 46 %), 
digitonin (44 %), n-octyl-α-d-glucopyranoside (OG, 42 %) and decanoyl-n-hydroxyethylen-
glucamide (HEGA-10, 35 %) (Figure 6.8). 
The stability of Mdl1p was next tested by applying the solubilised protein on a blue-native-gel 
(Figure 6.9). Again, most Mdl1p was obtained after solubilisation with FC-14 and sodium 
cholate, but Mdl1p appeared on the gel as a smear over almost the complete running distance, 
indicating that Mdl1p is not very stable in these detergents. Defined bands at a molecular 
weight of ~ 250 kDa were observed with UDM, DDM and digitonin. Almost no Mdl1p was 
detectable using TDAO, OG or HEGA-11. Chapter 6  Results 
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Figure 6.9: Detergent screen using Blue-Native gel electrophoresis and subsequent immunodetection of Mdl1p. 
Mitochondria (500 µg) were solubilised in different detergents (1 %; 1: FC-14, 2: TDAO, 3: sodium cholate, 4: 
Triton X-100, 5: C12E8, 6: Digitonin, 7: HEGA-10, 8: UDM, 9: DDM, 10: OG) and proteins were separated by Blue-
native gel electrophoresis. Mdl1p was detected by immunostaining with an anti-Mdl1p antibody at ~ 250 kDa 
corresponding to a high molecular weigth marker. Red stars indicate a fine band of Mdl1p appearing upon solubi-
lisation in Triton X-100, C12E8, Digitonin, UDM and DDM showing Mdl1p in a higher oligimoeric state. 
Three detergents were selected for further analysis: (i) FC-14 as the most efficient detergent 
(ii) DDM known to preserve active ABC transporters (Margolles et al., 1999) and (iii) digi-
tonin reported to hold fragile membrane protein complexes together (Schägger and Pfeiffer, 
2000) and used for purification. Mdl1p was purified using a single Ni-affinity chromatogra-
phy step. Samples of solubilised mitochondrial membranes, fractions collected at different 
points of the purification procedure and purified protein were analysed by Coomassie stained 
SDS-PAGE (digitonin, Figure 6.10, FC-14 and DDM, data not shown). Chapter 6  Results 
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Figure 6.10: Purification of Mdl1p. Different steps in the solubilisation/purification of His-tagged Mdl1p showing the 
total mitochondrial membrane extract (Mi), the pellet after solubilisation (P), the supernatant after solubilisation 
with 1 % digitonin (S), the flow through (FT), the wash fraction with 60 mM imidazole (W) and eluted Mdl1p (200 
mM imidazole) after Ni
2+-chelating affinity purification (E). Identity of the eluted band was confirmed by immu-
nodetection and peptide mass fingerprinting MS analysis (first match Mdl1p (gi  | 6323217) with 27 queries 
matched and a score of 177 (protein scores greater than 75 are significant (p < 0.05 %); the next match of a non-
homologues protein (gi | 432206) has a score of 44). 
Like many integral membrane proteins, Mdl1p migrates at a lower apparent molecular mass 
than predicted from the deduced amino acid sequence, here 62 kDa instead of 69 kDa. Using 
FC-14 solubilised Mdl1p approximately 1 mg of Mdl1p of over 95 % purity can be isolated 
from 1 litre yeast culture whereas in case of DDM and digitonin 0.2 and 0.1 mg respectively 
were obtained. In addition to immunodetection by the specific antibodies Mdl1p was unified 
by peptide mass fingerprint. 
ATP hydrolysis of the different purifications were measured and showed remarkable differ-
ences in ATPase activity (in collaboration with A. Zutz, Institute of Biochemistry, Goethe-
University Frankfurt; Figure 6.11). As expected from its instability on the BN-PAGE, the FC-
14 solubilised Mdl1p showed only a low ATPase activity. Based on its high ATPase activity, 
Mdl1p purified in the presence of digitonin was selected for further characterisation. Chapter 6  Results 
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Figure 6.11: ATPase activity of Mdl1p in selected detergents. Mitochondria (5 mg/mL) prepared from S. cerevisiae 
over-expressing Mdl1p were solubilised in different detergents (as indicated) and Mdl1p was purified as described 
in “Methods”. The ATP hydrolysis of the purified protein was measured at 30 °C in the presence of 5 mM ATP. 
At least two ways for targeting of mitochondrial proteins are discussed. One option requires a 
N-terminal leader sequence of up to 105 amino acids the other signal is encoded by a internal 
protein fold. To answer the question how Mdl1p is targeted to the inner mitochondrial mem-
brane the purified protein was transferred to a PVDF membrane and analysed by N-terminal 
Edman degradation. Two result files were obtained. One showed the first eight amino acids 
with the following sequence: E-S-D-I-A-Q-G-K. Due to background noise a additional se-
quence was suggested: Q-N-P-N-T-?-Y-?. A second sample where the first six amino acids 
were analysed gave the following sequence: E-S-D-I-A-Q. The result of this sample was clear 
and not disturbed by any background signals. Alignment of the obtained sequence with the 
original Mdl1p-sequence showed that cleavage of the leader sequence occurs after amino acid 
59. Why the first amino acid revealed by Edman degradation is a glutamate instead of a 
glutamine, which is found in the original Mdl1p sequence, is not known. 
6.2.3 Mdl1p  specifically  binds  ATP 
The purified solubilised full-length Mdl1p was further characterised by 8-azido-[α-
32P]ATP 
photocross-linking experiments. The apparent affinity constant for 8-azido-ATP was 7 µM 
according to a Langmuir-type (1:1)-binding curve (Figure 6.12). In the presence of 5 µM 8-
azido-[α-
32P]ATP, an IC50 value of 0.45 µM was obtained for ATP (Figure 6.13). 
Based on the apparent affinity of 8-azido-ATP, an apparent dissociation constant for MgATP 
of 0.26 µM was calculated. Chapter 6  Results 
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Figure 6.12: ATP competition of 8-azido-[α-32P]ATP. Solubilised Mdl1p (0.5 µM) was incubated with 5 µM 8-
azido-[α-
32P]ATP and increasing concentrations of ATP. The intensities were plotted against the ATP concentra-
tion and fitted to an IC50 value of 0.45 µM. 
ADP, CTP, GTP and UTP (inhibition between 50 % and 85 %, Figure 6.14) showed a similar 
binding pattern as observed for the isolated NBD. This demonstrated that the isolated solubi-
lised full-length Mdl1p binds nucleotides with a similar affinity as the isolated NBD, suggest-
ing that the TMDs do not affect the nucleotide-binding step. 
 
Figure 6.13: 8-azido-[α-32P]ATP titration. Digitonin-solubilised Mdl1p (0.5 µM) was incubated with 8-azido-[α-
32P]ATP for 5 minutes at 4 °C and cross-linked by UV-light. For concentrations of 10 µM and above (indicated by 
stars), 8-azido-ATP was supplemented 1:5 with non-radioactive 8-azido-ATP. The intensities of substituted 8-
azido-ATP were adjusted to the non-substituted 8-azido-ATP by comparing the intensities at 10 µM. The intensi-
ties were quantified by phosphor-imaging plotted against the 8-azido-ATP concentration and fitted to a Langmuir-
type (1:1)-binding curve resulting in an apparent dissociation constant (Kd) of 7 µM. 
AMP-PNP, the non-hydrolysable ATP analogue, also bound with a reduced affinity, further 
demonstrating previous observations, that AMP-PNP does not mimic ATP binding perfectly. 
Also other studies (Nikaido et al., 1997; Sharma and Davidson, 2000) have seen that AMP-Chapter 6  Results 
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PNP binds with a reduced affinity, and indeed AMP-PNP can not induce dimerisation of the 
NBDs. As expected, AMP did not compete with 8-azido-ATP-binding. 
 
Figure 6.14: Nucleotide-binding specificity of Mdl1p. Digitonin-solubilised Mdl1p (0.5 µM) was incubated in the 
presence of 5 µM 8-azido-[α-
32P]ATP together with different other nucleotides at a concentration of 300 µM each. 
A sample without competitor nucleotide was set to 100 %. The residual signal in presence of ATP is below 10 % 
reflecting a high affinity of ATP to Mdl1p. In comparison the AMP signal account for 85 % showing almost no 
affinity of AMP to Mdl1p. 
6.2.4 Mdl1p  is  active  in ATP hydrolysis 
To specify the activity of the isolated Mdl1p, ATP hydrolysis was characterised. The solubi-
lised protein showed Michaelis-Menten kinetics (Hill coefficient = 0.98) in ATP hydrolysis 
with a KM(ATP) of 0.85 mM and a turn over number (kcat) of 2.5 ATP per second (Figure 6.15). 
To demonstrate that the ATPase activity observed for the solubilised Mdl1p was derived from 
the purified protein, and not from a highly active ATPase which copurifies at such low con-
centrations that it is not observed on Coomassie and silver stained gels, inactive mutants of 
Mdl1p were used. In recent years, several studies have benefit from mutagenesis of the con-
served glutamine one amino acid downstream of the Walker B motif and the histidine in the 
H-loop, to analyse the dimerisation reaction of the NBDs. After mutagenesis of these resi-
dues, the NBDs are trapped in an ATP induced dimeric state, in which the hydrolysis of ATP 
is either greatly reduced or abolished. Mutagenesis of the glutamine in the NBD of Mdl1p 
(E599Q) resulted in a 3,000-fold lowered ATPase activity. Mutagenesis of the histidine in the 
H-loop of HisP (H211) (Shyamala et al., 1991) or MalK (H192) (Davidson and Sharma, 
1997) resulted in an ATPase activity below 2 %, and transport was completely abolished 
(Davidson and Sharma, 1997; Nikaido and Ames, 1999). When the conserved histidine 
(H662A) of the NBD of HlyB, was mutated, only background levels of ATPase activity 
(< 0.1%) were detected (Zaitseva et al., 2005c). Chapter 6  Results 
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Figure 6.15: ATPase activity of wild-type and mutant Mdl1p. ATPase activity as a function of the ATP concentra-
tion was measured at 30 °C with 0.1 µM Mdl1p. Digitonin solubilised wild-type Mdl1p (■) is active in ATP hydroly-
sis with a kcat of 2.5 ATP per second and a KM(ATP) of 0.85 mM. The data were fitted to the Hill equation (y = 
(ax
n/(b
n + x
n)) resulting in a best fit (R
2 = 0.98) with a Hill coefficient (n) of 0.98. H631A Mdl1p (▲) binds specifi-
cally ATP as shown in 8-azido-[α-
32P]ATP photocross-linking experiments (see inset) but is deficient in ATP hy-
drolysis. The same is true for the E599Q mutant (•). 
Indeed, both mutants (H631A and E599Q) in full-length Mdl1p showed specific ATP binding 
in 8-azido-ATP photocross-linking and competition experiments but were defective in ATP 
hydrolysis (A. Zutz, Institute of Biochemistry, Goethe-University Frankfurt; personal com-
munication and (Hofacker et al., 2006); Figure 6.15). This demonstrated that these mutants 
behave in a similar manner as in the isolated NBDs, and that the observed ATPase activity 
resulted from purified Mdl1p. At the protein concentrations at which the experiment was per-
formed, the activity of the full-length protein is much higher then the activity of the isolated 
NBD at similar concentrations. Remarkably, the activity of the isolated NBD was strongly 
dependent on the concentration of the NBD (van der Does et al., 2006), and therefore also the 
activity of the full-length protein as a function of the protein concentration was determined. 
For the full-length protein the ATP hydrolysis was independent of the protein concentration 
between 0.01 µM and 1 µM. This showed that, contrary to what was observed for the isolated 
NBD, the association rate of the NBDs is not rate-limiting in the full-length protein. Most 
likely, this is caused by the fact that in the full-length transporter the NBDs are within once 
vicinity and therefore are present at high local concentration. 
6.2.5 Reconstitution  of  Mdl1p into lipid vesicles 
Mdl1p has been shown to be involved in transport of peptides energised by hydrolysis of 
ATP. To further study this process, purified Mdl1p was reconstituted into liposomes immedi-Chapter 6  Results 
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ately after purification by mixing the protein with DDM-destabilised liposomes containing E. 
coli phospholipids. Subsequently, the DDM was removed by absorption to polystyrene beads. 
 
Figure 6.16: Lipid to protein stoichiometry after reconstitution. Lipid vesicles were harvested after reconstitution 
and applied on top of a discontinuous sucrose gradient (10 – 30 %). Protein was quantified by immunodetection 
and phospholipids according to chapter 5.2.19. Reconstitution was evident from cocentrifugation of the lipid 
(dashed line) and the protein fractions (solid line) as both peaks appear at a sucrose concentration of 16 %. The 
final ratio of phospholipids to protein in the peak fraction was determined to be 160 to 1 (mol/mol). Empty lipo-
somes (doted line) were detected at 11 % sucrose. 
The incorporation of the protein into the liposomes was determined by sucrose gradient cen-
trifugation. Proteoliposomes were applied on top of the gradient and after centrifugation, the 
position of the liposomes in the sucrose density gradient was determined by measurements of 
the phosphate content of the collected fractions while the position of Mdl1p in the gradient 
was determined by Western blotting. Reconstitution of Mdl1p in the liposomes is evident 
from comigration of Mdl1p and lipids (Figure 6.16). 
Empty liposomes were recovered at 11 % sucrose, while the protein containing liposomes 
were recovered at 16 % sucrose (Figure 6.16). Since no free protein was detected at the bot-
tom of the gradient, all Mdl1p was inserted into liposomes. Additional, this shows that Mdl1p 
did not aggregate during the reconstitution procedure. In collaboration with Dr. Haase from 
the Max-Planck-Institute of Biophysics Frankfurt micrographs of freeze fractured proteolipo-
somes were analysed and showed well formed lipid vesicles with protein incorporated in the 
lipid membrane and no evidence of aggregated protein (Figure 6.17). Chapter 6  Results 
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Figure 6.17: Reconstitution of Mdl1p into lipid vesicles. Proteoliposomes with reconstituted Mdl1p were analysed 
by freeze fracture electron microscopy. 
Determination of the protein and lipid content of the proteoliposomes (s. chapter 5.2.19) 
showed that Mdl1p was reconstituted in a molar Mdl1p to lipid ratio of 1 to 160 lipid mole-
cules. To finally demonstrate that the reconstituted Mdl1p was active, ATP hydrolysis of the 
proteoliposomes was determined. Indeed 85 % of the ATPase activity as observed for the 
digitonin-solubilised protein was found (Figure 6.18). In addition, this result indicates that a 
significant fraction of Mdl1p is reconstituted with the NBDs facing the outside. Under the 
assumption that the ATPase-activity of Mdl1p did not change in the lipid environment one 
can conclude that these proteoliposomes contain Mdl1p with the correct inside-out orientation 
of the NBDs to perform uptake experiments. 
 
Figure 6.18: ATPase activity of Mdl1p after reconstitution. Functionality of the reconstituted Mdl1p was analysed 
in respect of ATP hydrolysis after reconstitution. Activity was measured at 30 °C for 10 minutes in presence of 
5 mM ATP. Hydrolysis of the wild-type protein was preserved in the lipid bilayer as shown in comparison to the 
soluble protein. Chapter 6  Results 
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6.2.6 Transport-assay 
Mdl1p was shown to play an important role in the export of peptides between 6 and 20 amino 
acids in length from the mitochondrial matrix. Combinatorial peptide libraries were shown to 
be an extremely useful method to characterise substrate and transport specificity of various 
prokaryotic and eukaryotic transporters (Detmers et al., 2000; Doeven et al., 2004; Uebel et 
al., 1999). Therefore two peptide libraries X(8) and X(23) (where X represents all 19 amino ac-
ids, excluding cysteine, in equimolar distribution) were tested in transport assays using Mdl1p 
reconstituted into proteoliposomes. The libraries were radiolabelled and initial ATP-
dependent transport was followed within 6 minutes. However, only background levels of ra-
dioactivity were detected indicating no significant transport of peptides into the liposomes 
(data not shown). 
6.2.7  Single particle analysis of Mdl1p 
Single particle analysis (SPA) of Mdl1p and image processing was done in collaboration 
with/performed by Dr. K. Model from the Max-Planck-Institute of Biophysics Frankfurt. 
SPA provides a relatively fast three dimensional reconstruction method for proteins even with 
low protein concentrations and has been used to investigate the quarternary structure and oli-
gomerisation state of the ABC proteins CFTR (Awayn et al., 2005), TAP1/TAP2 (Velarde et 
al., 2001), Pdr5p (Ferreira-Pereira et al., 2003), P-glycoprotein (Rosenberg et al., 1997), 
MRP1 (Rosenberg et al., 2001) and YvcC (Chami et al., 2002): two reports showed data that 
were interpreted as monomeric particles for P-glycoprotein (Rosenberg et al., 1997) and 
TAP2 (Velarde et al., 2001), whereas the other four studies reported particles that were identi-
fied as dimeric complexes YvcC (Chami et al., 2002), Pdr5p (Ferreira-Pereira et al., 2003), 
CFTR (Awayn et al., 2005) and MRP1 (Rosenberg et al., 2001). Here, a first three-
dimensional reconstruction at low resolution from digitonin-solubilised Mdl1p particles (1404 
particles) has been calculated (Figure 6.19 d + e). 
Figure 6.19 B shows a representative micrograph of digitonin solubilised Mdl1p particles 
after negative staining with uranyl acetate (protein density appears white). The picture shows 
particles of a size range expected for the molecular weight range determined by SEC. Equiva-
lent particles were picked from micrographs of a tilt pair (two different projection views of 
the same particle) in order to determine the tilt angle and tilt axis. Particles from the zero de-
gree pictures were translationally and rotationally aligned and then classified using the neural 
network approach (Figure 6.19 C; (Sorzano et al., 2004). First indications of a (pseudo) 2-fold 
symmetry could be gained from refined classes averages of Mdl1p-particle projections. 
A 3D volume was calculated from corresponding particles of the 4 boxed nodes (Figure 6.19 
C; red square) enforcing 2-fold symmetry in z-axis perpendicular to the membrane plane 
(Figure 6.19 D). The dimension of the volume is determined to 125 x 110 x 95 Å
3. Chapter 6  Results 
  70
 
Figure 6.19: Single particle electron microscopy of Mdl1p (A) Sequence alignment of A-chains from MsbA trans-
porters with PDB accession numbers 1Z2R (closed form; (Reyes and Chang, 2005), 1JSQ (open form; (Chang 
and Roth, 2001) and 1PF4 (closed form; (Chang, 2003) and Mdl1p. The Walker A and B motifs, the Q-, C-, P-, D- 
and H-loops are boxed and coloured according to chemical properties of the amino acid residues. The overall 
colour code results from the BLOSUM62 score. (B) Typical electron micrograph of the negatively stained Mdl1p-
SEC fraction. The nodes and corresponding particles used for the subsequent 3D reconstruction are boxed in red. 
Scale bar 100 nm. (C) Self organising map of 5x5 nodes from the complete data set of untilted particle projec-
tions. (D) Surface views of a representative 3D reconstruction of Mdl1p along the two-fold axis marked in red (top 
and bottom side). (E) Comparison of Mdl1p with different MsbA-crystal structures. The 3D reconstruction of Mdl1p 
was oriented and compared to the two “arms” of MsbA (1JSQ depicted in yellow). The two main axes are indi-
cated by red dashed lines (left panel). A low-pass filtered volume of a closed MsbA structure was structurally 
matched and superimposed with all three 3D crystal structures of MsbA (right panel; 1Z2R blue, 1PF4 red and 
1JSQ yellow). Membrane dimensions are indicated by white lines. 
Figure 6.19 A shows an alignment of three MsbA amino acid sequences and Mdl1p demon-
strating their high similarities (51 % ). Since 3D crystal structures of the MsbA proteins are 
available they were compared to Mdl1p single particles. A low-pass filtered volume of a Chapter 6  Results 
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closed MsbA form was calculated and all three high resolution structures of MsbA were struc-
turally matched and superimposed. Interestingly it was found that the the Mdl1p volume more 
closely resembles the open form of MsbA rather than the two closed forms (Figure 6.19 E). 
The bottom and top views would logically resemble the potential hydrophilic nucleotide bind-
ing domains and the transmembrane domains respectively (Figure 6.19 D left and right 
panel). To date it remains to be verified by further experiments which side is anchored in the 
membrane and which part contains the nucleotide binding domains. Further refinement of the 
reconstruction is on the way in order to increase its resolution and perform fitting and docking 
of subunits into the volume. 
6.2.8  In organello translation and peptide export assay 
It has been shown that Mdl1p is involved in the export of peptides derived from mitochon-
drial encoded proteins. The exact nature of the transported peptides, and therefore the physio-
logical role remains however uncovered, mostly because the transport function of Mdl1p has 
not been confirmed using an in vitro assay. To identify the substrate and the function of 
Mdl1p, an in organello translation assay was established. Here subunits of the respiratory 
chain encoded by the mitochondrial genome can be synthesised by isolated mitochondria in 
the presence of [
35S]-methionine (Black-Schaefer et al., 1991; McKee et al., 1984) and subse-
quently analysed by Tricine-SDS-PAGE (Figure 6.20). Almost no differences in the transla-
tion pattern can be detected between different mitochondria preparations. 
 
Figure 6.20: In organello translation. Tricine-SDS-PAGE of [
35S]-methionine labelled mitochondrial encoded pro-
teins after an in organello translation assay. Different mitochondria preparations were analysed: 1 wild-type mito-
chondria grown in YEPD medium, 2 wild-type mitochondria grown in SCD medium, 3 mitochondria lacking Mdl1p 
and grown in SCD medium, M indicates protein marker in kDa. Chapter 6  Results 
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Since their nuclear encoded partners are missing these subunits are nor correctly assembled 
and degraded by AAA proteases after prolonged incubation (Arlt et al., 1996). A heterogene-
ous spectrum of degradation products is thus released from mitochondria. This can be meas-
ured as a time dependent accumulation of [
35S]-methionine labelled fragments in the super-
natant after proteolysis (Figure 6.21). 
 
Figure 6.21: Release of [
35S]-methionine labelled degradation products from mitochondria of the wild-type S. 
cerevisiae BY4743. Release of a heterogeneous spectrum of peptides and amino acid residues from mitochon-
dria. Supernatants were collected from wild-type mitochondria after 0 min, 7.5 min, 15 min and 30 min at 37 °C. 
The supernatants can be further analysed by SEC (Young et al., 2001). Beside full degrada-
tion to free amino acids which is reflected by a elution peak of [
35S]-methionine two other 
maxima containing oligopeptides from 600 - 200 Da and 2100 - 600 Da can be distinguished. 
Mitochondria isolated from wild-type and ΔMDL1 strains were used for labelling of mito-
chondrial encoded proteins and the release and nature of the degradation products were ana-
lysed. The release of long peptides (Fig 6.22, peak I), was reduced by 25 % in ΔMDL1 mito-
chondria, as revealed by size exclusion chromatography analysis of the supernatant fraction 
(Figure 6.22) in this particular case. Shorter peptides as well as free methionine accumulated 
at similar levels in supernatants harvested from wild-type or ΔMDL1 mitochondria. 
Figure 6.22: Mdl1p mediates peptide export from mitochondria. (A) Mitochondrial supernatants harvested after 
30 minutes from wild-type (black solid line), or ΔMDL1 (grey dashed line) strains were fractionated by a Superdex 
Peptide column and radioactivity in each fraction was determined. Total counts recovered from each column run 
were set to 100 %. (B) A “zoom in” showing peak I and II in more detail. Representative profiles from single ex-
periments are shown. Chapter 6  Results 
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However, upon comparison of degradation products generated after in organello translation 
using wild-type and ΔMDL1 mitochondria even after 17 runs no significant differences in 
peak I or II were detected. This is contrary to the observations of Young and colleagues 
(Young et al., 2001). 
6.2.9  Occluded state in full-length Mdl1p 
The isolated NBD of Mdl1p showed intermediate states with different nucleotide composi-
tions generated during the catalytic cycle. Either two ADPs were trapped (wild-type with 
BeFx or Vi) or states with two ATPs or one ATP and one ADP occluded in the dimer (E599Q 
mutant) were isolated (chapter 6.1.2 - 6.1.4). The question arose whether such an intermediate 
state exists in the full-length transporter to and whether there are differences possibly caused 
by superimposing effects of the TMDs. Therefore, the hydrolysis deficient mutant (H631A) of 
full-length Mdl1p was incubated with ATP supplemented with tracer amounts of [γ-
32P]ATP 
and applied to a superdex 200 size exclusion chromatography column. Radioactive nucleo-
tides coeluted exclusively with fractions 1 – 4 (Figure 6.23). 
 
Figure 6.23: ATP to Mdl1p stoichiometry: Gel filtration and corresponding immunodetection. Mutant Mdl1p 
(H631A; 50 µg/mL) was incubated with 4.82 mM ATP supplemented with 0.062 µM [γ-
32P]ATP for 5 minutes at 
4 °C. The Mdl1p peak (OD260 grey line, OD280 black line) elutes at 1.15 mL and is distributed over 120 µL. The 
protein amount was determined using the BCA assay whereas [
32P] was measured by β-counting and the 
stoichiometry in each fraction was calculated. 
All other fractions contained only background levels of radioactivity. The Mdl1p distribution 
was analysed by immunodetection and the protein concentration of each fraction was deter-
mined by the BCA assay. The amount of [γ-
32P]ATP bound per protein was determined and a 
stoichiometry was calculated for each of the 4 fractions (Table 6.2). Chapter 6  Results 
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Table 6.2: Summary of the ATP to Mdl1p stoichiometry found in different fractions after SEC. 
Fraction 1 shows the highest nucleotide content with a value of 26.5 % meaning that only half 
of a nucleotide is incorporated into one Mdl1p-dimer. This value needs to be consider care-
fully since a large error in protein determination might occur due to the low protein amount. 
All other fractions show values below 0.1 ATP per monomeric protein. These data show that 
however, in full-length Mdl1p no occluded state exists in the time-frame of 45 minutes con-
trary to the results obtained for the Mdl1p-NBD. 
6.2.10  Peptide cross-linking experiments 
Mdl1p was reported to play a role in peptide export from the mitochondrial matrix. Therefore, 
peptide photocross-linking experiments were performed to investigate this function in more 
detail. For this purpose an approach described in (Uebel et al., 1997) was modified. Beside 
the peptide R9* used in the study of also other peptides were designed. 
N-formylated peptides derived from mitochondrial encoded respiratory chain subunits have 
been detected as minor antigens in complex with MHC I molecules at the surface of mammal-
ian cells (Fischer Lindahl et al., 1991; Morse et al., 1996) peptides deduced from MHC I-
presented sequences e.g. subunit I of cytochrome c oxidase were synthesised containing the 
photocross-linker benzophenyl-alanine. In addition, the peptides contained a tyrosine, which 
was used for radiolabelling with Na
125I. The advantage of the photocross-linking approach is 
that even transient interactions between substrate and Mdl1p can be detected. 
Figure 6.24: (A) Different mitochondria preparations (1: Y24137 (ΔMDL1) in YEPD medium; 2: BY4743 (WT) in 
YEPD medium; 3: Y24137 + pMdl1p-065 (gal-promoter, Mdl1p + His-tag w/o linker) in SCD medium; 4: + pMdl1p-
GPD (gpd-promoter, Mdl1p + His-tag) in SCD medium; 5: BY4743 + pMdl1-065 in SCD medium; 6: Y24137 + 
pMdl1-068 (gal-promoter, Mdl1p + His-tag + linker) in SCD medium; each 75 µg) were solubilised with 0.8 % 
Triton X-100 and incubated with the peptide T10 (f-MYQR-Bpa-LYST-COOH, 4 µM) for 3 minutes on ice. Cross-
linking was performed using UV-light for 10 minutes. Samples were analysed by 10 % SDS-PAGE and autoradio-
graphy. Control samples with 100-fold access of unlabeled peptide are marked with “+”. (B) Microsomes (12.5 µg) 
with the peptide transporter TAP expressed in Sf9-insect cells were used as reference samples with the peptides 
T10 (1) and R9* (2; NH2-RΦYQΨSTEL-COOH; each 4 µM). Unlabeled competitor peptide (+) was used in an 
100-fold access. 
Mitochondria isolated from yeast cells expressing either no Mdl1p or Mdl1p under different 
conditions were incubated with the cross-linker peptides R9* and T10* after solubilisation. 
Bound peptide was cross-linked by exposure to UV light. Cross-linking products were sepa-
Fraction  ATP (pmol)  Mdl1p (pmol)  ATP/Mdl1p-monomer 
1 2,07  7,79  0,265 
2 1,98  24,84  0,080 
3 1,56  25,69  0,061 
4 1,29  22,02  0,058 Chapter 6  Results 
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rated by SDS-PAGE and the gel was exposed to an x-ray film after drying which was devel-
oped after 48 hours (Figure 6.24). In order to test the specificity of the reaction cross-linker 
peptides were competed out by a 100-fold access of unlabeled peptide. Since the transporter 
associated with antigen processing TAP was reported to translocate peptides in the range of 8 
to 16 amino acids (van Endert et al., 1994) microsomes from insect cells expressing TAP 
were used as control samples and cross-linking of T10* to TAP was compared with the cross-
linking product between TAP and R9* which served as a positive reference. For samples 
without Mdl1p (ΔMDL1-cells) and (for unknown reasons) mitochondria from cells expressing 
Mdl1p plus a His-tag without a spacer in a ΔMDL1 strain no cross-linking products could be 
obtained whereas all other samples showed cross-linking products running at the expected 62 
kDa. The labelled cross-linker peptide can be competed out by an access of unlabelled peptide 
in all cases indicating a specific interaction of the peptide with Mdl1p. While changing pa-
rameters in subsequent experiments e.g. peptides with different length, cross-linking time and 
mitochondrial preparations either no cross-linking products were obtained or all samples 
showed bands in the autoradiography even mitochondria lacking Mdl1p indicating that the 
peptides are cross-linked to another protein probably mtHsp70 which has a similar mass than 
Mdl1p. Chapter 7  Discussion 
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7 Discussion 
7.1  ATP hydrolysis cycle of the Mdl1p-NBD 
Several crystal structures showed that the catalytic pocket for ATP hydrolysis is formed only 
through the cooperation of two NBDs (Hopfner et al., 2000; Locher et al., 2002; Smith et al., 
2002) explaining the positive cooperativity in ATPase activity observed for MalFGK2 and 
HisQMP2 (Davidson et al., 1996; Liu et al., 1999; Nikaido and Ames, 1999). The residues 
involved in ATP binding and subsequent dimerisation of the NBDs have been characterised 
(Fetsch and Davidson, 2002; Loo et al., 2002; Moody et al., 2002). Although it is widely 
agreed that the dimer is a functional intermediate, several models have been proposed for the 
mechanism by which ATP drives the translocation of the substrate. Although it was previ-
ously reported that NBDs form dimers (Kennedy and Traxler, 1999), it was not elucidated 
how dimerisation of the NBDs is coordinated by nucleotides during one catalytic cycle. 
Here several different intermediate states in the hydrolysis cycle of the Mdl1p-NBD were 
isolated and directly analysed in respect of their nucleotide content. Based on these data a new 
model for the hydrolysis cycle of an ABC transporter was proposed, unifying structural and 
functional data. Mdl1p has recently been identified as an intracellular homodimeric half-size 
ABC transporter localised in the inner mitochondrial membrane of S. cerevisiae (Young et al., 
2001). Focus of this work was to elucidate the mechanism of peptide transport across mem-
branes and how ATP drives this transport in particular. As Mdl1p is proposed to work as a 
homodimer, the NBD of Mdl1p was chosen as a model. 
The C-terminal domain (amino acids D423 – R695) corresponding to the NBD was over-
expressed as soluble protein in E coli and purified to homogeneity. The purified NBD was 
active in ATP binding and hydrolysis. The turn-over number of the Mdl1p-NBD 
(25 ATP/min) is comparable to the values obtained for other isolated NBDs (e.g. MJ0796, 
12 ATP/min (Moody et al., 2002) or CFTR 6.7 ATP/min (Annereau et al., 2003). In general, 
isolated NBDs show much lower turn-over numbers than the full-length transporters, and no 
substrate stimulation (Booth et al., 2000). The ATPase activity of the isolated Mdl1p-NBD 
was observed to be non-linearly dependent on protein concentration, indicating that the active 
form of Mdl1p is a dimer. Surprisingly, the NBD did not reveal positive cooperativity with 
increasing ATP concentration. This is in contrast to the behaviour of the isolated MJ0796 
NBD, which showed positive cooperativity with a Hill-coefficient of 1.7 (Moody et al., 2002). 
However, in agreement with our data, other isolated NBDs like HisP and MalK displayed no 
cooperativity for ATP, while cooperativity in ATPase activity was determined in the fully 
assembled transporters HisQMP2 and MalFGK2 (Davidson et al., 1996; Nikaido et al., 1997). 
This different behavior of various ABC transporters shows that although dimerisation of the 
NBDs is proposed for all, there are differences in the cooperativity of the NBDs, which in 
some cases might be influenced by the TMDs. Chapter 7  Discussion 
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The NBD of Mdl1p behaved as a monomer in size exclusion chromatography studies inde-
pendently of the presence of nucleotides as previously shown for other isolated NBDs 
(Nikaido et al., 1997). Using either ortho-vanadate or beryllium fluoride the Mdl1p-NBD 
could be trapped as a dimer. ADP could not replace ATP in the trapping reaction, demonstrat-
ing that ATP binding and hydrolysis is essential for dimerisation. Even in the absence of or-
tho-vanadate or BeFx, an ATP dependent dimer was obtained by mutation of the conserved 
glutamate downstream of the Walker B motif of Mdl1p (E599Q). The formation of stable 
dimers upon ATP binding was described by size exclusion chromatography of mutant ar-
chaeal NBDs (MJ0796(E171Q)/MJ1267 (E179Q)) (Moody et al., 2002). These mutants were 
deficient of steady-state ATPase activity as assayed by standard ATPase assays (Pi or ADP 
release) as were the equivalent mutants (E552Q/E1197Q or E556Q/E1201Q) of human and 
mouse P-glycoprotein (Sauna et al., 2002; Urbatsch et al., 2000b). The structures of some 
ABC transporters have suggested that this conserved glutamate is the most likely candidate to 
play the role of the catalytic carboxylate (Diederichs et al., 2000; Gaudet and Wiley, 2001; 
Hopfner et al., 2000; Hung et al., 1998; Karpowich et al., 2001; Smith et al., 2002). On the 
other hand, this glutamate of human P-glycoprotein was suggested not to function in the 
cleavage between β- and γ-phosphate but to be part of the switch region of ABC transporters 
possibly involved in the transmission of interdomain signals from the substrate binding site to 
NBDs (Sauna et al., 2002). 
In this study the nucleotide composition of the trapped states of Mdl1p was analysed in detail 
by incorporating [α-
32P]ATP or [γ-
32P]ATP into the dimer. After size exclusion chromatogra-
phy, the nucleotide concentration was analysed by β-counting and correlated to the protein 
concentration. The nucleotide species were identified by TLC. Radioactive nucleotides were 
associated exclusively with the dimer. This observation demonstrated that ATP binding to the 
monomer is transient resulting in either subsequent dimerisation of the NBDs or dissociation 
of ATP from the monomer. It was shown that non-trapped NBDs have very fast koff  rates for 
nucleotide binding (Urbatsch et al., 1995b). Radioactive ADP in the presence of various con-
centrations of ATP was not incorporated into the dimer. Based on these results, ATP binding 
is regarded as essential and sufficient for dimerisation of the mutant. 
Interestingly, although AMP-PNP or ATPγS binds with similar affinity to the E599Q mutant 
as ATP, none of these analogues were able to induce ATP dependent dimerisation. This ob-
servation is in line with results obtained for mutants from M. jannaschii (Moody et al., 2002). 
Incubation of the wild-type NBD of Mdl1p with an equimolar ratio of unlabeled MgATP and 
MgATPγS under BeFx trapping conditions did not result in any incorporation of ATPγS in the 
dimer. This suggests that either the dimer interface is disturbed in the presence of ATPγS due 
to sterical hindrance or both nucleotides have to be hydrolysed to obtain the BeFx trapped 
intermediate. Chapter 7  Discussion 
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Analysis of the dimer always showed two nucleotides bound per dimer. In case of the BeFx 
trapped NBD, the nucleotide species was solely ADP (with no Pi in the dimer), while in the 
E599Q mutant exclusively two ATP molecules were incorporated. These data demonstrated 
that both NBDs bind ATP during the ATPase cycle. During size exclusion chromatography, 
which takes 10 – 30 minutes, no nucleotides, but only the phosphate is released from the as-
sembled dimer. Thus, these results demonstrate that both nucleotides have to be bound to both 
monomers before the stable dimer is formed, and that the two nucleotides then remain associ-
ated during the entire hydrolysis cycle. 
Surprisingly, incubation of the E599Q mutant with ATP in the presence of Mg
2+ at 30 °C re-
sulted in slow hydrolysis of ATP, indicating that the E599Q mutant still hydrolyses ATP (but 
at a 3,000-fold reduced rate compared to the wild-type). This opened up the elegant possibil-
ity to explore the nucleotide composition of the mutant E599Q dimer of Mdl1p under single 
turnover conditions. After prolonged incubation in the presence of limiting amounts of ATP, 
an intermediate state, which contained one ATP and one ADP was formed. This intermediate 
state could be isolated for a prolonged period of time under strictly ATP limiting conditions, 
since in the presence of excess of ATP a state with two ATPs was isolated (data not shown). 
Such an asymmetric ATP/ADP state can be explained by a hydrolysis-event of the second 
ATP which is slower than hydrolysis of the first one, and suggests that the ATP hydrolysis 
occurs by a sequential mechanism. 
Mutants in the conserved glutamate in human P-glycoprotein were shown to be able to hydro-
lyse one ATP molecule but unable to initiate a second ATP hydrolysis (Hrycyna et al., 1999; 
Sauna et al., 2002; Urbatsch et al., 2000b). However, the E599Q-NBD of Mdl1p catalyses 
multiple turn-overs. This is probably caused by dimer dissociation of the intermediate state 
with one ATP and one ADP, and rebinding of ATP by the monomers, starting a new cycle in 
which again only one ATP is hydrolysed. Indeed under ATP limiting condition this dimer 
dissociates before it hydrolyses the second ATP. To examine the hydrolysis of the second 
ATP the fate of the nucleotides after re-isolation of the dimer using size exclusion chromatog-
raphy was followed. Unfortunately, after dilution by size exclusion chromatography, the asso-
ciation-dissociation kinetics of the equilibrium between the monomeric and dimeric states and 
the rate of ATP hydrolysis were of the same order (t1⁄2 = ~ 30 min), severely complicating the 
analysis. To examine the coupling of ATP hydrolysis, Pi release and dimer dissociation in 
detail, either methods with a better time resolution or an E599Q mutant with a faster hydroly-
sis rate should be used. 
Interestingly, an asymmetric state with equimolar amounts of ATP and ATPγS was observed 
after incubation of the E599Q mutant with both of these nucleotides. This resulted in incorpo-
ration of one ATPγS molecule per dimer (data not shown). The wild-type protein did not in-
corporate ATPγS suggesting that binding of ATPγS to the NBD disturbs the dimer-dimer in-
terface. The E599Q mutant seems to retain its ability to form a dimer, if only one ATPγS is 
bound, while the wild-type protein cannot accommodate the ATPγS in the dimer. The γ-Chapter 7  Discussion 
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phosphate contacts residues in both NBDs, thus stabilising the dimer. Small changes in the 
NBD around the γ-phosphate thus strongly influence the ability of the NBD to form dimers, 
and the wild-type protein seems more affected by this than the E599Q mutant. 
Published crystal structures of NBDs with a dimeric architecture showed high symmetry of 
the two monomers and equal occupation of both nucleotide-binding sites (Hopfner et al., 
2000; Smith et al., 2002; Zaitseva et al., 2005a) even in the full-length structure of BtuCD 
(Locher et al., 2002). However, based on ortho-vanadate trapping experiments combined with 
8-azido-ATP photolabeling, for P-glycoprotein and homologues a model was proposed in 
which only one NBD hydrolyses ATP at a time, but in an alternating manner (Senior and 
Gadsby, 1997; van Veen et al., 2000). Under hydrolysis conditions, it was shown for P-
glycoprotein as well as for MalFGK2 that 8-azido-ATP photolabeling of a BeFx- or ortho-
vanadate-trapped state resulted in approximately one [γ-
32P]ADP bound per dimer (Sankaran 
et al., 1997; Senior et al., 1995; Sharma and Davidson, 2000; Urbatsch et al., 1995b). 
This stoichiometry of the dimer is in contrast to the data presented in this work. For all iso-
lated Mdl1p-NBD dimers two nucleotides were found. Also in the BeFx-trapped state two 
[γ-
32P]ADPs per dimer were obtained. This state contradicts the alternating-site model. The 
biochemical data acquired in this work are supported by observed nucleotide occupancy in 
different crystal structures. In summary three different intermediate states of the ATP hy-
drolysis cycle of the Mdl1p-NBD were isolated, containing two ATPs, one ATP and one 
ADP, or two ADPs. 
Based on the experimental data a processive clamp model was proposed, which is depicted in 
Figure 7.1. As a first step in the ATPase cycle, ATP binds to the monomeric NBD. Since the 
ATP concentrations in the cell (for Mdl1p, in the mitochondrial matrix) are far above the KD 
value determined for ATP binding, almost all of the NBDs would be in the ATP bound state 
under physiological conditions. Upon ATP binding, the NBDs dimerise. This state is in a dy-
namic equilibrium between the association, dissociation as well as hydrolysis of the ATP. 
In the next step, one ATP is hydrolysed. In the experiments with the E599Q mutant, hydroly-
sis of the second ATP could not be observed, because in the ATP/ADP or the ADP/ADP 
bound state, the dimer is unstable and dissociates. In the slow hydrolysis cycle of the E599Q 
mutant, the dissociated monomers are reloaded with ATP and in a next cycle again one ATP 
is hydrolysed. Hydrolysis in the wild-type NBD however is 3,000-times faster and here two 
ADPs can be trapped in the dimer. Chapter 7  Discussion 
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Figure 7.1: A processive clamp model for the ATPase cycle of the NBD from Mdl1p. ATP binding (step 1) on both 
NBD monomers induces formation of the dimer (step 2). After ATP hydrolysis by the first NBD (step 3), either the 
Pi is released first (step 4), followed by hydrolysis of the second ATP (step 5) and release of the second Pi (step 
8), or the second ATP is hydrolysed first (step 6) and then both phosphates are set free (steps 7 & 8; the resulting 
ADP-ADP-Dimer is instable and can only be isolated with the wild-type NDB under trapping conditions). After both 
ATPs are hydrolysed to ADP and both phosphates are released, the dimeric complex dissociates (step 9) and 
ADP (step 10) is released. The hydrolysis cycle can then start again with ATP binding. Not depicted in the figure: 
BeFx or ortho-vanadate trapped the wild-type NBD in the intermediate state with two bound ADPs. Mutation of the 
catalytic glutamate resulted in E599Q-NBD, which under non-hydrolysis conditions was trapped with 2 ATPs 
inside the dimer and under hydrolysis conditions one ADP along with one ATP molecule was incorporated into the 
dimer. 
Based on the much faster kinetics of ATP hydrolysis and the trapping of two ADPs in the 
wild-type NBD, this work suggests that both ATPs be hydrolysed sequentially in one cycle, in 
a processive mode. Finally, after both ATPs are hydrolysed, the dimer disassembles and both 
ADPs are released. 
How exactly such a hydrolysis cycle is coupled to transport of the substrate and conforma-
tional changes of the TMDs, and whether the TMDs superimpose a regulatory effect on the 
NBDs remains unknown and requires further investigations. Smith and colleagues (Smith et 
al., 2002) proposed a possible model for the coupling of ATP hydrolysis to substrate trans-
port. In this model, the TMDs of the non-substrate bound transporter forced the NBDs to re-
main in their monomeric state. Binding of the substrate to the high affinity site in the TMDs 
changes the conformation of the TMDs and removes the restrain on the NBD. Only then the 
ATP-loaded NBDs can form a dimer. Formation of the dimer forces a change on the TMDs 
and displaces the substrate-binding site, which results in transport of the substrate across the Chapter 7  Discussion 
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membrane. Hydrolysis of the ATP and subsequently dissociation of the dimer resets the 
transporter. 
In such a model, which fits to both the crystal structures and the experimental data obtained in 
this work, the formation of the ATP-bound dimer would be the power stroke. This would also 
explain how substrate binding induces ATPase activity by transmission of conformational 
changes between TMDs and NBDs (Chen et al., 2003b; Gorbulev et al., 2001; Neumann et 
al., 2002; van Veen et al., 2000). The mechanism of the coupling of ATP hydrolysis and sub-
strate transport however requires further investigation. Chapter 7  Discussion 
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7.2  Fingerprint of full-length Mdl1p 
In order to see whether the Mdl1p transport complex is associated with other proteins in the 
inner mitochondrial membrane the YLR188W strain expressing Mdl1p fused to the tandem 
affinity tag (Rigaut et al., 1999) was used in this work. To prevent false positive association 
of proteins simply because one of them is expressed in high amounts all proteins should be 
expressed via the intrinsic wild-type promoter. Unfortunaly Mdl1p is expressed in such low 
amounts that it is not visible in Coomassie or silver stained gels. Hence, no interaction part-
ners of Mdl1p could be identified using this method. 
ABC transporters residing in the inner mitochondrial membrane are challenging to analyse 
due to the complex two membrane architecture of mitochondria, the high membrane protein 
content of all kind of proteins with high affinity to ATP and many different other “transport-
ers”. Hence, to study the structure, function, and mechanism of Mdl1p at molecular level, it is 
necessary to have the protein in a pure and active form. By systematic screens, the homolo-
gous over-expression of Mdl1p was established and the first fingerprint of Mdl1p is presented 
in this work. The galactose controlled expression system was successfully used to reach 100-
fold over-expression of Mdl1p. The transporter was purified to homogeneity via one step af-
finity chromatography and the expressed protein was functional in respect of ATP hydrolysis. 
Furthermore, Mdl1p was reconstituted into liposomes preserving its activity. 
Two prokaryotes were selected for expression: (i) the gram-negative E. coli and (ii) the gram-
positive L. lactis but in none of them high levels of Mdl1p were reached. It is tantalising to 
speculate that the different lipid composition in these organisms compared to the inner mito-
chondrial membrane prevent accurate membrane insertion. Here cardiolipin was pointed out 
to provide essential function for structural maintenance of inner mitochondrial membrane 
proteins e.g. the cytochrome bc1 complex (Lange et al., 2001), which is missing in the expres-
sion hosts. In addition, improper targeting might play a role since Mdl1p is predicted to have 
an N-terminal leader sequence, which was deleted in the prokaryotic expression cassettes. 
Recently, an approach for heterlogous expression of Atm1p – another ABC transporter in the 
inner mitochondrial membrane of S. cerevisiae – was suggested to be a general strategy for 
the recombinant production of ABC transporters especially for mitochondrial ABC transport-
ers (Kuhnke et al., 2006). In this study a fusion gene containing the sequence of the OmpA 
signal peptide an octa-His-tag the ATM1-gene without the first 26 codons and a C-terminal 
Strep-tag II was used. Atm1p was expressed in an E. coli strain lacking the two major prote-
ases Lon and OmpT. For expression “standard” conditions were used meaning growth at 37 
°C in LB-medium. The purified product was processed yielding a protein without the OmpA 
signal peptide, the His-tag and part of Atm1p. The protein was analysed in regard to ATP 
hydrolysis both in detergent and reconstituted into proteoliposomes and displayed significant 
activity. Interestingly the ATPase activity of solubilised Atm1p was stimulated 5-fold upon 
the addition of cardiolipin emphasising the crucial role of this lipid for proteins of the inner Chapter 7  Discussion 
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mitochondrial membrane. According to the authors, a major benefit using this strategy com-
pared to a homologous expression of Atm1p with a Strep-tag II was the amount of protein 
obtained. In S. cerevisiae the yield was 50 µg/L culture where it increased 20-fold to 0.4 – 1 
mg/L using E. coli. It is interesting whether this approach is sufficient for heterlogous expres-
sion of Mdl1p and seems to be worth to try. 
Another striking observation is the fact that homologous over-expression of Mdl1p is not 
achieved by using strong constitutive promoters. This is underlined by the observation that 
even after specifically controlled expression Mdl1p yields decrease drastically after 12 hours 
of induction. The protein does not seem to be toxic for the cells as growth continues without 
significant phenotype while Mdl1p is expressed via a GPD-promoter. Whether Mdl1p disap-
pears due to transcriptional or translational regulation or due to simple degradation of excess 
protein is yet unclear. In conclusion, homologues expression only worked by switching from 
constitutive strong promoters to the inducible GAL1-system. 
Solubilisation of membrane proteins means that they are extracted from their natural sur-
roundings and that the lipid bilayer is exchanged by an artificial environment of the detergent 
micelle (Poolman and Konings, 1993). The choice of the detergent used for the solubilisation 
and purification of membrane proteins is critical (Knol et al., 1998; Knol et al., 1996) in par-
ticular for proteins from the inner mitochondrial membrane due to its special lipid composi-
tion. At least two aspects must be fulfilled by the detergent: (i) reasonable protein amounts 
must be extractable from the membrane which is best done by tetradecylphosphocholine (FC-
14) in the case of Mdl1p. (ii) More important yet is the activity of Mdl1p which is shown to 
be strongly affected by the type of detergent used. The data of this work show that Mdl1p 
keeps a significant ATPase activity after purification in 0.1 % digitonin, demonstrating that it 
remains folded in an active state whereas the zwitter-ionic detergent tetradecylphosphocholine 
almost destroys the ATPase activity of Mdl1p. The presence of n-dodecyl-β-D-maltoside in 
the 
ATPase experiments drastically decreased ATP hydrolysis of Mdl1p. Strikingly, this deter-
gent was recently reported to preserve the ATPase activity of the ABC transporter Atm1p 
from the inner mitochondrial membrane of S. cerevisiae to a certain extend when stored over-
night and compared to n-octyl-β-D-glucoside or Hecameg (digitonin was not tested in this 
study) (Kuhnke et al., 2006). Digitonin was reported to keep mitochondrial protein formations 
and its higher oligomers e.g. complexes III, IV and V of the respiratory chain in a stable and 
active form (Schägger and Pfeiffer, 2000). Hence, digitonin is the detergent of choice for pro-
tein electrophoresis under native conditions. Since ATPase activity of Mdl1p was preserved 
in digitonin, it was used in the following experiments. 
In order to determine the apparent binding constant of ATP for Mdl1p, 8-azido[α-
32P]ATP 
photocross-linking experiments were performed, in which 8-azido[α-
32P]ATP is a competitive 
substrate for ATP with a similar specificity constant (kcat/KM) as ATP. Remarkably, the appar-
ent dissociation constant of MgATP of 0.26 μM for Mdl1p was obtained. This value is 2 to 3 Chapter 7  Discussion 
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orders lower than that of other ABC transporters (Horn et al., 2003; Lapinski et al., 2003; Qu 
et al., 2003; Wolters et al., 2005). Since the ATP concentration inside the matrix is in the 
lower millimolar range (1 – 5 mM; Prof. U. Brandt, Medical School, Goethe-University 
Frankfurt, personal communication) Mdl1p is always “loaded” with ATP. The KM(ATP) of 850 
µM, which is more than 3,000 times higher than KD(ATP) implies that ATP-binding and ATP-
hydrolysis are different steps which are independent from each other. It is possible that hy-
drolysis is triggered by an external signal e.g. substrate binding. 
As shown in this work on the isolated NBD of Mdl1p, ATP binding induces a conformational 
change of the NBD enabling the dimerisation of the catalytic domain, which is the first step in 
ATP hydrolysis and substrate transport. In competition assays with 8-azido[α-
32P]ATP, using 
solubilised full-length Mdl1p, the nucleotide specificity was alighted and the following order 
was obtained: ATP as the physiological substrate shows the highest affinity for Mdl1p 
whereas ADP, AMP-PNP, CTP, UTP and GTP have an intermediate affinity. This demon-
strated that the isolated solubilised full-length Mdl1p binds nucleotides with a similar affinity 
as the isolated NBD, suggesting that the TMDs do not affect the nucleotide-binding step. 
AMP-PNP, the non-hydrolysable ATP analogue, also bound with a reduced affinity, further 
demonstrating previous observations, that AMP-PNP does not mimick ATP binding perfectly. 
Other studies (Nikaido et al., 1997; Sharma and Davidson, 2000) as well have demonstrated 
that AMP-PNP binds with a reduced affinity, and indeed AMP-PNP can not induce dimerisa-
tion of the NBDs. 
AMP displays a very low affinity as expected and did not compete with 8-azido-ATP-binding. 
This is important in view of publications which showed that CFTR has an adenylate kinase 
activity (Gross et al., 2006). Since Mdl1p does not bind AMP, it is clear that this is not a gen-
eral property of ABC proteins. 
In summary, Mdl1p can be energised by different nucleoside triphosphates. This broad speci-
ficity is also found for other ABC transporters (al-Shawi and Senior, 1993; Meyer et al., 1994; 
Müller et al., 1994) and results only from a π-π interaction between the base of the nucleotide 
with the NBD (Hung et al., 1998). 
Purified Mdl1p shows a high ATPase activity (2.1 µmol * min
-1 * mg
-1). To proof that the 
observed activity was derived from the purified protein and not from another ATPase which 
was copurified in very low amounts two ATPase deficient mutants were used. The E599Q 
mutant of the conserved glutamine one amino acid downstream of the Walker B motif showed 
already in the soluble NBD a 3,000-fold lowered ATP hydrolysis activity. The mutation of the 
histidine in the H-loop of different ABC transporter NBDs (Davidson and Sharma, 1997; Ni-
kaido and Ames, 1999; Shyamala et al., 1991; Zaitseva et al., 2005c) led to proteins that 
showed almost no ATPase or transport activities. 
The E599Q and H631A mutant of full-length Mdl1p were able to bind ATP but were defec-
tive in ATP hydrolysis. This demonstrated that these mutants behave in a similar manner as in Chapter 7  Discussion 
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the isolated NBDs, and that the above observed ATPase activity resulted from purified 
Mdl1p. The activity of the full-length protein is much higher then the activity of the isolated 
NBD at similar concentrations. Remarkably, the activity of the isolated NBD was strongly 
dependent on the NBD concentration where it was independent of the concentration in the 
full-length protein. This showed that the association rate of the NBDs is not rate-limiting in 
the full-length protein most likely because of the high local concentration of the NBDs in the 
full-length transporter due to their close vicinity. 
In vivo complementation studies described by Chloupková and colleagues (Chloupková et al., 
2003) where used to further analyse the E599Q and H631A mutant in a more natural envi-
ronment. ΔATM1 cells show a strong growth defect that can be overcome by over-expression 
of Mdl1p. Since the influence of different yeast strains and selection markers should be ex-
cluded the same strains and plasmids applied in the report above were used (kindly provided 
by M. Chloupková, Portland OR). The only change was made by introducing the point muta-
tions in the MDL1-gene. No rescue of the ΔATM1 phenotype was achieved with the E599Q 
and H631A mutant of Mdl1p (S. Gompf, Institute of Biochemistry, Goethe-University Frank-
furt; personal communication). This is in line with the observation that an ATPase deficient 
ABC transporter in vitro leads to an non-functional transporter in vivo. 
The observed activity of Mdl1p is higher than activities reported for the majority of ABC 
transporters e.g. MRP (0.46 µmol * min
-1 * mg
-1, (Chang et al., 1997), MsbA (0.04 – 0.15 
µmol * min
-1 * mg
-1, (Doerrler and Raetz, 2002) or BmrA (1.2 µmol * min
-1 * mg
-1, (Ravaud 
et al., 2006). Only Atm1p which like Mdl1p is an ABC transporter of the inner mitochondrial 
membrane showed a similar turn over of 127 * min
-1 (1.9 µmol * min
-1 * mg
-1) (Kuhnke et al., 
2006) compared to 150 * min
-1 in case of Mdl1p. It is possible that the high activity of Mdl1p 
is caused by a stimulating factor e.g. the substrate or a certain lipid e.g cardiolipin (s. above) 
that is bound to the protein during purification and still present in the ATPase assay. 
The ATPase activity of Mdl1p was measured in the presence of DTT. DTT, glutathione and 
β-mercapthoethanol slightly stimulate the ATPase activity of Mdl1p about 1.3-fold (Ariane 
Zutz, Institute of Biochemistry, Goethe-University Frankfurt, personal communication). A 
similar stimulation of the ATPase activity by DTT was seen in P-glyoprotein 
(MDR1/ABCB1) (Urbatsch et al., 2000a; Urbatsch et al., 2000b). Mdl1p has five non-
conserved cysteines: one in the putative targeting sequence, which is cleaved off in the func-
tional transport complex, one in TMH 4 and three in non-conserved regions of the NBD. 
Whether the stimulatory effect of DTT is due to reduced cysteines and opend disulphide 
bridge(s) in Mdl1p is not yet clear. 
In a recent report the influence of different thiolgroup-containg compounds on the ATPase 
activity of Atm1p was investigated in more detail (Kuhnke et al., 2006). At millimolar con-
centrations of glutathione, cysteine, cysteinyl-glycine and DTT stimulated the ATP hydrolysis 
3.5 to 5-fold. The oxidised forms of the chemicals did not increase the ATPase activity. Cys-Chapter 7  Discussion 
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teine thiol groups in peptides already increased the ATPase activity at micromolar concentra-
tions suggesting that in addition to the thiol groups Atm1p recognises the peptide backbone. 
Since Mdl1p is a high copy suppressor of the Atm1p knock-out phenotype it would be inter-
esting whether these substrates influence the ATPase activity of Mdl1p. 
Surprisingly, no occluded state with two nucleotides (2 ATPs, 1 ATP and 1 ADP or 2 ADPs) 
trapped inside Mdl1p could be isolated using the H631A full-length Mdl1p mutant as it was 
found for the isolated E599Q mutant NBD. Since ATP binding is not changed in the full-
length transporter this observation can be explained by a much faster off-kinetic in case of 
full-length Mdl1p meaning that the nucleotides are lost on the way through the gel filtration 
column (45 – 60 min). 
In this work purified Mdl1p was used for structural analysis via single particle electron mi-
croscopy. Single particle analysis has successfully been applied to other ABC transporters 
demonstrating the power of this method already for particles below 750 kDa. The Mdl1p 
preparation method uses digitonin to extract the protein from the membrane, affinity purifica-
tion, and a step via size exclusion in order to obtain a monodisperse preparation. This proce-
dure yields suitable Mdl1p particles ready for a first structure determined via SPA. 
Although conformation by fitting and further analysis of the present data needs to be done in 
the single particle analysis Mdl1p appears to be in a dimeric state in digitonin since the di-
mensions of the particle of 125 x 110 x 95 Å
3 are most likely to small for a dimer of a dimer 
and to large for a monomer. Since the protein is active in ATP hydrolysis in this detergent the 
minimal functional unit of Mdl1p is a dimer as it was already concluded from the Mdl1p-
NBD data. Interestingly, there are different particles obtained for different ABC transporters. 
The full-size transporters MRP1, Pdr5p and CFTR gave particle dimensions which fit to 
(homo) dimers whereas in particles of P-glycoprotein which is a full-size transporter only a 
monomer can be imagined. Similar sizes were obtained for the half-size transport complex 
TAP1/TAP2 and YvcC implicating heterodimeric or homodimeric structures respectively. 
In a further step it would be interesting to see whether a modified preparation for SPA adding 
lipids and a subsequent detergent removal step with Bio-beads leads already towards 2D crys-
tallisation (refer to chapter of reconstitution). Possibly this method would result in Mdl1p-
lipid patches like it was shown for YvcC. Therefore, this work shows a first glimpse of a mi-
tochondrial ABC transporter and understands it self as a step towards high resolution 3D 
structure determination giving not only insights to the mode of action of Mdl1p but in addi-
tion uncovers its natural substrate. 
Mdl1p was reconstituted into DDM destabilised proteoliposomes prepared from E. coli lipids. 
The method has been successfully used for the functional reconstitution of a variety of trans-
porters (Driessen et al., 1988; Knol et al., 1996; Patzlaff et al., 2003; Poolman et al., 2005). 
Reconstituted Mdl1p shows 85 % of the ATPase activity as observed for the digitonin solubi-
lised protein confirming that Mdl1p is stable during the reconstitution procedure. In addition, Chapter 7  Discussion 
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this result indicates that a significant fraction of Mdl1p is reconstituted with the NBDs facing 
to the outside. Under the assumption that the ATPase-activity of Mdl1p did not change in the 
lipid environment a inside-out orientation of most of the protein can be implied which makes 
the proteoliposomes suitable for uptake experiments. 
Strikingly, no transport activities for peptides included in combinatorial X(8) or X(23) peptide 
libraries could be detected with this system. Either this is due to the fact that Mdl1p has rather 
high substrate specificity and this explicit peptide(s) is/are underrepresented in the peptide 
pool of the libraries and hence not detectable in the uptake studies. Alternatively, the substrate 
of Mdl1p is not only a set of peptides but also more complex. This speculation would fit into 
the context that for example ABC-me a homologue of Mdl1p in mice erythrocytes is up regu-
lated upon increased heme biosynthesis (Shirihai et al., 2000). In this case, the peptide servers 
as a kind of chaperone for a potential intermediate in the course of heme biosynthesis and 
Mdl1p would function as a linker between the two compartments of heme synthesis namely 
the mitochondrial matrix and the cytosol. 
Another explanation for the negative result in the transport assay with purified reconstituted 
protein might be the C-terminal manipulation of Mdl1p by the octa-His-tag. In vitro assays 
performed in this study clearly showed Mdl1p to be active in ATP hydrolysis. Complementa-
tion assays where Mdl1p is used to overcome the phenotype of a Atm1p knock-out indicate 
that only the wild-type but not the His-tagged version is able to substitute Atm1p (S. Gompf, 
Institute of Biochemistry, Goethe-University Frankfurt; personal communication). Both re-
sults indicate that ATP hydrolysis is a very robust property of ABC transporters conserved in 
vitro but the whole transport process might be much more fragile. This is in line with the ob-
servation that already subtle changes at the C-terminal end of the ABC transporter TAP lead 
to transport deficient mutants (Ehses et al., 2005). 
In this context another remark needs to be considered. Mdl1p was suggested to be a peptide 
transport using a rather indirect method. Different supernatants were compared in respect of 
[
35S]-methionine labelled peptides exported from mitochondria. Since Mdl1p resides in the 
inner membrane one can imagine a processing of the substrate transported by Mdl1p in the 
inter membrane space. Hence, the identified peptides outside in the supernatant can be dra-
matically misleading especially concerning the length of the peptide. 
In order to decrease the complexity of a whole transport event in a reconstituted system an-
other experiment was used to approach the substrate specificity of Mdl1p. Solubilised Mdl1p 
was tried to be cross-linked with UV-light activated peptides. The advantage of the photo-
cross-linking approach is that even transient interactions between substrate and Mdl1p can be 
detected and a accumulation of this product is achieved. Unfortunaly promising results where 
a 9mer peptide mimicking the C-terminal end of Cox1p was specifically cross-linked to 
Mdl1p were not reproducible. Peptides of a Cox1p homolog in mouse were found on cell sur-
faces presented by MHC class I molecules (Fischer Lindahl et al., 1991) meaning that these 
minor antigens need to be transported from the mitochondrial matrix to the ER lumen. There-Chapter 7  Discussion 
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fore, it was speculated that a similar pathway might exist using Mdl1p even so that S. cere-
visiae lacks an immune system. 
Finally, the peptide export experiments based on a in organello translation set-up did not 
show significant differences between Mdl1p containing mitochondria and organelles lacking 
the ABC-transporter. This is in contrast to data published by Young and colleagues (Young et 
al., 2001). Here differences in culturing the cells e.g. harvesting the cells at different ODs and 
therefore at different timepoints in the cell life cycle or subtle differences during assay han-
dling might account for this discrepancy since the reported effects in ΔMDL1 cells are tiny. 
Several computational analysis predicted Mdl1p to contain a presequence for mitochondrial 
targeting and inner membrane insertion (Claros and Vincens, 1996). Based on these data two 
constructs lacking the first 59 and 68 amino acids respectively were generated in order to test 
the ability to switch the insertion of Mdl1p from the inner mitochondrial membrane to the 
endoplasmatic reticulum or the plasma membrane. Immuno-gold labelling experiments con-
firmed the localisation of Mdl1p in the ER membrane (Gompf et al., 2006). This approach is 
based on the idea to analyse the transport activity of Mdl1p in simpler environment compared 
to the situation inside the mitochondrion. 
Microsomes prepared from wildtype BY4743, ΔYll048c and ΔYll048c cells expressing 
Δ68Mdl1p where used for uptake experiments (a modified assay is described in chapter 
5.2.23). Various radiolabelled peptide libraries containing 5 to 23 amino acid residues, and 
the peptide R9LQK, which is a model peptide for the TAP transporter were used but no 
Mdl1p specific accumulation was detected indicating that no transport occurred. As a further 
remark these libraries did also not stimulate ATP hydrolysis of digitonin solubilised Mdl1p 
later on (A. Zutz, Institute of Biochemistry, Goethe-University Frankfurt; personal communi-
cation). The same was true for the 6, 9 and 12 amino acid residues long peptides T8, T9, T10 
whose sequences were deduced from findings that formylated peptides were found in com-
plex with class I major histocompatibility molecules at the surface of mammalian cells as mi-
nor antigens derived from mitochondrial encoded respiratory chain subunits (Fischer Lindahl 
et al., 1991) e.g. subunit I of cytochrome c oxidase. To test the possibility that Mdl1p is in-
volved in the heme-biosynthesis pathway shuttling intermediate products from the matrix to 
the cytosol [
14C]aminolevulinic acid was used in transport experiments using microsomes 
with Δ68Mdl1p, but again no transport was observed (S. Gompf, Institute of Biochemistry, 
Goethe-University Frankfurt; personal communication). 
As mentioned above mitochondrial targeting is often mediated through N-terminal leader se-
quences consisting of up to 105 residues highly enriched in basic, hydrophobic and hydroxy-
lated amino acids (Graf et al., 2004; Neupert, 1997). Also much less is known about sequence 
and structure of internal mitochondrial targeting signals such internal leader sequences have 
been observed e.g. for the ATP/ADP carrier or the oxoglutarate carrier (Kubrich et al., 1998; 
Palmisano et al., 1998). In addition, such a internal signal for targeting was discussed for Chapter 7  Discussion 
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Mdl1p in a recent report (Janas, 2002). To answer the question of the targeting sequence puri-
fied Mdl1p was analysed by N-terminal sequencing (Edman degradation) in this work. The 
sequence, which was obtained by this approach, continued on position 60 of the original 
Mdl1p sequence meaning that the protein is cleaved after amino acid 59. In combination with 
the immuno-gold labelling results of yeast cells expressing a Δ59 version of Mdl1p that is 
found in the endoplasmatic reticulum (Gompf et al., 2006) a N-terminal targeting sequence of 
59 amino acids can be assumed for Mdl1p. In two out of three sequences the first amino acid 
revealed by Edman degradation is a glutamate instead of a glutamine which is found in the 
original Mdl1p sequence at position 60. So far, no modification by the cleavage enzyme in the 
mitochondrion turning a carbonyl function to an amine group is described so far. However, 
there is a chance caused by the sequencing procedure itself that in each step approximately 
10  % of glutamine turns into glutamate (Prof. H. Schägger, Medical School, Goethe-
University Frankfurt, personal communication) 
The in organello translation assay established in this work was used to synthesise the sub-
strate of Mdl1p by its natural source. The supernatant after such an assay and subsequent pro-
teolysis was used for uptake assays using proteoliposomes and inverted membrane vesicles 
(IMVs) generated from mitochondria. The IMVs were shown to contain Mdl1p with the 
NBDs facing to the outside serving the basis for import studies (S. Gompf, Institute of Bio-
chemistry, Goethe-University Frankfurt; personal communication). Again no significant 
transport of the [
35S]-methionine-labelled peptides were measured. 
To summarise all experiments (which are: peptide cross-linking, stimulated ATP hydrolysis, 
peptide transport assays with proteoliposomes and microsomes containing an Mdl1p variant 
and IMVs plus substrate generated by in organello synthesis) performed in order to reveal the 
potential substrate of Mdl1p and to illuminate its physiological role as a peptide transporter 
somehow missed a clear positive answer. 
More drastically the peptide export assay described by Young and colleagues (Young et al., 
2001) (that pointed Mdl1p out be a peptide exporter) established in this work did however not 
confirm the differences in the pattern of exported peptides between mitochondria containing 
Mdl1p and mitochondria lacking the transporter. Therefore, the role of Mdl1p as a “simple” 
peptide exporter from the mitochondrial matrix to the intermembrane space should be recon-
sidered. A complex situation like the one which is found for Mdl1p potentially bares a com-
plex substrate. Chapter 7  Discussion 
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7.3 Outlook 
To current knowledge, the expression of a mitochondrial ABC transporter to a level as high as 
1 % of total membrane protein, as obtained in this study, has not been reported so far. Addi-
tionally this study provides an efficient procedure to obtain highly purified Mdl1p, function-
ally reconstituted into liposomes prepared from E. coli lipids. The availability of straightfor-
ward methods for over-expression and purification of Mdl1p, and the ease of DNA manipula-
tion due to the gene cassette approach provide the basis for future studies on structure and 
function of Mdl1p. 
It is now feasible to resolve the transport function and substrate specificity of the protein 
complex in vitro and to investigate the molecular mechanism by which ATP binding and ATP 
hydrolysis drive solute translocation. 
Furthermore, the chemo-mechanical coupling between the two motor domains and the trans-
membrane domains can now be studied by different biochemical and biophysical methods. 
Finally, the reported expression and purification procedure is a basis to determine the struc-
tural organisation of the homodimeric Mdl1p complex including its membrane topology, the 
architecture of the translocation pore and potential substrate-binding sites. 
To identify the substrate specificity and transport function of Mdl1p, an in organello transla-
tion assay with isolated mitochondria was established. Here, the mitochondria-encoded genes 
are translated and labelled with [
35S]-methionine. These translation products are degraded by 
AAA proteases. The export of radiolabelled fragments from mitochondria isolated from 
ΔMDL1, wild-type and Mdl1p over-expressing strains can now be examined in more detail 
especially by mass spectrometry. In parallel, the accumulation of degradation products in 
Mdl1p positive and negative mitochondria can be compared. 
Furthermore in organello translation provides an elegant way of synthesising the potential 
substrate of Mdl1p in an already labelled way. This way the substrate can be exported from 
Mdl1p-containing mitochondria after in organello translation into the supernatant and recov-
ered from there or it is kept inside the matrix of mitochondria lacking Mdl1p. 
To test the alternative hypothesis if Mdl1p is involved in transport function related to iron 
homeostasis or heme biosynthesis mitochondria can be exposed through various radioactive 
compounds e.g. iron or organic precursors and the trace can be followed throughout the ex-
ported material. Comparison of mitochondria isolated from ΔMDL1, wild-type and Mdl1p 
over-expressing strains may shed light on the physiological role of Mdl1p.  
Another technique to identify compounds transported by Mdl1p might be a test for stimulated 
ATPase activity like it was shown for several ABC transporters (Borths et al., 2005; Gorbulev 
et al., 2001). This setup uses the circumstances that ABC transports display a much higher 
turn-over rate of ATP hydrolysis in the presence of the (bound) substrate. This approach can Chapter 7  Discussion 
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be applied to reconstituted Mdl1p as well as to solubilised protein in a simpler design. Basi-
cally a whole catalogue of (hydrophobic) substances can be screened this way. 
As depicted above, ATP binding induces dimer formation of the NBDs. By means of site-
directed mutagenesis of catalytic residues (e.g. E599Q) or trapping reagents (BeFx or ortho-
vanadate), a dimer with two nucleotides bound can be arrested. Since it turned out to be more 
complicated to transfer this experiment to the full-length protein monitoring of catalytic proc-
esses upon ATP binding needs a different attempt. One possibility is site-specific labelling of 
the transporter by fluorescent adaptors. The fluorophores bind to the C-terminus of each nu-
cleotide-binding domain via Ni
2+-NTA-groups (van der Does et al., 2006), which, based on 
biochemical and structural data of other ABC transporters, undergo large conformational 
changes during the transport cycle. Thus, ATP-induced dimer formation also in the 
homodimeric Mdl1p complex reconstituted into liposomes should be followed by homo-
FRET or fluorescence quenching. 
One of the key questions concerning primary transporters is how the energy of binding and 
hydrolysis of ATP is transferred to substrate translocation. Based on structural and biochemi-
cal similarities with secondary transporters, it was proposed that ABC transporters function 
via an alternating access model, where formation of an ATP-sandwiched dimer of the NBDs 
results in transfer of the substrate across the membrane (van der Does and Tampé, 2004). To 
validate this model, conformational changes within the TMDs dependent on ATP binding or 
hydrolysis need to be identified. Guided by the MsbA structure from Vibrio cholera (Chang, 
2003) or S. typhimurium (Reyes and Chang, 2005) cysteines will be introduced in TM2 and 
TM5 of Mdl1p, which are possibly located on the dimer interface. A cysteine-less Mdl1p has 
already been created by replacing all five cysteines to alanines or serines. After expression of 
single-cysteine mutants, a screen for disulphide cross-linked Mdl1p monomers after addition 
of copper o-phenanthroline or thiol-specific cross-linkers with different spacer lengths can be 
performed. Furthermore, it can be determine how ATP binding, dimer formation, or possibly 
substrate binding in wild-type and mutant Mdl1p (E599Q, H631A, etc.) modulates the identi-
fied contacts with the transmembrane domains. The accessibility of single-cysteine residues 
toward thiol-specific reagents at different stages of the translocation cycle will be examined. 
These studies will provide important information regarding to conformational changes within 
the transporter and help to identify the step where the energy stored in the NBD is transferred 
to the TMDs. In order to study the interaction between the NBDs and the TMDs, cysteine-
scanning mutagenesis will be applied. Based on homology modelling, cysteines will be in-
serted on the transmission interface of the NBDs, which will be able to form disulphide cross-
links after oxidation with copper o-phenanthroline or thiol-specific cross-linkers. Again, 
whether these cross-links are modulated by different transport conditions will be investigated. 
The reconstitution of Mdl1p was optimised, and 85 % of the protein is oriented with the NBD 
facing the outside according to the ATP hydrolysis data assuming that no activity of Mdl1p is 
lost or stimulated in the liposomes. However, a direct proof of the orientation is still waiting. Chapter 7  Discussion 
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To answer this question one can use protease protection assays in which the His-tag is cleaved 
off by Factor Xa (a cleavage-site lies between the C-terminal end of Mdl1p and the His-tag). 
Exact quantification can be achieved by taking fully solubilised proteoliposomes as back-
ground and non-cleaved proteoliposomes as a 100 % value. To optimise reconstitution, the 
effect of different lipids on the ATPase activity can be systematically analysed. 
Single particle EM pictures already made the entry into structure determination of Mdl1p. For 
higher resolution, attempts will be made to reconstitute Mdl1p at high protein-to-lipid ratios, 
to thus obtain 2D crystals. These 2D crystals will also be studied by negative stain and cryo 
electron microscopy. After optimising the over-expression and purification, sufficient protein 
amounts are available to start the study of the 3D structure of the Mdl1p complex. A long-
term objective might be structure determination of the transport complex Mdl1p by x-ray 
analysis. Within the last years, significant achievements have been made in the structural 
analysis of various bacterial transporters. However, eukaryotic transporters, in particular ex-
pressed at low levels, are still a challenge in structural biology. A necessary step here is to 
scale up the expression to high volume fermentation Also the solubilisation and purification 
procedure might need to be further adapted for this purpose. 
A last proposal in order to reveal the physiological role of Mdl1p includes the fact that yeast 
mitochondria contain a non-proteinaceous pool of copper in the matrix (Cobine et al., 2004) 
and serve as copper storehouse. Copper is essential for several enzymes but excess accumula-
tion of copper results in toxicity since it is used as fungicide, molluscide and algicide. Balanc-
ing of copper in different cell compartments must be attained to minimise deleterious effects. 
Moreover, copper distribution must be very flexible to adapt the cell to different environ-
mental influences. In yeast copper ions are required for at least three key enzymes: the cytoso-
lic superoxide dismutase Sod1p, the plasma membrane enzyme ferroxidase Fet3p and the mi-
tochondrial inner membrane enzyme cytochrome c oxidase. Therefore, it is obvious that ex-
change of copper between the cytosol and the matrix and vice versa must occur. How copper 
is exported from the matrix is unknown so far. To prevent free copper ions it is likely that it is 
chelated e.g. by a peptide with a coordination site composed of several cysteines. It is alluring 
to speculate whether Mdl1p can be the pathway for such a copper chelater complex. This 
would be an elegant way to combine the following observations: (i) Mdl1p is involved in the 
export of peptides between 6 and 20 amino acids from the mitochondrial matrix, (ii) Mdl1p 
can substitute Atm1p function, (iii) Mdl1p plays a role in resistance to oxidative stress and 
(iv) Atm1p is stimulated by cysteine (thiol group) containing peptides in the area of 16 amino 
acids. 
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8 Abbreviations 
ABC ATP  binding  cassette 
AAA  ATPases associated with a variety of cellular activities 
ABCA  ABC transporter subfamily A 
ABCB  ABC transporter subfamily B 
ABCC  ABC transporter subfamily C 
ABCD  ABC transporter subfamily D 
ADP   Adenosine diphosphate 
ALDP Adrenoleukodystrophy 
AMP Adenosine  monophosphate 
APS Ammonium  peroxodisulphate 
Atm1p  IMM ABC transporter exports precursors of Fe/S-clusters 
ATP   Adenosine triphosphate 
BCA Bicinchonic  acid 
BSA  Bovine serum albumin 
BtuCD Vitamin  B12 import system permease 
C12E8  Octaethylene glycol monododecyl ether 
CFTR  Cystic fibrosis transmembrane conductance regulator 
CMC  Critical micelle concentration 
Cox  Subunit of cytochrome c oxidase 
Cta1 Catalase  A 
CTP Cytosine  triphosphate 
CysA  Sulphate transport ATP-binding ABC transporter protein 
Da Dalton 
DDM  n-Dodecyl-β-D-maltoside 
DMF Dimethylformamide 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic  acid 
Dpp  Dipeptide ATP binding/permease complex 
DtpT Di-/tripeptide  transporter 
DTT   1,4-Dithio-DL-threitol 
E. coli  Escherichia coli 
EDTA   1-(4-Isothiocyanatobenzyl)ethylenediamine-N,N,N',N'-tetraacetic acid 
EGTA Ethylene  glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
ER Endoplasmic  reticulum 
ERp57  Protein disulphide isomerase-associated 3 
FC-14 Tetradecylphosphocholine 
Fhu  Ferrichrome ATP transport complex 
FtsY  Cell division protein 
g  Gram or gravity constant 
GIP  General import pore 
GlcSTUV2  Glucose transport ABC complex 
GTP Guanosine  triphosphate 
h hour 
H(10) deca-His-tag 
H(6) hexa-His-tag 
HEGA-10 Decanoyl-n-hydroxyethylenglucamide Chapter 8  Abbreviations 
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HEPES   N-(2-hydroxyethylpiperazine)-N´-2-ethanesulfonic acid 
HisQMP2  Histidine transport ABC complex 
HlyA/B  α-Hemolysin/translocation ATP permease 
HPLC  High performance liquid chromatography 
IDA Iminodiacetic  acid 
IMAC Immobilised  metal  affinity  chromatography 
IMM  Inner mitochondrial membrane 
IMS Intermembrane  space 
IPTG   Isopropyl β-D-thiogalactopyranoside 
kb kilo  base 
kcat  Catalytic constant 
KD  Dissociation constant 
KM  Michaelis-Menten constant 
L liter 
L. lactis  Lactococcus lactis 
LB Luria-Bertani 
Leu1p Isopropylmalate  isomerase 
LiAc Lithium  acetate 
LmrA  Multidrug ABC exporter (Lactococcus lactis) 
LPS Lipopolysaccharide 
m meter 
M mol/L 
MALDI  Matrix-assisted laser desorption/ionization 
MalFGK2  Maltose transport ABC complex 
Mdl1p  Multi-drug resistance like protein 1 
MDR Multidrug  resistance 
MHC  Major histocompatibility complex 
min minute 
MOPS 3-(N-Morpholino)propanesulfonic  acid 
MRP  Multi-drug resistant protein 
MS Mass  spectrometry 
MsbA  Lipid A export ATP binding/permease protein 
mt mitochondrial 
NBD Nucleotide-binding  domain 
o/n overnight 
OD Optical  Density 
OG  n-Octyl-α-D-glucopyranoside 
OMM  Outer mitochondrial membrane 
Opp  Oligopeptide ATP binding/permease complex 
PAGE  Polyacrylamide gel electrophoresis 
PAM  Presequence translocase associated motor 
PBS Phosphate  buffered  saline 
PCR  Polymerase chain reaction 
PDR  Pleiotropic drug resistance 
PEG Poly(ethylene  glycole) 
pH Potentia  hydrogenii 
Pi Inorganic  phosphate 
PMF  Proton motive force 
PMSF Phenylmethanesulfonyl  fluoride Chapter 8  Abbreviations 
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Rad50  DNA double-strand break repair ATPase 
RbsA  Ribose transport ATP-binding protein 
Rli  RNase L inhibitor 
RNA Ribonucleic  acids 
RNC  Ribosome nascent chain complex 
rpm Rounds  per  minute 
RT room  temperature 
s second 
S. cerevisiae  Saccharomyces cerevisiae 
SAM  Sorting and assembly machinery 
SBP  Substrate binding protein 
SC(D)  Synthetic complete (dextrone)/ sodium cholat 
SDS  Sodium dodecyl sulphate 
Sec/SEC  Membraneprotein “secretion” system/ Size exclusion chromatography 
SPA  Single particle analysis 
SRP  Signal recognition particle 
Ste6  Mating factor A secretion protein 
TAP  Transporter associated with antigen processing 
Tat  Twin arginin translocation complex 
TBS(T)  Tris buffered saline (Tween) 
TCA/TFA  Trichloroacetic acid/ Trifluoroacetic acid 
TDAO n-Tetradecyl-N,N-dimethylamine-N-oxide 
TEMED N,N,N’N’-Tetramethylethylenediamine 
TIM/TOM  Translocase of inner/outer membrane 
TMD Transmembrane  domain 
TMH Transmembrane  helix 
TOF  Time of flight 
TolC  Type I secretion channel of the outer membrane 
Tris Tris-(hydroxymethyl)-aminomethane 
Tween 20  Polyoxyethylenesorbitan monolaurate 
UTP Uridine  triphosphate 
UV Ultraviolet 
V Volt 
Var1  Mitochondrial ribosomal protein of the small subunit 
Vi Inorganic  vanadate 
vmax  Maximum reaction velocity 
W Watt 
wt   wild-type 
YEPD  Yeast peptone dextrone 
Yme1  Subunit of the mitochondrial inner membrane i-AAA protease 
Yta10  Component of the mitochondrial inner membrane m-AAA protease Chapter 9  References 
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